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2 Abstract 
Nanotechnology offers vital tools for cancer diagnosis, early detection and 
novel treatments. Gold nanoparticles (AuNPs) are at the forefront of biological 
and biomedical research and show an increased promise in targeted cancer 
therapy due to their unique physicochemical properties. They offer the advantage 
of biomolecular interaction both at the cell surface level and inside the cell.   
In this thesis, 2nm AuNPs surface functionalised with a 50:50 ratio of a 
thiolated α-Galactose derivative and a thiol-PEGamine were examined for their 
toxicity and uptake in normal and cancer cell lines in vitro. Using this simple ligand 
structure, a selective cancer toxicity was observed, which was highly dependent 
upon the nanoparticles’ synthesis duration. This observation was correlated to 
ligand density, which decreased with shorter synthesis time, making particles less 
toxic. Detailed insight into the mechanism of toxicity and uptake was gained by 
energy-dependent experiments and cell death assays, revealing a significant 
adhesion of these particles to filopodia. The proposed mechanism of cell death 
in HSC oral squamous carcinoma cells exposed to AuNPs was identified to be 
the extrinsic apoptotic pathway, as toxicity was abrogated by inhibition of either 
caspase 3/7 or caspase 8, but not by inhibition of caspase 9. 
Future directions include batch standardisation of the optimum nanoparticle 
synthesis conditions and elucidation of the mechanisms of cell uptake and toxicity 
in a variety of cancer and normal cell lines. 
 
Keywords: gold nanoparticles, toxicity, cancer therapy, mechanism, extrinsic 
apoptosis 
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4 Preface 
The choice of nanoparticles in this thesis was based on previous work 
conducted in the group’s laboratory which showed that 2nm AuNPs surface 
functionalised with a 50:50 ratio of a thiolated α-Galactose derivative and a thiol-
PEGamine resulted in selective uptake and toxicity towards skin cancer cells at 
low nanomolar concentrations (Grellet et al., 2017). Previous published data by 
Lund and colleagues also correlated with the above findings and additionally 
revealed that ligand organization around the Au core was of crucial importance 
to the internalization rate of AuNPs by colorectal cancer cells (Lund et al., 2011). 
Both of these studies were funded by Midatech Pharma Plc and was a core 
motivation of this thesis.    
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1 Chapter 1: Introduction 
Cancer is a highly complex heterogeneous disease characterized by 
abnormal continuous cellular growth affecting many physiological functions, such 
as cell signalling and apoptosis (Feinberg et al., 2006).  Despite important 
breakthroughs in cancer biology, cancer still remains a challenge and a leading 
cause of death worldwide. So far, more than 200 different types of cancer have 
been reported demonstrating the variability and complexity of this disease 
(Madani et al., 2011, Blackadar, 2016). 
The widespread occurrence, recurrence after treatment and high death rates 
indicate an unmet need for early diagnosis and improved therapies (Ferlay et al., 
2010, Jaffee et al., 2017). Most of the cancer treatments include combinations of 
surgery, radiotherapy and chemotherapy. Chemotherapeutic agents confer 
limited disease-free state. Limitations also exist regarding drug resistance and 
non-specific tissue toxicity (Chidabaram et al., 2011, Sinha et al., 2006). 
Challenges in radiotherapy are associated with development of resistance and 
damage to healthy surrounding cells and tissues, while surgery can only be used 
for discrete solid tumours and risks incomplete excision at tumour margins (Misra 
et al., 2010, Wang et al., 2008, Choi et al., 2010). 
 Some of the biological processes underlying cancer are summarized into 
disturbances in cell-cycle checkpoints and signal transduction pathways which 
lead to triggering of angiogenesis and apoptosis (Nebbioso et al., 2018, Sasahira 
and Kirita, 2018). Extensive ongoing research in cancer biology revealed 
processes vital for the disease initiation and progression and led to identification 
of novel targets and compounds for cancer management (Sikora, 2002, Singh 
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and Nehru, 2008). This chapter is a brief introduction of the basic topics 
presented in this thesis, followed by a more extensive review in each chapter.  
1.1 Nanotechnology in cancer  
The goal in every cancer therapy is to specifically target the tumour site 
with minimal destruction to normal healthy surrounding tissues and cells. 
Nanotechnology offers this advantage and constitutes one of the most promising 
emerging fields in cancer management (Chen et al., 2018). This research field is 
based on the utilization and creation of materials that range from 1-100 nm in size 
and spans across various disciplines from chemistry and biology to engineering 
and material sciences (Bharali et al., 2009).  Nanotechnology has remarkable 
potential in cancer diagnosis, early detection and therapy (Rosenblum et al., 
2018, Cai et al., 2008, Sengupta et al., 2005).  
Also, nanotechnology research shows promise of overcoming obstacles 
of resistance and targeted toxicity by encapsulating chemotherapeutic agents 
into site-specific drug delivery systems which provide enhanced efficacy of 
treatment (Bharali et al., 2009). This enhanced efficacy of treatment can be 
achieved by designing nanomaterials that consist of high-affinity specific ligands 
for target cells, carry high concentrations of a drug, as well as multiple drug 
molecules for a combined therapeutic outcome (Misra et al., 2010). Therefore, 
nanotechnology-based systems confer many advantages over conventional 
therapies, which are: stability, high carrier capacity, long shelf-life, improved bio-
distribution of drugs and administration by various routes (intraocular, nasal, 
parenteral, oral) (Chidabaram et al., 2011). These advantages are attributed to 
their unique physicochemical properties, such as small size, surface nature and 
pharmacokinetics (Chen et al., 2018, Ferrari, 2005).      
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1.1.1 Types of nanotechnology-based tools in cancer management 
The types of nanotechnology-based drug tools that are used in cancer 
detection and therapy are summarized into: liposomes, nanoparticles, polymeric 
micelles, dendrimers, quantum dots and carbon nanotubes (Figure 1.1).  
 
Figure 1.1: Nanotechnology-based systems used in cancer therapy and 
detection. A. Liposomes, B. Nanoparticle, C. Polymeric micelles, D. Dendrimers, 
E. Quantum dots and F. Carbon nanotube.  
 
1.1.1.1 Liposomes   
 Liposomes are one of the most versatile tools in cancer management due 
to their wide range of structures and compositions as drug delivery agents. They 
are artificial small spherical vesicles comprised of a phospholipid bilayer 
membrane that encapsulate drug molecules or genetic material for their delivery 
into cells or tissues (Cevc, 1993, Torchillin, 2006). Their lipid bilayer is a highly 
chemically reactive component and provides a platform for coupling agents and 
tags such as antigens, antibodies, cell receptors and more (De Serrano and 
Burkhart, 2017). There are various ways by which liposome contents are 
efficiently delivered. These include fusion of their bilayer with the plasma 
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membrane and diffusion of the drug payload into the cell, or targeting of the 
endocytic pathway (Barani and Montazer, 2008, Park, 2002). Liposomes can also 
be designed in a way that have high or low pH and can deliver their soluble 
contents by diffusion through the plasma membrane (Bertrand et al., 2010). 
Another method of liposome content delivery is to design their size in a way to 
activate phagocytic uptake by macrophages (Wang et al., 2008). Uptake and 
digestion by macrophages leads to dissolving of the liposome contents and thus 
effective release of the drug. Uptake of liposomes by other cell types can be 
mediated by the use of ligands such as opsonins on their surface (Qureshi et al., 
2011).  
Targeting of cancer is achieved by designing liposomes at sizes <400 nm 
and their internalization due to the enhanced permeability and retention effect 
(EPR), a phenomenon which is characterized by enhanced accumulation of 
certain sized particles in tumour rather than in healthy tissues (Qureshi et al., 
2011). Examples of liposomes that are approved by FDA, as drug delivery 
systems and are currently on the market, include doxorubicin and daunorubicin 
for the treatment of ovarian cancer and Kaposi’s sarcoma (James et al., 1994, 
Gibbs et al., 2002, Fassas and Anagnostopoulos, 2005). A study by Immortino et 
al., showed the effective delivery of doxorubicin in vivo by folate receptor targeted 
liposomes (Immordino et al., 2006).  
1.1.1.2 Nanoparticles 
 Nanoparticles are the most widely used nanomaterials in cancer therapy 
and detection. Their unique properties render them at the forefront of 
nanotechnology research for use as drug delivery or imaging agents (Singh et 
al., 2018). The control of their size and shape during synthesis allows for fine 
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tuning of their physico-chemical properties such as light emission/absorption 
properties, stability and chemical reactivity (Portney and Ozkan, 2006, Mohanty 
and Sahoo, 2010). Nanoparticles are sub-micron sized materials which either 
encapsulate a therapeutic agent in their core or are covalently or ionically 
conjugated to an agent via their surface (Sahoo and Labhasetwar, 2003). 
Depending on the targeting molecule used during their synthesis, 
nanoparticles are engineered in a way that can bind specifically to receptors 
expressed by cancer cells and deliver the encapsulated contents (Portney and 
Ozkan, 2006). Also, depending on their coating or surface properties, they confer 
the advantage of crossing biological barriers such as the blood-brain barrier. 
Kreuter et al., demonstrated drug delivery to CNS by polysorbate-80-coated 
butylcyanoacrylate nanoparticles (Kreuter et al., 2003). Misra et al., increased the 
therapeutic capacity of the anticancer drug doxorubicin by specifically targeting 
the drug to the nucleus via conjugation of a nuclear localisation sequence on the 
surface of nanoparticles (Misra and Sahoo, 2010).  
1.1.1.3 Polymeric micelles 
 Polymeric micelles are composed of amphiphilic surfactant molecules. 
They are mainly used for the delivery of compounds to the tumour site (Croy and 
Kwon, 2016). Torchillin et al., found that an antibody conjugated polymeric micelle 
encapsulating the drug Taxol efficiently recognized cancer cells in vitro (Torchillin 
et al., 2003). Some of the advantages of this type of nanomaterial include the 
solubilisation of poorly solubilized substances, protection of encapsulated drugs 
from degradation and sustained release (Bae et al., 2005). Numerous PEG-
micelle molecules have undergone phase I clinical trials as cancer therapeutics 
delivery systems (Portney and Ozkan, 2006). 
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1.1.1.4 Dendrimers 
 Dendrimers are star-shaped, highly branched macromolecular 
compounds whose shape and size can be altered accordingly to confer desired 
properties (Svenson and Tomalia, 2005). Their unique architecture enables the 
attachment of targeting moieties or imaging probes, critical for the efficient 
diagnosis or treatment of cancer (Menjoge et al., 2010). For example, Choi et al., 
prepared DNA-assembled polyamidoamine dendrimers for targeting of tumours 
(Choi et al., 2005).  
1.1.1.5 Carbon nanotubes 
 Carbon nanotubes are carbon cylinders made of graphene sheets that are 
rolled into a cylinder shape. They are engineered in a way that specific groups 
functionalized in their surface provide desirable physico-chemical properties for 
use as carriers for gene, proteins and drug delivery (Abdelbary et al., 2012). Also, 
their high optical absorbance properties render them a valuable tool in cancer 
irradiation, leading to destruction of cancer cells with internalized nanotubes 
(Ferrari et al., 2005). Their mechanism of uptake by cancer cells is still not well 
understood but it is being considered that their cylinder shape facilitates 
membrane passage (Clump et al., 2006). It has been shown in vitro that drugs 
carried by carbon nanotubes are internalized more efficiently into cells as 
opposed to the free drug alone (Abdelbary et al., 2012). 
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1.1.1.6 Quantum dots 
 Quantum dots represent a class of nanometre sized semiconductor 
particles with distinct optical and electronic properties (Misra et al., 2010). They 
are mainly used as fluorescent labels for imaging and therapeutic purposes (Gao 
et al., 2005). Their resistance to photo-bleaching along with the intense 
fluorescent signals they produce makes this type of nanomaterials of great 
significance as fluorescent tags for in vivo imaging (Pinaud et al., 2006).  They 
also provide a scaffold of various agents that can modify their specificity, solubility 
and sensitivity. For instance, the use of PEG-silica makes them biocompatible, 
eliminating toxicological concerns in vitro (Misra et al., 2010).  Nie et al., 
demonstrated the imaging and targeting ability of prostate membrane antigen 
labelled quantum dots in animal models (Nie et al., 2007). 
1.1.2 Targeting of nanomaterials to tumour site 
 There are various factors determining the effectiveness of any of the above 
discussed nanotechnology-based systems in cancer management, such as their 
toxicity, degradation/elimination and their capacity of carrying an active agent 
(Muller and Keck, 2004). Important factors also include the ability of these 
systems to penetrate biological barriers and selectively bind to cancer cells 
without affecting the normal cells and tissues (Rosenblum et al., 2018). There are 
two strategies that can be utilized in the design of nanomaterials for their delivery 
inside the cancers cells. These include the design in a way to either undergo 
passive or active targeting (Figure 1.2). 
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1.1.2.1 Passive targeting 
The accumulation of a drug in the tumour site due to its physico-chemical 
properties is called passive targeting. Apart from the properties of a nanomaterial, 
the properties of cancer cells, including the tumour microenvironment, facilitate 
this type of targeting (Sagnella et al., 2012). In the tumour vasculature, 
angiogenic blood vessels have large gaps of up to 800 nm between the adjacent 
endothelial cells, leading to a defective and leaky vasculature and poor lymphatic 
drainage, whilst the gaps in normal vasculature are much smaller and the vessels 
are not leaky (Maeda et al., 2000, Nakamura et al., 2016). This feature is 
described as the EPR effect which enables the transport of nanomaterials 
through the gaps and their subsequent accumulation to the tumour site 
(Matsumura and Maeda, 1986).  
Accumulation of nanoparticles in cancer cells is also affected by cellular 
properties. These properties are defined by a hyper-proliferative ability, high 
metabolic rates and an acidic microenvironment (Misra et al., 2010). This 
environment allows for example, the design of pH sensitive liposomes to target 
cancer cells and release their drug contents at tumour sites with a lower than 
normal pH value, whilst they are stable at the normal cell/tissue pH of 7.4 (Misra 
et al., 2010).  
1.1.2.2 Active targeting 
 Active targeting includes the attachment of a targeting moiety on the 
surface of a nanomaterial such as a ligand or an antibody, for the delivery of the 
therapeutic drug to cancer cells via a molecular recognition process (Nakamura 
et al., 2016). This process involves mainly internalization via receptor mediated 
endocytosis, which will be described in detail in chapter 4. In order for this 
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strategy to be efficient, the targeted receptors should be expressed only by 
cancer cells. Using ligands such as growth or folate factors, provides advantages 
over antibodies in terms of lower immunogenicity (Fenart et al., 1999, Muller and 
Keck, 2004). An example of the delivery of a chemotherapeutic drug, paclitaxel® 
by active targeting involves the delivery of artificially engineered antibodies 
coupled as a conjugate to affisomes (thermosensitive liposomes) and 
polyethylene glycol maleimide copolymer (Alexis et al., 2008, Puri et al., 2008).  
 
Figure 1.2: Passive and active targeting strategies utilized by nanomaterials 
for the delivery of therapeutic drugs in cancer management. Passive 
targeting is characterized by transport of nanomaterials to the tumour site due to 
EPR effect, leaky vasculature and cancer cells microenvironment. Active 
targeting is achieved via targeting moieties attached to a cell surface receptor 
leading to receptor mediated endocytosis and internalization. From Park, 2012. 
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1.2 AuNPs in cancer 
 Amongst all the nanomaterials presented above, gold nanoparticles 
(AuNPs) are at the forefront of the nanomedicine research due to their unique 
physico-chemical properties (Singh et al., 2018). Their use ranges from targeted 
delivery of drugs to contrast agents for imaging and detection of cancer (Ghosh 
et al., 2008, Eck et al., 2010, Bhattacharya et al., 2008). Gold in its elemental 
form is considered as an inert, bio-compatible, non-toxic noble metal. However, 
when the size of gold is significantly small, at nanoscale level, it behaves very 
differently from its elemental form and can be considerably toxic (Connor et al., 
2005). This feature, along with its strong optical properties, ease of surface 
chemistry modifications and control of its size and shape, contribute to the strong 
preference of using gold instead of other types of nanoparticles in a range of in 
vitro and in vivo applications (Cobley et al., 2011, Kim et al., 2009, DeLong et al., 
2010).  
1.2.1 Toxicity of AuNPs 
The term ‘toxicity’, refers to the adverse reactions that a substance has on 
living subjects and its principle was introduced almost five centuries ago by 
Paracelsus, when he expressed that “most drugs are beneficial at low doses, but 
toxic at high doses” (Timbrell, 1998, Schmid et al., 2009, Grass et al., 2010). 
There is a variety of conflicting studies showing both the toxicity (Dobrovolskaia, 
2007, Patra et al., 2007, Peng et al., 2009) and non-toxicity (Pan et al., 2007, 
Zhang et al., 2009, Sung et al., 2011) of AuNPs. The nature of such conflicts 
relies on the fact that gold is toxic both in vitro and in vivo but various factors can 
affect the level of toxicity. These factors are mainly summarized into coating 
materials, size, shape and surface chemistry. More specifically, the various 
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physicochemical characteristics of NPs, such as surface charge, surface area 
and stabilizing coating agents could affect the biological readout of NPs toxicity 
along with their concentration, incubation time, types of assays and cells used 
(Soenen et al., 2011). It is frequently found that the toxicity of AuNPs depends on 
the specific cell type examined in toxicity assays. For instance, citrate-capped 
AuNPs (13 nm in diameter) were found to be toxic to a human carcinoma lung 
cell line but not to a human liver carcinoma at the same dose (Patra et al., 2007).  
1.2.2 Synthesis of AuNPs 
AuNPs are synthesized by the chemical reduction of HAuCl4. This process 
results in neutral gold atoms via reduction of Au3+, which are subsequently 
precipitated and supersaturated into atomic clusters of gold particles (Sardar et 
al., 2009, Low et al., 2010). Most of the synthesis methods for AuNPs involve 
HAuCl4 as the main source of gold atoms with different modifications to control 
the rate of AuNP growth and the type of capping agent to preserve AuNP integrity.  
One of the modifications is the Turkevich method by which citrate ions act 
as capping and reducing agents to produce spherical mono-dispersed AuNPs 
suspended in water (Kimling et al., 2006). AuNPs in water-immiscible organic 
liquids can be produced by the Brust method (Brust et al., 1994). AuNP seeds 
are made by the Perrault method, which utilizes hydroquinone as reduction agent 
for HAuCl4 in an aqueous solution (Perrault et al., 2009). Reduction of HAuCl4 by 
NaBH4 results in monodisperse AuNPs coated with borate ions in water by the 
Martin method (Martin et al., 2010). Lastly, the Sonolysis process generates 
AuNPs based on ultrasound and the use of sugar and hydroxyl pyrolysis as 
reducing agents in an aqueous solution of HAuCl4 in glucose (Vinodgopal et al., 
2010). There are numerous alternatives to these methodologies for AuNPs 
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production, as their main disadvantage is lack of process reproducibility. These 
alternatives rely on biological agents such as microorganisms (yeast and 
bacteria), microbial enzymes and plant phytochemicals. For example, chickpea 
leaves have been shown to induce the reduction of 0.1mM HAuCl4 solution to 
AuNPs at room temperature (Chauhan et al., 2011). 
1.2.3 Characterization of AuNPs 
Various techniques are used to characterize AuNPs. The size and the 
shape of the nanoparticles is characterized by electron microscopy and dynamic 
light scattering (DLS) (Fratoddi et al., 2015). EM is a technique that allows 
visualization of a small number of particles and subsequent size analysis, 
whereas DLS analyses the entire population in solution. However, some 
limitations exist with these methods. Artefacts may arise from EM as it operates 
for highly polydisperse systems under vacuum conditions. High scattering 
intensity of large objects could lead to difficult data interpretation of DLS analysis 
because of false estimates of mean particle size.  
Laser Doppler electrophoresis is the technique by which surface charge of 
the nanoparticles is obtained by measuring their ζ-potential (Fratoddi et al., 2015). 
The ζ-potential can be affected by various parameters that should be taken into 
consideration for its accurate measurement. These parameters include the 
concentration of the particles present in the solution, their aggregation state, pH 
of the solution and the electrical conductivity. The gold concentration of a solution 
can be measured by inductively coupled plasma atomic emission spectrometry 
(ICP-AES), atomic absorption spectroscopy (AAS) and inductively coupled 
plasma mass spectrometry (ICP-MS) (Fratoddi et al., 2015).  
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Accurate AuNP characterization is vital for correlating it to toxicity. Trace 
impurities within the nanoparticle formulation, coating modifications and 
aggregation state can interfere with the cellular environment and the toxic effects 
observed. Such interference is unrelated to nanoparticles themselves. For 
example, a study showed that nano-rod formulations included impurities of free 
cetyltrimethylammonium bromide (CTAB) in solution and caused toxic effects in 
human colon carcinoma cells (Alkilany et al., 2009).  
1.2.4 Applications of AuNPs 
1.2.4.1 Cancer detection and imaging 
 AuNPs are a vital tool in cancer diagnosis due to their unique optical 
scattering properties which make them appropriate probes for cancer imaging in 
vitro and in vivo (Kumar et al., 2007). AuNPs have the ability to scatter and absorb 
visible light. This phenomenon is termed as surface plasmon resonance, which 
represents a quantum mechanical feature that occurs when the size of the 
nanoparticle is smaller than the wavelength of the incident light (Kumar et al., 
2007). Numerous techniques are used for the detection of AuNPs at a site of 
interest, such as dark field microscopy, phase contrast optical microscopy and 
photothermal imaging (Roth et al., 1996, Sperling et al., 2008). Also, a study of 
antibody-conjugated gold nanospheres has shown the use of surface enhanced 
Raman spectroscopy (SERS) in the imaging of HER-2 markers overexpressed in 
MCF-7 cells (Less et al., 2009).  
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1.2.4.2 Delivery agents 
AuNPs are promising carriers in drug delivery for cancer therapy due to 
their small size, shape, biocompatibility, ease of synthesis and functionalization 
(Zhang et al., 2009). However, limitations exist with regard to their use and the 
effective delivery of drugs and molecules inside the cells. Some of these 
limitations relate to the penetration rate being affected by biological barriers, their 
specificity and selectivity on the tumour site and their retention in the blood 
circulation (Kim et al., 2009, De Jong et al., 2008). Phase I clinical trial on 
PEGylated colloidal gold-TNF construct showed promising results in patients with 
advanced solid cancers (Libutti et al., 2010). 
1.2.4.3 Photo-thermal therapy   
Traditionally, hyperthermia, induced via external electromagnetic 
radiation, has been used to trigger cell death. Sources of heat include laser, 
radiowaves or ultrasound waves (Liu et al., 2009). For instance, it has been 
shown before that either cancer or normal cells when exposed to temperatures 
ranging from 41oC-47oC show signs of apoptosis, whereas at temperatures 
above 50oC, cell death via necrosis has been observed (Cherukuri et al., 2010). 
The issue that exists with this approach is the damage to healthy surrounding 
cells and tissues. AuNPs provide the advantage of minimum damage to non-
cancerous cells due to their specific uptake into cancer cells and strong 
absorbance of the light. Thus, the hyperthermic effect is greater in cancer cells 
than in surrounding healthy tissues (Huang et al., 2008). Cherukuri et al. 
illustrated that AuNPs heated with radio-frequency fields, applied to cells after 
NPs internalization, resulted in cancer cell death by a localized heat effect 
(Cherukuri et al., 2010). 
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1.2.4.4 Radiation therapy  
 Several studies have revealed the application of AuNP as radiosensitizers. 
The effectiveness of AuNPs as radiosensitizers is attributed to their surface 
functionality and the nature of their coating (Hebert et al., 2010, De Long et al., 
2008). However, conflicting studies exist about the size and the tumour cell type 
being responsible for the radiosensitizing properties of AuNPs (De Long et al., 
2008). For instance, 1.9 nm AuNPs enhanced the X-Ray effect on mice with EMT-
6 mammary carcinoma leading to 86% cell death as opposed to 20% or 0% with 
X-Rays and NPs alone, respectively (Hainfeld et al., 2004). On the other hand, 
another study on 1.9 nm AuNPs provided evidence of cytotoxic effects of AuNPs 
by causing DNA damage and oxidative stress leading to apoptosis (Butterworth 
et al., 2010). Therefore, an understanding into the properties of AuNPs that confer 
desired abilities is crucial in order to improve their therapeutic potential as tools 
for cancer management.  
1.3 AuNPs challenges and limitations 
There is a great promise for the use of AuNPs in cancer therapy and this 
is evident by the numerous publications on the topic. Currently, most of the 
scientific community focusses on improvements of AuNPs treatments by 
changing AuNP functionalization and surface characteristics. However, little or 
no evidence exist on the exact mechanism of toxicity and induction of cell death 
caused by the AuNPs. Cell-type dependent differences in toxicity and uptake 
complicate the optimization of AuNPs for cancer therapy. If such differences are 
clearly understood, more selective and efficient AuNPs can be designed to target 
only the tumour microenvironment without affecting the normal cells and tissues. 
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1.4 Aims of the thesis 
 As discussed above, AuNPs represent a class of nanomaterials with 
promising advantages in cancer management. AuNPs are developed as drug 
vectors due to being biocompatible, easy to manufacture and inert. However, 
there is evidence that AuNPs can be toxic. The main aim of the thesis was to 
characterize the mechanism by which AuNPs cause toxicity in cancer and normal 
cells in vitro. Midatech Pharma’s AuNP technology was used for the production 
of 50:50 αGal:PEGamine AuNPs utilized throughout the majority of the project. 
The key advantages of this technology were their ease of synthesis and 
penetration into the cells. Also, their production and scalability could be 
performed and controlled in the company’s cGMP facility and R&D departments. 
In detail, the objectives listed below were addressed in this thesis and were 
analysed within each chapter: 
- Chapter 3: Assessment of different physico-chemical and cellular 
factors affecting AuNP toxicity. 
- Chapter 4: Role of the synthesis time and ligand density in AuNP 
toxicity and their effect on the transport of AuNPs. 
- Chapter 5: Analysis of the mechanisms of cell death caused by 
AuNPs. 
- Chapter 6: Evaluation of AuNP toxicity in a range of cancer and normal 
cell lines. 
A list of appendices is also included in this thesis along with copyright permission 
evidence attached at the back, for each figure used.  
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2 Chapter 2: Materials and Methods 
2.1 Gold Nanoparticle Based Methods 
2.1.1 Chemical synthesis 
All AuNPs were supplied and synthesized by Midatech Pharma PLC 
(Oxford, UK). They consist of a gold core (~1.2 nm in diameter) to which an 
organic layer of HS-C2-α-galactose (Sigma Aldrich®, 134031) and 1-amino-6-
mercapto-hexaethyleneglycol (PEG-amine) were attached via gold-sulphur 
bonds, as described previously (Lund et al. 2011). In detail, the AuNPs were 
synthesized by the reduction of 100 g/L HAuCl4 (Sigma-Aldrich®, 254169) with 
90 mM NaBH4 in the presence of disulfide-containing ligands with Milli-Q water 
as a solvent (ELGA purification system). The synthesis process was carried out 
for 1h, 2h and 5h. After the end of the synthesis incubation times, the samples 
were purified either by spin washing with excess Milli-Q water using an Amicon 
10kDa ultrafiltration device. AuNPs were resuspended in Milli-Q water to 2 mg/ml 
[Au] and stored in amber vials at 4ºC.  
Throughout the project, various nanoparticle formulations with different 
characteristics were tested. These different characteristics ranged from 
differences in the nanoparticle synthesis time, scale of synthesis, method of 
purification, Au stock concentration and ligand ratios. A list of all the nanoparticle 
formulations’ code and description is presented in the table below (Table 2.1).  
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Table 2.1: A list of all the AuNPs formulations supplied by Midatech. 
 
Category 
Midatech’s 
Identification Code 
Description 
AuNPs with different 
ligand ratios 
M175-042-01 0:100 GalC2 
 M175-042-02 11:89 PEG:GalC2 
 M175-065-03 30:70 PEG:GalC2 
 M175-065-04 45:55 PEG:GalC2 
 M175-042-05 51:49 PEG:GalC2 
AuNPs with different 
synthesis time 
M218-024-01 50:50 1h reaction 
 M218-024-02 50:50 2h reaction 
 M218-024-05 50:50 5h reaction 
AuNPs with different 
purification method 
M218-095-01 
 
50:50 no purification 
MeOH/H2O 
M218-095-02 
 
50:50 MeOH/H2O 
purified 
M218-104-01 
 
50:50 alkaline purified 
AuNPs with different 
scale of synthesis 
M218-086-01 50:50 Small scale 
 M182-073-1 50:50 Large scale 
Identical AuNPs with 
different synthesis day  
M229-062-01 50:50 2h reaction 
 M229-062-02 50:50 2h reaction 
 M229-062-03 50:50 2h reaction 
AuNPs from previous 
work in the lab 
NP146-49 
NP 118-40-1 
50:50 
50:50 
 
Note: 50:50 ratio refers to αGal:Pegamine AuNPs.  
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2.1.2 Nanoparticle physico-chemical characterization 
2.1.2.1 Transmission Electron Microscopy (TEM) 
The core size of the nanoparticles was determined by TEM.  Samples were 
prepared by drying drop-coating films of the nanoparticle solutions on 
electrostatically discharged carbon-coated copper TEM grids and visualized on a 
JEM-1400 model EM (JEOL, USA) operated at an accelerating voltage of 80 kV 
and 100,000x magnification.  Core sizes were calculated from TEM images using 
the automated particle analysis feature based on the threshold approach on 
ImageJ 1.49 software, as described in detail below.  
Specifically, 5 images were taken for each nanoparticle sample and 
loaded into the software for subsequent analysis. The brightness of the images 
was adjusted in order to visualize dark (black) nanoparticles in a bright (white) 
background. A threshold was applied to the adjusted images and the nanoparticle 
area was measured by the function “Measure particles”. Pixel dimensions were 
converted into nanometres based on the magnification factor. The dimensions for 
size estimates calculations were set between 1 nm-infinity. All the measurements 
from each individual image were transferred and combined into an excel 
spreadsheet and the diameter of the nanoparticles was calculated by the 
formula: 𝑑 = 2 ∗ √𝐴/𝜋, where A=measured area, d=diameter and π=3.14. 
2.1.2.2 Dynamic Light Scattering (DLS)/Zeta potential 
The hydrodynamic diameter and zeta potential of the AuNPs (500 μg/ml) 
were calculated using a Nano ZSP zetasizer (Malvern instruments). Zeta 
potential measurements were made in 20% PBS at pH 7 in a DTS1070 cell, 
whereas DLS was measured in pH 7.4 PBS in a ZEN0040 cell.  
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2.1.2.3 1H-Nuclear Magnetic Resonance (1H-NMR) 
The ligand shell of the nanoparticles was analysed by 1H-NMR. For each 
sample, 5 mg of gold was transferred into D2O using ultrafiltration (Amicon Ultra-
4, MWCO 10kDa). Three centrifugation steps were performed in 2 ml D2O (4,000 
rpm, 12 min). After the last centrifugation step, the particles were transferred into 
Eppendorf tubes and treated with 0.3M KCN/0.1 M KOH. The samples were kept 
at 37oC overnight before transfer to NMR tubes. Samples were then centrifuged 
(4,000 rpm, 1 min) and analysed by 1H-NMR at 500 MHz (Avance III HD, Bruker) 
and MestReNova software. The protons for the αGal and PEGamine ligands were 
identified to resonate at 4.95 ppm and 2.75 ppm, respectively. These correspond 
to the single anomeric proton of αGal (NMR doublet) and the two CH2 protons 
proximal to the terminal NH2 group in the PEGamine linker (NMR triplet), thus 
their integrals were used to quantify the abundance of the two ligands. 
2.1.2.4 Au concentration assay 
In order to determine the Au concentration of the samples, a 
spectrophotometric assay was used. Three gold standards were prepared at 0, 5 
and 10 mg/ml concentrations (Gold standard for AAS, 1000 mg/L Au in 
hydrochloric acid, Sigma-Aldrich®, 08269). 10 μl of AuNPs were mixed with 30 
μl of 30% fresh cold aqua regia in H2O and 150 μl of 2 M NaBr and run against 
the prepared gold standards in a 96-well plate. The absorbance was read 
immediately in a microplate reader (OPTIMA FluoSTAR) at a wavelength of 382 
nm.  
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2.1.2.5 UV-Vis Absorbance spectrum 
 The surface plasmon resonance of the AuNPs was checked by their 
absorbance at 520 nm. 200 μl of 100-400 μg/ml AuNPs were measured against 
a water blank in 96-well plates in a Labtech Spectrostar Nano spectrophotometer.  
2.1.2.6 X-ray Photoelectron Spectroscopy (XPS) 
The ligand density for each nanoparticle was estimated by XPS in 
Midatech’s external collaborators facilities, CIC BioMagune, Spain. XPS 
experiments were performed in a SPECS Sage HR 100 spectrometer with a non-
monochromatic X-ray source at 1253.6 eV energy and 250 W.  The selected 
resolution for the spectra was 15 eV of pass energy and 0.15 eV/step. All 
measurements were conducted in an ultra-high vacuum (UHV) chamber at a 
pressure around 5x10-8 mbar. The calculation of the ligand density was obtained 
via Au:S ratio and is based on the fact that each ligand on the AuNPs surface 
carries a single S atom, while Au atoms constitute the AuNP core. For simplicity 
of calculation, the geometry of AuNPs is assumed to be spherical as verified by 
TEM images. 
2.1.2.7 Scanning Electron Microscopy (SEM) 
The ligand density of the AuNPs was also confirmed by SEM. 3 μl of 2 
mg/ml AuNPs were dried onto aluminium stubs and analysed with a Zeiss Supra 
55VP Field Emission Gun Scanning Electron Microscope (FEGSEM) at 20 kV. 
Analysis was performed with AZtec Energy software (Oxford Instruments) for 
measurements of the % Wt of Au and S atoms.  
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2.1.2.8 FPLC 
Any possible aggregation of the AuNPs was tested by FPLC. Aggregated 
and individual nanoparticles were separated by ÄKTA™ pure chromatography 
FPLC system (GE Healthcare, UK). The particles were incubated with PBS or 
DMEM+10% FBS for 30min at 37oC at a concentration of 200 μg/ml. Samples 
were run on a Superdex 200 10/300 GL FPLC column at 0.5 ml/min, using a 100 
μl injection loop. The absorbance was monitored at 400 nm.  
2.1.2.9 Agarose gel electrophoresis 
The AuNPs were also run in an agarose gel in order to separate and 
visualize mixed charged/sized particles within a single population. 20 μl of a 2 
mg/ml nanoparticle solution was diluted 1:1 in H2O, PBS or 10% FBS and left for 
3h at room temperature and 37oC in order to examine any aggregate formation. 
Particles have a positive net charge and therefore run towards the negative 
electrode. 1% agarose gel was prepared in 0.5% TBE buffer and left to set into 
the gel tray of the electrophoresis apparatus (Thermo Scientific, Owl™ 
EasyCast™) for approximately 30 minutes. Samples were loaded with 5 μl of 
30% glycerol diluted in H2O and run for 45 min at 100 mV and 0.5X TBE buffer. 
A DNA ladder was used as a marker (Quick-Load® Purple 1 kb Plus DNA Ladder, 
BioLabs, N05525). Gel was visualized using the ImageJ software.  
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2.2 Cell Culture Based Methods 
2.2.1 Cell Culture 
A list of all the cell lines used throughout the project is presented in the table 
below (Table 2.2). The origin of the cell lines was: Homo sapiens, human.  
Table 2.2: A list of all the cell lines used throughout the project. Alternated 
shading corresponds to pair of cell lines indicating normal and cancer cell type. 
Abbreviation Tissue/Disease 
HSC-3 Oral squamous/carcinoma 
HaCaT Keratinocyte 
MCF-7 
Mammary gland, breast; derived from 
metastatic site: pleural 
effusion/adenocarcinoma 
HMEC Mammary Epithelial Cells 
hA Primary astrocytes 
U-373 Glioblastoma/astrocytoma 
A-498 Kidney/carcinoma 
HEK-293 Embryonic kidney 
Caco-2 Colon colorectal/adenocarcinoma 
HeLa Cervix/adenocarcinoma 
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HSC cells were purchased from the American Type Culture Collection. 
HaCaT cells were obtained from Erik Walbeehm, Erasmus Medical Centre 
(Rotterdam, Netherlands) and hA cells were supplied by ScienCell Research 
Laboratories (Carlsbad, California, USA). For all other cell lines, vials were taken 
from the archived liquid nitrogen facility at The Open University.  
All cell lines apart from hA, HMEC and Caco-2 were cultured in low 
glucose (1 g/L) DMEM media (Gibco®, 21885-108) supplemented with 10% FBS 
(Sigma-Aldrich®, F9885) and 1% penicillin/streptomycin (ThermoFisher 
Scientific, 15140122) in a humidified incubator at 37oC with 5% CO2. Cells were 
grown in T-75 culture flasks to about 80% confluency before passage. hA cells 
were cultured in Astrocyte Medium (ScienCell™,1801) supplemented with 2% 
FBS and 1% astrocyte growth supplement (ScienCell™,1852). HMEC cells were 
cultured in HuMEC Ready Medium (Gibco®, 12752-010), containing 1% HuMEC 
supplement (Gibco®, 12754-016) and 25 mg bovine pituitary extract (Gibco®, 
13028-014). Caco-2 cell culture conditions and medium were the same as for all 
the cell lines apart from being supplemented with 20% FBS instead of 10%. To 
plate cells at required densities for various experiments, cells were washed with 
Ca2+ free HBSS (Sigma-Aldrich®, H6648) and trypsinized with 0.05 % T/E 
(Invitrogen™ Life Technologies, 25200056) for less than 10 min at 37oC. 
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2.2.2 Cytotoxicity of AuNPs 
2.2.2.1 Clonogenic assay 
 The toxicity of the AuNPs and their effect on cell survival and proliferation 
was evaluated using clonogenic assays on HSC, HaCaT, A-498 and HEK-293. 
The rest of the cell lines listed above (Table 2.2) did not grow in colonies. HSC 
and HaCaT cells were seeded at 300 cells/well in a 24-well plate, HEK-293 at 
1,000 cells/well and A-498 at 800 cells/well and allowed to adhere overnight. The 
next day, cells were acutely exposed for 3h to 0, 1, 3 and 10 μg/ml AuNPs.  Cells 
were left to grow for 6 days to form colonies. At the end of day 6, cells were briefly 
rinsed with water, stained and fixed with 2% methylene blue in 50% ethanol 
solution for 3h. The staining/fixation solution was removed, plates were rinsed 
with distilled water and dried.  
 Images of stained plates were captured using a G:Box Chemi XX6 gel 
documentation system with GeneSys v1.4.6 software (Syngene). Colonies 
containing >50 cells were quantified using GeneTools v.4.03 software (Syngene). 
Automated counts were verified by eye. IC50 values were estimated from 
logarithmic plots of AuNP concentration versus percent of control colonies. IC50 
is the concentration at which the AuNPs cause 50% cell colony reduction 
compared to the untreated controls. 
2.2.2.2 CyQUANT cell proliferation assay 
 The proliferation and cell number of all the cell lines listed in Table 2.2 
were assessed by CyQUANT cell proliferation assay (ThermoFisher Scientific, 
C35006). This assay is based on a DNA-intercalating fluorescent dye, which 
determines the amount of DNA present in a sample. Cells were seeded in a 96-
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well plate at a density of 2,000 cells/well and incubated at 37oC and 5% CO2 for 
6 days after an acute 3h AuNP exposure at 0, 5, 10 μg/ml.  At day 0, 1, 2, 3, 4, 
5, and 6 cells were washed with HBSS and frozen at -80oC for at least 24h for 
subsequent analysis.  A mixture of CyQUANT dye and cell lysis buffer in distilled 
water was prepared as follows. The cell lysis buffer stock solution was diluted 20-
fold in distilled water and the CyQUANT stock solution was diluted 400-fold into 
the 1X cell lysis buffer.  For up to 100,000 cells detection, 200 μl of the mixture 
was added to the 96-well plates and incubated for 5 min at room temperature in 
the dark.  Readings of DNA content/well were obtained by fluorescent microplate 
reader at Ex480/Em520 nm. Background fluorescence was subtracted when 
plotting the data. 
2.2.3 Silver staining 
 Detection of AuNPs using a standard light microscope was achieved by 
silver staining. Cells were seeded at 30,000 cells/well and exposed to AuNPs for 
3h. After the end of the exposure time, media was removed, cells were washed 
with PBS and fixed by 4% PFA (Merck, 100496) for 15 min.  The cell membrane 
was permeabilized by 0.05% Triton™ X-100 (Sigma-Aldrich®, X100) in PBS for 
2 min. The silver staining developer and enhancer solutions (R-Gent, Aurion, 
500.011) were allowed to reach room temperature equilibrium and mixed at 50:50 
ratio.  The complete silver staining solution was applied to cells for 5-10 min in 
the dark.  Cells were then washed twice with PBS and samples were stored at 
4oC for subsequent imaging.  Samples were imaged by bright-field and phase 
contrast microscopy at 20x and 40x objective.  
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2.2.4 TEM 
2.2.4.1 TEM for cellular uptake quantification of AuNPs 
 Cellular uptake was quantified by TEM. Cells were seeded onto 12 trans-
well inserts at a density of 100,000 cells/insert and left to adhere overnight. The 
next day, cells were incubated with AuNPs for 3h at a concentration of 10 μg/ml 
at 37oC or 4oC. In the latter case, cells were kept at 4oC for at least 30 min prior 
to AuNPs exposure. At the end of the incubation period, cells were washed 3x 
with HBSS, fixed and the AuNPs were silver enhanced (R-Gent, Aurion, 500.011) 
for 45 min at room temperature and processed for TEM imaging according to 
Gromnicova (Gromnicova et al., 2013). Ultrathin sections of cells were visualized 
on a JEOL 1010 TEM operated at an accelerating voltage of 80 kV at 15,000x 
and 50,000x magnifications.  
2.2.4.2 Nanoparticle TEM counts on cells 
 A systematic sampling method was used to evaluate nanoparticle counts 
in cells. This method was based on acquiring 25 TEM images at the same 
magnification and same settings across the samples at regular intervals which 
included every fifth field of view with a cell. Each picture was loaded into ImageJ 
software, where the area of the nucleus, cytoplasm and the length of the cell 
surface was measured. Nanoparticles in each region were manually counted and 
their number was assigned to one of the three different categories (nucleus, 
cytoplasm and cell surface). Data were expressed as nanoparticles per micron 
for cell surface nanoparticle counts or nanoparticles per micron2 for 
nuclear/cytoplasmic nanoparticle counts. Three independent experiments were 
performed for AuNPs quantification with two technical replicates per condition. 
Images shown are from a representative experiment.    
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2.2.4.3 Fascin inhibition 
 Fascin-G2, a fascin Inhibitor (Xcessbio, M60269-2s) was used to inhibit 
filopodia formation. Cells were exposed to the inhibitor at 50 μM for 2h at 37oC 
prior to AuNP exposure. Cells were then incubated with 10 μg/ml AuNPs in 50 
μM Fascin-G2 for a further 3h, either at 37ºC or at 4ºC. At the end of the 
incubation times, cells were washed, fixed and prepared for TEM analysis. 
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2.3 Mechanism of Cell Death Related Assays 
2.3.1 Apoptosis/Necrosis 
In order to discriminate between apoptotic, necrotic and live cells within a 
cell population after an acute 3h exposure to AuNPs, a cytometry based assay 
kit, Annexin V-FITC Apoptosis Detection (Sigma-Aldrich®, APOAF-20TST) was 
used. Quantification was obtained via the Tali® Image-Based Cytometer 
(ThermoFisher Scientific, T10796). HSC cells were seeded at 25,000 cells/well 
in a 24-well plate and left to adhere overnight. The next day, cells were exposed 
to 10 μg/ml of AuNPs for 3h and a time-course of 3h, 24h, 48h and 72h was 
followed to establish a cell death time-course of events. Staurosporine (Abcam, 
ab120056) was used at 1 μM for 3h as a positive control for apoptosis induction. 
For quantification after each time-point, the supernatant was kept in a 1.5 ml 
Eppendorf tube and cells were washed with HBSS and trypsinized with 0.05% 
T/E for 7 min. The trypsinized samples with their supernatant were centrifuged at 
1,000 rpm for 5 min and the pellet was washed twice in PBS.  
Each pellet was re-suspended in 1x Binding Buffer (Sigma-Aldrich®, B9796) 
at a concentration of ~1 x 106 cells/ml and 5 μl of Annexin V FITC Conjugate 
(Sigma-Aldrich®, A9210) plus 10 μl of Propidium Iodide Solution (Sigma-
Aldrich®, P2667) was added to each tube. The samples were incubated at room 
temperature for exactly 10 minutes, protected from light. Red (Ex535/Em617 nm) 
and green (Ex494/Em518 nm) fluorescence of the cells was immediately 
quantified by Tali cytometer. Cells that were early in the apoptotic process were 
stained positive only for the Annexin V FITC Conjugate. Live cells showed no 
staining and necrotic/late apoptotic cells were stained by both Propidium Iodide 
and Annexin V FITC Conjugate.  
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2.3.2 Caspases 
2.3.2.1 Caspase 3/7 Activation 
 Further insight into the apoptotic cell death mechanism involved 
quantification of the caspase 3/7 activity via a fluorescence assay. CellEvent™ 
Caspase-3/7 Green Detection Reagent (ThermoFisher Scientific, C10723) was 
used to determine the caspase 3/7 activation in HSC cells. HSC cells were 
seeded at 25,000 cells/well in a 24-well plate and left to adhere overnight. The 
next day, cells were exposed to 10 μg/ml of AuNPs for 3h and a time-course of 
3h, 24h, 48h and 72h was followed to establish a cell death time-course of events. 
Staurosporine was used at 1 μM for 3h as a positive control for apoptosis. Cells 
were prepared as described above for subsequent analysis. The CellEvent™ 
Caspase-3/7 reagent was diluted into PBS+5% FBS and added to cells at an 
optimized concentration of 6 μM for 30 min at 37oC. The fluorescence was 
recorded by Tali cytometer at Ex502/Em530 nm.  
2.3.2.2 Caspase 3/7 inhibition 
  Caspase 3/7 mediated apoptosis in HSC cells after an acute 3h exposure 
was also validated by using a caspase 3/7 inhibitor, Z-VAD-FMK (Abcam, 
ab120382). HSC cells were seeded at 300 cells/ well at a 24-well plate for 
clonogenic assay. Cells were left to grow overnight and the next day, they were 
pre-loaded with 50 μM of the caspase inhibitor for 1h at 37oC before exposure to 
AuNPs. After 1h, 10 μg/ml of AuNPs was added to the cells for 3h at 37oC. 
Antimycin-A (Abcam, ab141904) was used at 10 μM as a positive control. At the 
end of the incubation period, cells were washed with media and left to grow for 6 
days for clonogenic assay. Data were expressed as percentage of control 
colonies. 
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2.3.2.3 Caspase 8/9 inhibition  
 To effectively distinguish between extrinsic and intrinsic apoptotic 
pathways, caspase 8 and caspase 9 inhibition was evaluated. HSC cells were 
seeded at 300 cells/ well at a 24-well plate for clonogenic assay. Cells were left 
to grow overnight and the next day they were pre-incubated with either 70 nM 
caspase 8 inhibitor I (Merck, 218773) or 50 nM caspase 9 inhibitor II (Merck, 
218776) for 1h prior to addition of 10 μg/ml AuNPs and incubation for 3h. 
Antimycin-A (Abcam, ab141904) at 10 μM was used as a positive control for 
apoptosis and 50 ng/ml Apo2 ligand/TRAIL as a positive control for inducing 
extrinsic apoptosis. Clonogenic assays were analysed after 6 days, as previously 
described. 
2.3.3 Mitochondrial membrane potential 
2.3.3.1 JC-10 
Alterations in the mitochondrial membrane potential were assessed by 
using the JC-10 fluorescent dye. The JC-10 Mitochondrial Membrane Potential 
Assay Kit (Abcam, ab112133) is based on the principle that JC-10 dye diffuses 
out of mitochondria in apoptotic/necrotic cells, staining cells in green fluorescence 
as opposed to red staining in live cells. An orange colour is observed when the 
mitochondrial membrane becomes more polarized. A ratio of green to red 
fluorescence was plotted for analysis and FCCP was used at 20 μM as a positive 
control. In detail, HSC cells were seeded at 25,000 cells/well in a 24-well plate 
and left to adhere overnight. The next day, cells were exposed to 10 μg/ml of 
AuNPs for 3h and a time-course of 3h, 24h, 48h and 72h was followed.  
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For quantification after each time-point, the supernatant was kept in a 1.5 
ml Eppendorf tube and cells were washed with HBSS and trypsinized with 0.05% 
T/E for 7 min. The trypsinized samples and their supernatants were centrifuged 
at 1,000 rpm for 5 min and the pellet was washed twice in PBS. 1X JC-10 dye 
solution (component A) was prepared in assay buffer (component B) and 100 μl 
was added to each cell suspension ranging from 2-5 × 105 cells/sample. The 
samples were incubated for 30 minutes at 37oC and 5%CO2, protected from light. 
The fluorescence of each sample was monitored by Tali cytometer in red 
(Ex535/Em617 nm) and green channels (Ex494/Em518 nm). 
2.3.4 ROS oxidative measurements 
2.3.4.1 ROSBrite 
 Oxidative damage caused by AuNPs to HSC cells was determined by 
measuring the ROS increase on a Tali cytometer. Cells were seeded and 
prepared as described previously. A 10 mM stock solution of ROS Brite™ 570 
(AAT Bioquest, 16000) was prepared in DMSO. TBHP at 150 μM was used as 
positive control to induce ROS production. Trypsinized cells were incubated with 
10 μM ROSBrite solution diluted into HBSS with 20 mM HEPES buffer at pH 7.4 
and left to incubate for 15 minutes at 37oC and 5%CO2. The dye loading solution 
was replaced by HBSS and fluorescence was read at Ex556/Em566 nm. 
2.3.5 Cell cycle  
 In order to evaluate whether the AuNPs cause cell cycle arrest at a specific 
checkpoint, Tali™ Cell Cycle Kit (ThermoFisher Scientific, A10798) was used. 
HSC cells were prepared as described above and exposed to 10 μg/ml of AuNPS 
for 3h and 24h. At the end of the exposure times, cells were washed twice with 
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PBS by centrifugation at 1,000 rpm for 5 minutes and fixed with 70% ice-cold 
ethanol. Samples were placed at -20oC overnight and analysed the next day. For 
analysis, cells were centrifuged for 5 minutes at 4oC and re-suspended in PBS. 
PBS was removed and cells were stained with 200 µL of Tali solution to a final 
concentration of 1 × 105 –5 × 106 cells/ml for 30 minutes at room temperature 
protected from light. Samples were imaged using the Tali cytometer at 
Ex535/Em617 nm. Nocodazole at a concentration of 50 nM for 24h was used as 
a positive control for causing G2 arrest. 
2.4 Statistical analysis 
 Data were analysed using GraphPad 6.0 Prism® software. One-way or 
two-way ANOVA with Tukey’s post-tests were performed to determine significant 
differences at a critical value of α=0.05. An unpaired two-tailed t-test was used 
for comparison of the mean value between two groups.  All the experiments were 
performed in triplicate and on three independent times, unless otherwise stated. 
Asterisks indicate significant differences of *P<0.05, **P<0.01, ***P<0.001, 
****P<0.0001. Non-significant differences were not plotted. Mean±SEM was 
plotted on all graphs.   
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3 Chapter 3: Assessment of Different Physico-chemical 
and Cellular Factors Affecting AuNP Toxicity  
3.1  Introduction 
The toxicity of the AuNPs is a topic, on which contradictory evidence is 
frequently published. Few studies propose that AuNPs are non-toxic, whereas 
others describe them as toxic. Specifically, a study using 3.5 nm AuNPs on 
immune system cell lines showed that particles were internalized by endocytosis 
and did not cause toxicity as measured by MTT assays (Shukla et al., 2005). 
Similarly, Villiers et al. found that 10 nm citrate capped AuNPs were not toxic in 
dendritic cells and did not alter the phenotypic profile of the cells (Villiers et al., 
2009). In contrast to these results, Goodman et al., explained the toxicity of 
cationic gold nanospheres by their ability to interact with the cellular membrane, 
leading to membrane depolarization (Goodman et al., 2004). Data from Pan et 
al. also showed that 1.4 nm gold nanospheres were cytotoxic in a range of cell 
lines by triggering mitochondrial damage and ROS production (Pan et al., 2009).  
 There are numerous potential reasons for this controversy. It is difficult to 
compare published data because of the cytotoxicity assays used which often 
differ between the studies. Other differences might include the cell type used or 
the nanoparticle properties themselves. For instance, Patra et al., showed that 
15 nm citrate-capped AuNPs were toxic to cancer lung cell type but not to a liver 
carcinoma cell line when using the same concentration of particles (Patra et al., 
2007). In addition, the dose and exposure time of the particles make it difficult to 
compare results. This chapter will explain the factors that need to be considered 
for toxicity evaluation and how nanoparticle physicochemical parameters affect 
toxicity in vitro.  
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3.1.1 Experimental considerations in the design of cytotoxicity assays 
 The majority of published research is based on examination of the 
cytotoxicity of AuNPs in vitro due to the ease in the design and execution of the 
experimental set up and the overall control. Careful design of cytotoxicity assays 
in vitro could mimic in vivo conditions and therefore, certain considerations need 
to be taken into account. Some of these considerations that will be discussed in 
detail below include finding the appropriate cell type to be used, the choice of the 
toxicity assay, the dose of the AuNPs along with exposure time and the effects of 
the physicochemical properties of the AuNPs. 
3.1.1.1 Cell types 
 In general, the choice of cell types to be used when evaluating the 
cytotoxicity of AuNPs is dependent on the target organ and the administration 
route (Oberdörster et al., 2005). Cell types are characterized by differences in 
their proliferation rate, membrane and cell physiology, therefore it is important to 
understand the effects of the nanoparticles in a range of cell lines. Regarding the 
administration route of nanoparticles for biomedical applications, the most 
common routes include subcutaneous, intramuscular, intraocular or intravenous 
pathways (Oberdörster et al., 2005). Therefore, the cell lines to be used in 
evaluation of the cytotoxic potential of a nanoparticle should represent the 
exposure route or organs to be targeted such as nervous system, kidney, liver or 
endothelial cells.  
 It is important for the cytotoxicity assays to go beyond a single cell type 
study as AuNPs elicit different systemic responses. Depending on the route of 
exposure, particles can accumulate in various parts of the body and trigger an 
immune response, inflammation or stress (Dobrovolskaia and McNeil, 2007, Nel 
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et al., 2006). For instance, macrophages, a type of a white blood cell, are 
responsible for identifying and eliminating any foreign particles from the body 
(Jepson and Clark, 1998). Thus, it is important to study the effects of any 
nanoparticle on immune cells, which will provide further information into the 
effective design of nanomaterials (Rothen-Rutishauser et al., 2005).  
In addition to studying uptake and toxicity in macrophages and other 
immune cells, the use of endothelial and epithelial cells could provide an insight 
into nanoparticles cytotoxicity in an in vivo situation. Optimization of cell density 
and culture conditions are of crucial significance in cytotoxicity assays as there 
are cell type dependent differences in proliferation rates and cell death 
mechanisms (Frattodi et al., 2015). Also, cells at the logarithmic growth phase 
are more susceptible to nanoparticle toxicity than cells at the stationary phase 
(Pan et al., 2007). All these factors affect the sensitivity of cells to nanoparticles 
and could translate into inconsistencies in toxicity.    
3.1.1.2 Dose of AuNPs in cytotoxicity assays 
 Many studies have presented the concentration dependent toxicities of 
AuNPs (Nan et al., 2008, Lewinski et al., 2010). The chosen concentrations to be 
tested in toxicity assays in vitro should be representative of the indicative dose to 
be administered in patients. However, it is a very complicated process to 
determine this dose in cell culture, as many parameters influence the actual value 
of the dose. Nanoparticle parameters itself, such as their aggregation state in 
media, affect the number of particles internalized into the cells (Teeguarden et 
al., 2007). Also, the fact that different studies do not express the nanoparticle 
dose in the same unit, makes it harder to compare and distinguish the most 
effective dosage. Most studies express the toxicity of a particle as μg/ml volume, 
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μg/cm2 surface area of a culture dish or μg/106 cells. For example, a report on 
the cytotoxicity of silica nanotubes converted the mass per unit volume to number 
of particles inside the cells when comparing 200 nm and 500 nm nanotubes. They 
found double the number of 200 nm nanotubes inside the cells as opposed to 
500 nm nanotubes, correlating the increased number of particles to increased 
toxicity due to smaller size of the nanotubes (Nan et al., 2008).  
 Apart from the actual administered concentration described above, there 
are specific methods that accurately determine the concentration of particles 
inside the cells. Some of these methods include the analytical techniques of LC-
MS, ICP-MS, MS and electron microscopy (Moss et al., 2007, Gulson and Wong, 
2016). Depending on the dosimetry computational method used, different 
information is acquired. For instance, microscopy provides a qualitative and 
visual analysis of the localization of particles inside the cells, but is hard to 
quantify at larger scale, whereas MS provides a quantitative analysis of a large 
number of cells with no information on localization. These limitations need to be 
considered before performing a cytotoxicity assay and attempting a comparison 
of uptake between nanoparticles.  
3.1.1.3 Choice of cytotoxicity assay  
The dose-dependent toxicity of nanomaterials in cells is mainly examined 
by assays of metabolic activity, proliferation/cell viability and apoptosis. The most 
common assays include PI or trypan blue tests, LDH leakage, MTT or MTS 
assays, calcein AM, measurement of caspase substrates or Annexin V (Marquis 
et al., 2009, Soenen and Cuyper, 2009). PI and trypan blue assays are indicative 
of the cell membrane permeability and allow entry of the dye into cells with a 
disrupted cell membrane. The LDH method also determines the level of cell 
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membrane disruption (Frattodi et al., 2015). The most common method in in vitro 
toxicological studies is the MTT assay, which measures the metabolic activity of 
mitochondria in cells and quantifies the number of metabolically active, 
proliferating cells. Calcein AM is non-fluorescent after being taken up into the 
cells and is becoming fluorescent only after cleavage by esterases, showing cell 
viability. In contrast, caspases 3/7 and Annexin V are indicative of apoptosis 
(Frattodi et al., 2015).  
Depending on the assay and the type of the nanomaterial being examined 
for toxicity, there is a possibility of the nanoparticle to interfere with the assay. For 
instance, in the case of aluminium nanoparticles, a strong interference occurred 
with the MTT dye leading to misinterpretation of data (Monteiro-Riviere et al., 
2010). Also, subcellular changes could take place with nanoparticles affecting 
specific cell functions, such as mitochondrial respiration without leading to cell 
death.  Effect on cell viability by AuNPs exposure might not be visible, but 
transcription alterations and genetic damage might occur which are not 
phenotypically expressed.     
3.1.1.4 Chemical properties 
In addition to the parameters explained above, the physico-chemical 
properties of the nanoparticles affect cytotoxicity. These properties include the 
size and shape of the particles, agglomeration state and the surface ligands. 
Besides the effects on the cytotoxicity, these properties also affect cellular 
uptake, bio-distribution and protein adsorption. A table of the effects of AuNPs 
toxicity on various cell lines depending on their properties is presented below 
(Table 3.1).  
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Size and shape  
 
  AuNPs are synthesized in numerous shapes, for instance spheres, tubes, 
wires and rods and sizes ranging from 1-500 nm. There are conflicting studies of 
whether toxicity is dependent on nanoparticle size or not (Lewinksi et al., 2010, 
Pan et al., 2007). Some studies showed that the smaller the size of a 
nanoparticle, the easier the penetration into biological systems (Frattodi et al., 
2015).  It is suggested that this size-dependent toxicity arises either because of 
the presence of specific coated surface ligands or because of the large surface 
area to volume ratio that increases the nanoparticle activity. For example, it is 
reported that 1.4 nm triphenylphosphine stabilised AuNPs tested on four cell lines 
were more toxic and induced cell death by necrosis than 15 nm AuNPs that found 
to be non-toxic in vitro (Pan et al., 2007). For various types of nanoparticles 
including silica nanotubes and quantum dots, it is proposed that as particle size 
decreases, toxicity increases (Lewinksi et al., 2010, Pan et al., 2007).  
 Apart from the size, nanoparticle shape also plays an important role in 
cytotoxicity. For instance, gold nanorods were more toxic than spherical gold 
nanomaterials on HaCaT cells (Lasagna-Reeves et al., 2010). The exact 
mechanism of this observation is not understood, but surface properties, such as 
the ligand shell might be a key reason. Table 3.1 summarizes the findings of 
various studies conducted so far on the effects of size, type of cell line and shape 
of AuNPs and their biological effects in vitro. 
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Table 3.1: Summary of some in vitro AuNPs cytotoxicity studies. 
Type of cell 
line 
Size 
of 
AuNP 
Dose 
Shape, 
Surface 
group 
Type of 
test 
Biological 
effect 
Ref. 
Human 
leukemia 
cells (K562) 
4, 12, 
18 nm  
25mM-
250mM 
Citrate 
coated 
MTT 
assay 
Non-toxic to 
these cells 
Murphy, 
2010 
Mytilus 
edulis 
 
1, ~13 
nm 
 
1mM 
 
 
 
Citrate 
coated 
Oxidative 
stress, 
catalase 
activity 
AuNPs induced 
oxidative stress 
in digestive 
gland 
Van 
Doren 
et al., 
2011 
Human 
dermal 
fibroblast 
10-50 
nm 
10, 50, 
100, 
200, 300 
μΜ 
Spherical
ly citrate 
coating 
MTT 20nm were not 
toxic even at 300 
μΜ 
Patra et 
al., 
2010 
Healthy 
volunteer 
blood 
specimens 
30-50 
nm  
0.450 & 
0.420 
mg/ml 
Colloids 
citrate-
stabilized 
2D PAGE, 
AFM, DLS 
& TEM 
69 different 
proteins bound 
to AuNPs 
surface.Change 
in plasma 
coagulation time 
Renault 
et al., 
2008 
Human 
umbilical 
vein 
endothelia 
(ECV-304) 
cells 
100 
nm 
20 μl Spherical
ly bare 
and 
PCL-
coated 
Au NPs 
Microtubul
e staining 
AuNPs found in 
endosomes or 
lysosomes, 
cytoplasm, 
nucleic envelope 
and nucleus. 
Bare were 
slightly toxic 
while PCL had 
no effect 
Ghosh 
et al., 
2008 
Human 
hepatocellula
r carcinoma 
(HepG2) 
cells 
25±35 
nm 
1.0 nmol 
/L 
AuNP, 
1.2 
mol/L 
Paclitax
el (T) 
Spherical 
particles 
MTT, 
quartz 
crystal 
microbala
nce 
(QCM) 
and flow 
cytometer 
assay 
AuNPs: low 
cytotocxicity but 
disrupt adhesion 
and enhance 
apoptosis 
Yum et 
al., 
2010 
Human skin 
cell line 
(HaCaT) 
Keratinocyte
s 
1.5 nm  10 μl Spherical
ly and 
nanorods 
CTAB 
coated 
MTT Spherical AuNPs 
were non- toxic. 
AuNP nanorods 
were highly toxic 
due to presence 
of CTAB coat 
layer  
 
 
Connor 
et al., 
2005 
Human 
prostate 
carcinoma 
PC-3 cells 
30-90 
nm   
1.5 nM Spherical 
AuNPs 
MTT and 
LDH 
assay 
No LDH leakage 
observed up to 
34 nM.  
Tsoli et 
al., 
2005 
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Pancreatic 
carcinoma & 
Cama-1 
20 nm  100 nM Cetuxim
ab 
conjugat
ed 
AuNPs 
 
Flow 
cytometry 
Panc-1 had 
viability of 46% ± 
12%, Cama-1 
cell had a 
viability of 92% ± 
2% 
Bar-Ilan 
et al., 
2009 
Optical cells 20 nm 2 mM protein-
coated 
Optical 
images 
AuNP were 
found to disrupt 
the mixed 
phospholipid/cho
lesterol 
monolayer 
Chithran
i et al., 
2006 
MRC-5 
human lung 
Fibroblasts 
20 nm 
 
1nM FBS 
coated 
AuNPs 
Oxidative 
stress 
PCR 
array, 
Lipid 
hydro-
peroxide 
assay 
 
Oxidative 
damage, induced 
up-regulation of 
antioxidants, 
stress response 
genes and 
protein 
expression 
Khan et 
al., 
2007 
Mammary 
adenocarcin
oma 
(SKBR3), 
Human 
leukemia 
cells (HL60) 
L= 
44.8±2
.8 & 
41.8± 
3.3 
W= 
18.5 
±1.6 
and 
11.7 
±1.4 
nm 
20 μl PEG 
coated 
nanorod 
and 
PSS-
coated 
nanorods 
MTS 
assay 
PEGylated 
particles did not 
induce toxicity to 
any cells tested. 
PEGylated 
gold nanorods 
exhibited better 
dispersion 
stability, PSS 
coated 
rods tended to 
flocculate or 
cluster with 
induced toxicity 
Hauck 
et al., 
2007 
A549 cells, 
human 
alveolar 
epithelial-like 
cell 
15 nm 200-
2000 μg 
AuNPs Real-time 
PCR, 
ELISA 
No adverse 
effects from 
AuNPs were 
observed. No 
induction of 
oxidative 
stress markers 
and 
inflammatory 
cytokines 
Fanord 
et al., 
2011 
Human 
Sperm 
9 nm 
 
500 μL AuNPs Media AuNPs 
penetrated the 
sperm cells head 
and tails. 25% of 
the sperm 
became non-
motile compared 
to 95% control 
Donalds
on et 
al., 
2009 
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Agglomeration state and surface coating 
 
 Agglomeration of nanoparticles greatly influences particle-cell interactions 
and leads to changes in their shape and size. Especially in in vitro studies, particle 
aggregation is affected by the cell culture media due to the presence of proteins, 
fixed pH and ionic strength (Auffan et al., 2010). Therefore, it is important to 
assess whether the surface chemistry, size and shape of the nanoparticles is 
altered by the surrounding environment before any toxicity evaluation. Surface 
modifications of the nanoparticles such as the introduction of a PEG molecule, 
enable the particles to remain well dispersed in solution (Bagwe et al., 2006). 
PEG is the most common functional group used as a modifying agent due to its 
solubility and amphiphilic characteristics (Dong et al., 2010).  
Although there are various ways to maintain a well dispersed solution of 
nanoparticles via addition of specific ligands and the use of surfactants there are 
two main issues that need to be considered. Firstly, the correct characterization 
of the actual size of the particles via methods such as DLS and TEM, which 
provide an accurate estimate and visualization of any aggregates. Secondly, the 
consideration of any sample impurities left after synthesis of nanoparticles and 
purification. Any impurity of the sample can lead to additional false positive toxic 
effects. For instance, it has been shown that cetrimonium bromide in solution 
after synthesis of gold nanorods, has led to toxicity in HeLa cells (Alkilany et al., 
2008). Similarly, an inflammatory response was produced via cytokine secretion 
due to un-purified AuNPs and iron oxide particles (Shvedova et al., 2005).  
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In the next section of this chapter, the cytotoxicity of 2 nm αGal:PEGamine 
AuNPs is presented. The toxic dose was established using various 
concentrations of the AuNPs to obtain an IC50 value. Prevention of particle 
growth and aggregation were achieved through the choice of the PEG ligand. The 
cytotoxicity was measured using clonogenic assays. This method is a cell 
proliferation and survival assay, enabling the determination of the long term 
AuNPs effects on cells as opposed to fast and real time readouts. It is a cost-
effective, straight forward assay that limits the risks of particles interaction with 
the reporter dye. However, this approach is limited to cell types which grow in 
discrete colonies.  
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3.2 Results 
Previous work in the lab identified 50:50 aGal:PEGamine AuNPs as the 
most selectively toxic particles towards HSC cells as compared with HaCaT cells 
(Grellet et al., 2017). The same cell lines and the same AuNP ligand ratio were 
used in this project in order to further characterize the mechanism by which these 
AuNPs cause toxicity and cell death. However, it was discovered early on that 
different batches of the 50:50 αGal:PEGamine AuNPs showed a variability in their 
toxicity. A range of parameters was investigated to identify what was the 
component of these AuNPs responsible for the batch variability observed. The 
relevant factors were separated into two categories: nanoparticle-related factors 
and cellular-related changes. Other factors such as pH, cell density and presence 
of proteins that could affect nanoparticle behaviour are not taken into account in 
this chapter as were kept consistent throughout all experiments.  
One major issue that was initially identified was that some of these 
formulations were made with different synthesis times and different scales of 
synthesis. Moreover, not every batch was characterised to the same extent, 
making it difficult to isolate those variables that were causing differences in 
cellular toxicity. This chapter will show that following the same synthesis protocol 
does not always produce identical particles with same features. The structure of 
this chapter is based on first identifying the batch variability issue, followed by an 
investigation of whether cellular maturation changes were involved. Lastly, 
unravelling of how the batch variability issue was solved will be discussed based 
on a table below of the various factors tested (Table 3.2).  
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Table 3.2: Parameters that could account for batch variability observed on 
the toxicity of the AuNPs. 
 
Parameters changing: 
1. Ligand ratio 
2. Surface charge 
3. Synthesis method 
4. Scale of synthesis 
5. Synthesis time 
6. Ligand density 
 
3.2.1 Batch variability was observed between AuNPs samples  
Three batches of AuNPs were initially tested for toxicity evaluation by 
clonogenic assays in HSC and HaCaT cells. Each of these AuNPs had an input 
ligand ratio of 50:50 αGal:PEGamine and it was therefore assumed that they 
would maintain this ratio on the fully-formed AuNPs. Two of them, the NP118-40-
1 and M175-042-05, were made in the R&D facility in Oxford, whereas the 
NP146-149 was made in the manufacturing facility in Bilbao. The toxicity of these 
particles was highly variable in HSC cells, with IC50 values ranging from 0.9 to 
>10 μg/ml (Figure 3.1A). A more consistent toxicity was observed in HaCaT cells, 
with IC50 values >10 μg/ml (Figure 3.1B). A selective toxicity was evident with all 
three particles, correlating with previously published data in the lab (Grellet et al., 
2017). However, the variation in IC50 values led to questioning of the batches 
reproducibility, and the underlying reason had to be solved by testing various 
chemical parameters and their effects on the toxicity of AuNPs. 
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Figure 3.1: Toxicity evaluation of three batches of 50:50 αGal:PEGamine 
AuNPs as tested by clonogenic assays in A. HSC and B. HaCaT cells.  The 
NP118-40-1 and M175-042-05 AuNPs were made in the R&D facility in Oxford, 
whereas the NP146-149 was made in the manufacturing facility in Bilbao. Data 
were expressed as % of control colonies and plotted as mean±SEM, n=3 
independent experiments. One-way ANOVA, **P<0.01, ***P<0.001, 
****P<0.0001.   
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3.2.2 Cellular changes evaluation 
 Before evaluating any chemical parameters related to the batch variability 
issue, the effect of any possible cellular maturation was addressed. Such effect 
was questioned as all of these experiments were performed in triplicate and on 
three independent days. The assessment was performed by taking one of the 
particles tested above, the NP146-149 and conducting the same clonogenic 
assay experiment on early (Passage number 4) and late passage cells (Passage 
number 30) (Figure 3.2). The passage number did not affect the toxicity in HSC 
cells (Figure 3.2A). In contrast, HaCaT cells of a high passage number were less 
sensitive to AuNP exposure at high concentrations with almost 2-fold differences 
to be observed in the AuNP IC50 value between high and low passage (Figure 
3.2B). This observation suggested a possible connection between cellular 
maturation and toxicity that had to be carefully taken into consideration in 
performing subsequent experiments.  
Cellular maturation could account for differences between experimental 
outcomes in HaCaT cells, but the batch variability observed in HSC cells could 
not be explained by the non-significant differences noted between high and low 
passage number of cells. Surprisingly, little variability was observed between the 
AuNPs tested for this cell type. Therefore, one or more other factors accounted 
for the variation in HSC cells. Throughout the following experiments and the cell 
culture of the cell lines, precautions were taken to maintain the cell cultures up to 
a specific passage. Reproducibility was ensured by always splitting the cells 
between 70-80% confluency in order to minimize the cell maturation element as 
much as possible between the experiments.   
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Figure 3.2: Evaluation of cellular maturation changes from comparison of 
the IC50 values of the 50:50 αGal:PEGamine AuNP NP146-149 obtained by 
clonogenic assays in A. HSC and B. HaCaT cells. The effect on toxicity was 
compared in high (30) and low passage number (4) of both cell lines. Data were 
expressed as % of control colonies and plotted as mean±SEM, n=3 independent 
experiments. One-way ANOVA, ***P<0.001, ****P<0.0001.  
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3.2.3 Stability of AuNPs 
Another issue that had to be tested was the stability of the AuNPs over 
time. To study the long term stability, the same 50:50 AuNP was tested for toxicity 
early in the project and then repeated after a period of 1.5 years. The IC50 value 
increased by approximately 3-fold, from ~5 μg/ml to ~12 μg/ml, with the particles 
to be less toxic upon aging (Figure 3.3). Therefore, when comparing any data of 
various tests performed on AuNPs and how they translate into toxicity, cellular 
maturation and batch age over time needed to be considered. 
 
Figure 3.3: IC50 value shift of the same 50:50 αGal:PEGamine AuNP M229-
062-02 over 1.5 years in HSC cells. The age of the AuNPs was examined for 
possible changes in their toxicity profile within 1.5 years apart since their 
synthesis. Data were expressed as % of control colonies and plotted as mean 
±SEM, n=3 independent experiments.  
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The agglomeration status of the AuNPs in DMEM cell culture media 
supplemented with 10% FBS was also evaluated. TEM was chosen as the best 
method to determine the agglomeration status, as it allows visualisation of large 
numbers of individual AuNPs. The presence or absence of FBS did not affect the 
agglomeration state of the NPs used in this study (Figure 3.4), a phenomenon 
that was also confirmed by FPLC studies as presented in chapter 4. A grey blob 
appearance under the TEM was attributed to serum componenets present in 
FBS.  
 
Figure 3.4: TEM images of the aggregation state of the AuNPs (M218-024-
05, 5h synthesis time) in 10% +/- FBS. Small dark dots represent the AuNPs, 
whereas the grey cloud appearing in the +FBS image was attributed to serum 
components. Images were taken at 100x magnification, Scale bar=5 nm. 
 
3.2.4 Uptake and toxicity of AuNPs in +/- FBS cell culture conditions 
AuNPs agglomeration state was not affected by the presence of FBS in 
solution. The next step was to test whether the uptake and toxicity of the AuNPs 
into the cells was different between +/-FBS cell culture conditions during their 
exposure on HSC and HaCaT cells. Silver staining of AuNPs exposed to HSC 
cells in +/- FBS conditions showed better uptake of the AuNPs in presence of 
FBS (Figure 3.5). Uptake data at varied FBS conditions are not presented for 
HaCaT cells as previous published data in the lab showed no AuNP 
internalization into this type of cell (Grellet et al., 2017).  
 51 
 
  
  
F
ig
u
re
 
3
.5
: 
U
p
ta
k
e
 
o
f 
5
0
:5
0
 
α
G
a
l:
P
E
G
a
m
in
e
 
A
u
N
P
s
 
in
 
H
S
C
 
c
e
ll
s
 
a
ft
e
r 
3
h
 
a
c
u
te
 
e
x
p
o
s
u
re
 
a
t 
+
/-
 
F
B
S
. 
P
h
a
s
e
 
c
o
n
tr
a
s
t=
2
0
x
, 
s
ilv
e
r 
s
ta
in
in
g
=
2
0
x
 o
b
je
c
ti
ve
. 
S
c
a
le
 b
a
r=
5
0
 μ
m
. 
 52 
 
In order to have a quantitative measure for the effects of the presence or 
absence of FBS on AuNP toxicity, clonogenic assays were performed using the 
50:50 αGal:PEGamine AuNPs (Figure 3.6). No significant differences in the 
toxicity of AuNPs were detected for either cell line, despite a trend for a reduced 
toxicity in the presence of FBS.  
 
 
Figure 3.6: Differences in the cytotoxicity of 50:50 αGal:PEGamine AuNPs 
when cells are grown in the presence or absence of FBS to A. HSC and B. 
HaCaT cells.  Data were expressed as % of control colonies. Data were plotted 
as mean±SEM, n=3 independent experiments.  
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3.2.5 Ligand ratio effects 
 A list of parameters that potentially affected the toxicity was given in Table 
3.2. To elucidate which is the critical factor responsible for batch variability, they 
were tested one by one. This allowed not only to specify the causes of batch to 
batch variability but also the main effector of the particle’s toxicity. The first factor 
to be tested was the ligand ratio of the AuNPs. Many studies have shown that the 
ligand organization affects the particle interactions with the cell membrane and 
the way they are internalized by cells (Beddoes et al., 2015, Chithrani et al., 
2009). According to the study by Grellet and previous work in the lab, the toxicity 
and the uptake of the AuNPs was influenced by the ratio of αGal:PEGamine 
ligands (Grellet et al., 2017).  
Therefore, AuNPs bearing different ratios of ligands were tested by 
clonogenic assays on HSC and HaCaT cells after an acute 3h exposure at 0, 3, 
10 and 30 μg/ml. The most selectively toxic formulations were the 51:49 ratio and 
the 0:100 ratio with IC50 values of 5.5 and 11.7 μg/ml, respectively for HSC cells 
(Figure 3.7A). This correlates with data from previous work in the lab that has 
shown a 50:50 ratio of AuNPs to be the most selectively toxic in HSC cells (Grellet 
et al., 2017). IC50 values of more than 10 μg/ml were noted for HaCaT cells for 
all the ratios (Figure 3.7B). Nonetheless, the ratio 45:55, is very close to the 50:50 
ratio of αGal:PEGamine, which represents the most selectively toxic AuNP in 
HSC cells, did not behave similarly to the 51:49 ratio. More than 2-fold differences 
were noted in their IC50 values. The fact that there were big differences in their 
toxicity despite small changes in the ligand ratio makes it very likely that toxicity 
is attributed to a factor other the ligand ratio.  
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Figure 3.7: Ligand ratio effects on the toxicity of the AuNPs in A. HSC and 
B. HaCaT cells as examined by clonogenic assays after an acute 3h 
exposure of all the AuNPs at 0, 3, 10 and 30 μg/ml. The ratios included: 0:100 
(M175-042-01), 11:89 (M175-042-02), 30:70 (M175-065-03), 45:55 (M175-065-
04), 51:49 (M175-042-05) αGal:PEGamine as measured by NMR. Data were 
expressed as % of control colonies and plotted as mean±SEM, n=3 independent 
experiments. One-way ANOVA, ***P<0.001, ****P<0.0001.  
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3.2.6 Surface charge 
 The differences in ligand ratio around the Au core can have an impact on 
the surface charge of the AuNPs (Feng et al., 2015). To investigate whether the 
AuNPs with different ligand ratios varied in their surface charge, measurements 
of their zeta potential were conducted and are presented in the table below (Table 
3.3). Despite showing different toxicities in HSC cells, small variations in zeta 
potential were found between 45:55 and 51:49 ratio AuNPs. Therefore, the ζ 
potential could not explain the variation observed in the toxicities between these 
particles. 
Table 3.3: Zeta potential measurements of the different αGal:PEGamine 
ratios of AuNPs. 
αGal:PEGamine ratio ζ potential (mV) ± SD 
0:100 (M175-042-01) +43.0±5.7 
11:89 (M175-042-02) +4.27±10.8 
30:70 (M175-065-03) +11.6±7.16 
45:55 (M175-065-04) +16.6±5.56 
51:49 (M175-042-05) +17.2±4.95 
 
 After ruling out the ligand ratio and the ζ potential as factors that affect the 
AuNP toxicity, differences in the surface charge of similarly sized particles were 
evaluated for their effects on the toxicity using clonogenic assays. A negatively 
charged AuNP containing only αGal (ζ=-16.0±6.3 mV) as a surface coating was 
compared to a positively charged 50:50 ratio αGal:PEGamine AuNP 
(ζ=+17.2±4.95 mV) and a positively charged PAMAM dendrimer G4 
(ζ=+37.2±1.95 mV) (Figure 3.8). All of the three nanoparticles had a 
hydrodynamic diameter of ~4 nm and their toxicity was tested on HSC and HaCaT 
cells at five different concentrations (0, 1, 3, 10, 30 μg/ml).  
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An estimated IC50 value of ~6 μg/ml for HSC and an IC50 of >10 μg/ml 
for HaCaT cells was calculated for the 50:50 AuNP (Figure 3.8A&B). The other 
two nanoparticles that were tested had much higher IC50 values and showed 
less selective toxicities between the cell lines. This result indicated that surface 
charge was not the only factor responsible for selective toxicity, as particles with 
positive charge and similar size did not show the same toxicity. 
 
 
Figure 3.8: Effect of surface charge and size as determined by clonogenic 
assays of three different nanoparticles on A. HSC and B. HaCaT cells. 50:50 
αGal:PEGamine, 4nm, +ve charge, αGal only AuNP, 4nm, -ve charge and 
PAMAM dendrimer G4, 4nm, +ve charge. Data were plotted as mean±SEM, n=3 
independent experiments. One-way ANOVA, *P<0.05, **P<0.01.  
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3.2.7  Synthesis method 
 One of the parameters changing between the R&D and manufacturing 
facilities was the synthesis method of the AuNPs. The effect of the purification 
method after synthesis had to be assessed for differences in toxicity in both HSC 
and HaCaT cell lines. When comparing the toxicity of the particles purified with 
the different methods on HSC cells (Figure 3.9A), particles prepared with 
methanol without being purified were more toxic, with an IC50 of <1 μg/ml than 
the other two synthesis types. A similar pattern was found in HaCaT cells with 
less selective differences to occur (Figure 3.9B). 
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Figure 3.9: Cell survival (expressed as % control colonies) determined by 
clonogenic assays of 50:50 αGal:PEGamine AuNPs prepared with either 
alkaline (M218-104-01) or methanol (M218-095-01, -02) method in A. HSC 
and B. HaCaT cells.  Data were plotted as mean±SEM, n=3 independent 
experiments. One-way ANOVA, *P<0.05, **P<0.01, ***P<0.001.   
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3.2.8 Scale of synthesis 
 Apart from the synthesis method changing between the two facilities, the 
scale of synthesis also varied. Particles prepared for research purposes were 
made at a small scale (2 ml) as opposed to the large scale (10 ml) of the 
manufacturing facility. Therefore, the toxicity of batches synthesized at small and 
large scale was compared in order to assess whether the scale of synthesis affect 
toxicity. To obtain comparable results, only the synthesis scale was changed. 
Clonogenic assays showed that there were no differences between the different 
synthesis scales for both HSC and HaCaT cells (Figure 3.10A&B).  
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Figure 3.10: Clonogenic assays of AuNPs acute exposure to A. HSC and B. 
HaCaT cells of AuNPs prepared at small and large scale.  Particles prepared 
for research materials were made at small scale (2 ml, M218-086-01) in R&D as 
opposed to the large scale (10 ml, M182-073-1) of the manufacturing facility in 
Bilbao. Data were plotted as mean±SEM. 
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3.2.9 Synthesis time 
During the large scale synthesis it takes more time to purify the particles, 
increasing their actual synthesis time, and thus the contact time between ligands, 
gold and reducing agent. Therefore, the effect of the synthesis time of AuNPs on 
their toxicity was tested by comparing the toxicities of the same batch of the 50:50 
AuNP aliquoted at 1h, 2h and 5h.  
The results showed that with increasing synthesis time, the toxicity 
increased and the selectivity decreased. Concentration-dependent significant 
differences occurred with 10 μg/ml to be very toxic for all synthesis time for HSC 
cells and less toxic for HaCaT (Figure 3.11A&B). Details of how changes in 
synthesis time of AuNPs leads to differences in ligand density and affects the 
mechanism of toxicity are presented in the next chapters. 
  
 62 
 
 
 
 
 
Figure 3.11: Clonogenic assays of 1h (M218-024-01), 2h (M218-024-02) and 
5h (M218-024-05) synthesis time AuNPs on A. HSC and B. HaCaT cells. 
Significant differences between 1h and 2h synthesis AuNPs are marked by * 
symbols, while significant differences between 1h and 5h synthesis AuNPs are 
marked by § symbols. Data were expressed as % of the number of control 
colonies and plotted as mean±SEM, n=3 independent experiments. One-way 
ANOVA, *P<0.05, **P<0.01, ***P<0.001.  
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3.3 Discussion 
3.3.1 Batch variability 
 A problem that often exists in pharmaceutical industries with the production 
of nanoparticles is the batch to batch variability. This can have a significant impact 
on the toxicity and behaviour of these particles in biological applications and 
therefore sufficient effort has to be made to ensure reproducibility (Roebben et 
al., 2013, Yu et al., 2012). Control over synthesis method, optimization and 
validation along with a better understanding of the physico-chemical parameters 
that produce batch to batch variability is of great importance. Such control was 
possible from Midatech after identification of the batch variability issues, which 
efficiently provided 3 identical batches (M229-062-01, -02,-03) under controlled 
conditions. These batches were tested for their toxicity towards HSC and HaCaT 
cells by clonogenic assay, resulting in similar IC50 values of around ~5 and 8 
μg/ml, respectively to these cells lines.   
 The Organization for Economic Co-operation and Development (OECD) 
has set up three main categories as an area of focus for method validation during 
the development of nanomaterials. These categories include characterization of 
the physico-chemical properties of the particles such as size, shape, composition 
and surface features, biological and environmental fate of the nanoparticles 
regarding toxicity, bio-distribution and solubility and lastly, reactivity in biological 
conditions, photo-reactivity and physical hazards (OECD 2016, Rasmussen et 
al., 2018). These categories describe most of the parameters that need to be 
evaluated in every batch and ensure reproducibility. In this chapter, 
physicochemical parameters of the different batches were not examined in detail 
as limited amount of material was provided for full chemical characterization.   
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3.3.2 Cellular maturation 
 The batch to batch variability can not only be attributed to the nanoparticle 
themselves, but in an in vitro situation cellular maturation could also be the reason 
of batches variations observed. When performing studies using cultured cells, 
long term cell culture can affect the biological readout of the toxicity of the AuNPs 
used in this project. The two cell lines used in this study, HSC and HaCaT cells, 
differed on the effect their passage number had on the AuNP toxicity. Whilst the 
passage number did not affect the toxicity of the particles in HSC cells, a 
decreased toxicity was found in HaCaT cells of high passage number (Figure 
3.2).  
 HSCs are an immortalized skin cancer cell line that in theory can be cultured 
indefinitely without differentiating and without changing their morphology and 
phenotype. HaCaT cells on the other hand are an immortalized keratinocyte cell 
line that its differentiation ability has been previously examined by Colombo and 
colleagues (Colombo et al., 2017). Colombo et al., has shown in his study that 
the differentiation of HaCaT cells was affected by both the cell seeding density 
and the level of extracellular Ca2+ in the medium of long-term in vitro cultures.  In 
order for HaCaT cells to be maintained in their basal non-differentiated level, 
which is characterized by high levels of the expression marker K14, the cells need 
to be cultured up to 80% confluency and kept in low Ca2+ conditions (Boukamp 
et al., 1988, Micallef et al., 2009). Although these conditions have been 
maintained throughout the cell culture of this project, it should be taken into 
account from the above studies, that HaCaT differentiation is a very likely event 
to occur, therefore any data interpretation regarding this cell line should be made 
with caution. 
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3.3.3 PEG stability 
 The IC50 values of the same batch of particles after long term storage 
(Figure 3.3) clearly showed that the AuNPs used throughout the project were 
changing and thus these data reinforced the idea that the ability to produce 
batches in a reproducible manner were of critical importance. The exact timing of 
when and how the particles changed was not studied as the main question of this 
thesis was not to identify how and why particles changed but try to understand 
why fresh batches varied.  
 According to literature, aging of PEG compounds lead to the reduction of 
pH, increased ionic strength and increased metal binding (Jurnak, 1986, Ray and 
Puvathingal, 1985). These effects can result from the presence of oxygen, light 
and elevated temperature (Jurnak, 1986). The aging of the PEG molecules can 
be minimized by storage at -20oC or 4oC in a sealed vial protected from light. 
Midatech’s AuNPs were stored at 4oC and it was ensured that a set of 
experiments was completed with one batch in a short period of time (within 6 
months) in order for the results to be comparable. A study published on 8 different 
polyethylene glycols stored in typical laboratory storage conditions proved that 
the molecules were stable up to 18 months as measured by their conductivity and 
pH (Jurnak, 1986). Therefore, with correct storage conditions PEG stability can 
be ensured.  
  
 66 
 
3.3.4 Aggregation  
 A factor that had also to be addressed before examining the physico-
chemical properties of the AuNPs and how they interfere with toxicity, was the 
aggregation state of the particles. Before performing the toxicity experiments, 
particles dispersity in solution was visualized under TEM to ensure homogeneous 
distribution in the storage solution and in culture media used for application of 
AuNPs in the cells. Particles did not aggregate in either solutions. However, many 
studies showed that any type of nanoparticle is prone to aggregation in culture 
media due to being exposed to proteins and ions that cause van der Waals 
attractive forces being greater than the repulsive forces on the surface of the 
particles (Rausch et al., 2010, Derjaguin et al., 1993, Qiu et al., 2010, Cingolani 
and Pompa, 2010).  
 Thus, the 50:50 AuNPs were tested for their toxicity and uptake in absence 
and presence of FBS as serum proteins can lead to a thermodynamically more 
favourable replacement of surface molecules with serum. Another reason for 
testing the AuNPs in presence and absence of serum was that increased 
concentration of ions in culture media after FBS addition could interfere with the 
charge on the nanoparticle surface and alter its properties. Although no significant 
differences were observed regarding the toxicity (Figure 3.6), AuNP uptake was 
influenced by the presence of serum (Figure 3.5), making the particles either to 
internalize more or stick more at the cell surface of HSC cells. The silver staining 
method performed did not provide the ability to distinguish between internalized 
particles and particles at the cell surface. Therefore, it was not possible to 
conclude whether serum facilitates nanoparticle uptake. Since no differences 
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were observed in terms of toxicity, particle aggregation was ruled out as a factor 
responsible for the batch variation.  
3.3.5 Physico-chemical Properties 
 The different physicochemical properties of AuNPs that likely influence 
biological activity and toxicity are the nanoparticle size, shape, charge and 
surface characteristics (Auffan et al., 2010). For example, AuNPs 1.4 nm in 
diameter capped with triphenylphosphine monosulfonate caused mitochondrial 
damage and necrosis via oxidative stress, while 3.7 nm AuNPs modified with 
PEG were non-toxic when internalized into the nucleus of HeLa cells (Goodman 
et al., 2004).  With Midatech’s AuNPs, the size and shape remained constant in 
every batch tested, therefore the variability was not based on these properties. 
However, surface characteristics were questioned. Specifically, ligands attached 
to the AuNPs modify their surface characteristics. Grellet et al., showed that the 
ligand ratio around the Au core influenced the toxicity of the AuNPs (Grellet et al., 
2017). However, in the data presented in this thesis the differences in toxicity 
observed between similar ratios batches did not explain the variation (Figure 3.7).  
 Depending on the nature of the charge, cationic or anionic, differences in 
reactivity with other protein complexes or molecules occurs (Goodman et al., 
2004). In the case of the AuNPs presented in this study no difference in the zeta 
potential was observed (Table 3.3) and thus, no conclusions could be made of 
whether charge influenced the particle toxicity and uptake by HSC and HaCaT 
cells. Other studies found that the more positive the charge of a particle, the 
higher the toxicity, whereas Schaeublin et al., have demonstrated that both 
positively and negatively charged particles were toxic to lymphoid cells by 
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generation of reactive oxygen species and changes in mitochondrial membrane 
potential (Schaeublin et al., 2011).  
 After investigating the basic parameters that could be different between the 
AuNPs received from Midatech, it was concluded that neither the size, shape, 
aggregation state or charge and ligand ratio were responsible for the variation 
observed in toxicities and varied IC50 values between batches. As a result, the 
synthesis protocol was questioned. It was found that manufacturing and R&D 
facilities differed in their AuNPs synthesis procedure and hence, after eliminating 
the parameters mentioned above, only this parameter of the synthesis process, 
could possibly account for the batch to batch variability. The synthesis method 
was changing between facilities and within the facility. Regarding the purification 
method, only the alkaline process was of interest as methanol preparation of 
AuNPs could lead to particle precipitation. Although the alkaline method was 
consistent between the batches, a variation in the toxicity was observed. The 
scale of synthesis did not cause significant differences between AuNPs made at 
small or large scale.    
 The most important factor that appeared to play a major role affecting the 
toxicity of these αGal:PEGamine AuNPs was the synthesis time. Synthesis time 
is a factor vital in the synthesis and production of any nanoparticle, however no 
published data exist as to its relevance to toxicity. A novel finding of this work was 
that the longer the synthesis time of the AuNPs, the greater the toxicity. Someone 
might argue that as synthesis time increases, changes in size and surface area 
to volume ratio is altered thus the toxicity. The effect was investigated in greater 
detail in the next chapter showing that size remained constant and the only 
parameter changing with particles made at different time points was their ligand 
density surrounding the Au core.  
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 To conclude, this chapter presented a series of parameters and factors that 
were taken into account in order to address the batch variability issue observed 
in the beginning of this project. By eliminating and narrowing down factors that 
are the only ones changing between the particles, a novel feature was identified 
that played a significant role in the toxicity of these AuNPs (Figure 3.12). Once 
an awareness was raised that batch variability was a problem and specific 
parameters led to it, particles made under identical conditions and at same 
synthesis time were synthesized and were fully characterized for next 
experiments. 
 
Figure 3.12: Schematic representation of the possible factors affecting 
AuNP toxicity, responsible for the batch to batch variability observed. 
Synthesis was one of the most significant parameters identified responsible for 
batch variability and most importantly synthesis time.  
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4 Chapter 4: Role of Synthesis Time and Ligand 
Density in AuNP Toxicity and Their Effect on The 
Transport of AuNP’s 
4.1 Introduction 
The surface chemistry of nanoparticles plays an important role as to how 
they interact with the cellular machinery. An understanding of the dynamics of the 
coating of AuNPs and its structure is crucial in order to examine the particles’ 
biological interactions. Such understanding is also vital in the design and 
synthesis of nanomaterials. A part of the nanoparticles surface coating are the 
ligands, a component that is used for providing stability and functionality to the 
particle (Boles et al., 2016, Albanese, 2012). The choice of ligands can control 
the size and charge of the particles (Lee et al., 2010). Many studies showed that 
the organization and the choice of ligands are key for targeting cells via the 
nanoparticle interaction with biological membranes (Chou et al., 2011, Verma et 
al., 2008). Other studies suggested that ligands can determine cytotoxicity and in 
vivo distribution of the nanoparticles (Kievit et al., 2011, Smith et al., 2008). 
4.1.1 Mechanisms of transport pathways utilized by AuNPs in cells 
 Many research groups are focusing on identifying routes of uptake of 
various types of nanoparticles but often discrepancies are observed in the 
published data due to nanoparticle internalization being highly dependent on 
multiple factors. Some of these factors are the properties of the nanoparticles 
such as size, charge and ligand design. In addition to the nanoparticle’s 
properties, cell dependent factors like the cell type and cell cycle phase can play 
an important part on the particle uptake. Due to the state of the cell also possibly 
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affecting the particle uptake, it is very difficult to conclude whether optimal cellular 
uptake can be achieved with one specific nanoparticle property configuration. 
 With regard to the features of the nanoparticle itself, different studies show 
that both the charge and the size are important for enhanced uptake. However, 
a controversy exists regarding the type of charge and the actual size of the 
nanoparticles. In theory, a positively charged nanoparticle will more efficiently 
bind to the negatively charged cell surface. This was supported by a study that 
compared the uptake of both positively and negatively charged mPEG-PLA 
nanoparticles of similar size by HeLa cells. The study found that the positively 
charged nanoparticles were taken up two times more than the negatively charged 
ones (Harush-Frenkel et al., 2007). In contrast, in HEK cells, higher uptake of 
negatively charged QDs nanoparticles was observed (Zhang and Monteiro-
Riviere, 2009). Also, reports revealed that nanoparticles of around 20-50 nm are 
internalized in a higher rate than smaller or larger particles (Shang et al., 2014). 
Nanoparticles have been shown to get internalized via the energy-dependent 
pathways of endocytosis and energy-independent mechanisms. There are two 
main categories of endocytosis: the pinocytosis and phagocytosis (Figure 4.1).  
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Figure 4.1: Mechanisms of internalization pathways utilized by 
nanoparticles. Nanoparticles (green dots) and other substances are internalized 
via endocytosis in a clathrin dependent and clathrin independent manner. They 
are taken up by either early endosomes (EE), phagosomes or macropinosomes 
(MP). Maturation of these vesicles lead to formation of late endosomes, 
multivesicular bodies (MVB) which fuse with lysosomes (Lys) down the 
degradative pathway. The pH of this compartment is acidic and around 4.0-5.5, 
which enables particle degradation via proteases and other enzymes. Particles 
can alternatively be recycled back to the cell surface through the EE or recycling 
endosomes (RE). From Iversen et al., 2011. 
 
4.1.1.1 Phagocytosis 
 Phagocytosis is the main route of internalization of particles larger than 
500 nm in diameter. The process is initiated by the immune’s system specialized 
cells, the phagocytes such as dendritic cells, monocytes and macrophages, 
which are responsible for the elimination of bacteria, viruses and infected or dead 
cells. Phagocytosis of nanoparticles occurs in 3 stages. The first one is the 
opsonisation process in which opsonin proteins like blood proteins and 
immunoglobulins are adsorbed into the nanoparticle’s surface and recognized by 
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phagocytes (Hillaireau and Couvreur, 2009, Sahay et al., 2010). This recognition 
triggers a cascade of signalling events leading to actin polymerization and 
development of cell surface protrusions called phagosome that cause 
nanoparticle uptake by an engulfing like mechanism. Phagosomes then fuse with 
lysosomes, leading to the degradation of the nanoparticles by the enzymes and 
acidic environment supplied by the lysosomes (May and Machesky et al., 2001). 
4.1.1.2 Pinocytosis  
 Internalization of smaller sized nanoparticles occurs via pinocytosis. This 
route of uptake is classified into clathrin-dependent and clathrin-independent 
pathways. The clathrin-independent pathways are categorized into 
micropinocytosis and caveolae or dynamin-mediated endocytosis (Iversen et al., 
2011).  
Clathrin-mediated endocytosis  
 The design of many ligands is directed on the recognition of EGF, LDL or 
Tf receptors on the cell surface. A non-receptor mediated uptake can also happen 
via electrostatic or hydrophobic interactions that will lead to internalization 
(Conner and Schmid, 2003). Clathrin mediated endocytosis begins at the cell 
surface level which is rich of the protein clathrin. Adaptor proteins such as Ap-2 
initiate the formation of a clathrin lattice on the cytosolic part of the plasma 
membrane followed by the creation of clathrin coated pits.  
Clathrin coated pits represent curved invaginations of the plasma 
membrane which are less than 200 nm in size (Munoz and Costa, 2012, Sahay 
et al., 2010). The clathrin coated pit narrows by dynamin acting on the neck of 
the pit to promote vesicle detachment from the membrane and formation of 
clathrin coated vesicles. Once the clathrin coated vesicles are detached, actin 
 74 
 
polymerization occurs to aid its movement inside the cell (McMahon and Boucrot, 
2011). The clathrin coat degrades and early endosomes are formed. After 
maturation to the late endosome either sorting to Golgi apparatus or lysosomes 
occurs leading to nanoparticle degradation by acidic pH and lysosomal enzymes 
or recycling of endosomes back to the cell surface (Tran and Webster, 2013).  
Caveolae-mediated endocytosis 
 Caveolae mediated endocytosis is the second pathway that draws major 
attention in nanoparticle drug delivery. This type of pathway has also been 
implicated in diseases such as cancer, viral infections and diabetes (Rothberg et 
al., 1992, Mora et al., 1999). Caveolae are cell membrane invaginations that are 
responsible for signal transduction pathways and vesicle formation. They are 50-
80 nm in size and they are enriched of two important proteins, caveolin 1 and 
caveolin 2. Caveolin 1 is the predominant protein that determines the shape of 
the caveolae, whereas caveolin 2 is responsible for structural stabilization 
(Pelkmans and Helenius, 2002). Internalization of caveolae is initiated by the 
binding of specific ligands such as albumin and folic acid followed by the 
formation of caveolar endocytic vesicles. Dynamin is releasing the vesicles from 
the membrane in order to move into the cytosol towards the caveosome, a pH 
neutral compartment. The internalized nanoparticles end up to ER or Golgi 
apparatus (Hillaireau and Couvreur, 2009).   
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Clathrin/caveolae independent endocytosis  
 The clathrin/caveolae independent pathways involve different cargos with 
specific lipid composition taken up by the cell such as Rho GTPase, Arf 6, Cdc42 
and flotillin (Kafshgari et al., 2015).  As in every endocytic pathway, the 
membrane engulfs the cargos into vesicles, which are sorted into caveosomes or 
endosomes. The final destination of the particles is either lysosomal degradation, 
delivery to the Golgi apparatus or ER, or release back to the cytoplasm.  
Macropinocytosis 
 Macropinocytosis is a process that does not involve any receptor mediated 
activation. However, it requires the activation of tyrosine kinases such as PDGFR 
or EGFR for actin polymerization increase and the formation of large ruffles or 
membrane extensions by cytoskeleton rearrangement (Kafshgari et al., 2015). 
Internalization of bulk fluid from the cell’s surroundings into cytoplasmic vacuoles 
called macropinosomes occurs via this pathway. The fusion of macropinosomes 
with lysosomes leads to its degradation and the release of nanoparticles. Release 
of nanoparticles into the cytoplasm is also possible due to the leaky nature of 
macropinosome.  
Other entry pathways 
 Apart from the endocytic mechanisms described above, other 
mechanisms of entry have been characterized, which involve passive uptake and 
hole formation. For instance, Wang et al., described how DPA QDs interacted 
with the lipid membrane bilayer leading to its reorganization and passive diffusion 
of the nanoparticles without affecting the membrane integrity (Wang et al., 2016). 
Moreover, artificial mechanisms have been utilized for entry of nanomaterials into 
the cells. For example, microinjection techniques have been used to directly 
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deliver metal oxide metallic nanoparticles and silver nanoparticles into the 
cytoplasm of Hela cells (Candeloro et al., 2011). The same approach was 
adopted for injection of compacted nanoparticles into cancer cells (Liu et al., 
2003). Another artificial method, called electroporation, involves the application 
of high voltage electrical impulses to cells, which creates membrane pores 
allowing entry of nanoparticles. This method was utilized for peptide conjugated 
QDs and oligonucleotide conjugated gold nanoparticles (Zhao et al., 2011, Jen 
et al., 2004).  
4.1.2 Filopodia at the cell surface 
 The role of this cellular structure and its mechanism of action is still not 
well understood. As mentioned above, for the various endocytic mechanisms, 
there is an important step before internalization of the nanoparticles. This step 
involves actin polymerization and assembly of actin filaments. Such 
polymerization is a precursor not only for endocytosis and phagocytosis but for 
cell migration as well. Cell migration is a dynamic process that depends on actin 
assemblies that are constantly adjusting on the cell membrane. These actin rich 
protrusions of the cell membrane are called filopodia. Their size ranges between 
0.1 to 0.3 μm (Mallavarapu and Mitchison, 1999). There are various functions in 
which filopodia are involved but their main role is in cell migration, embryonic 
development, wound healing and cell guidance towards chemoattractants (Faix 
et al., 2006, Gupton et al., 2007).   
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4.1.2.1 Cellular functions of filopodia 
 The best characterized function of filopodia is cell migration and motility. 
In this context, filopodia act as antennae for the cells to sense their 
microenvironment. They contain receptors for various signalling molecules and 
thus, play a major role in signal transduction pathways (Vasioukhin et al., 2000). 
It has been found that the migration and cell adhesion abilities of filopodia are 
attributed to cell adhesion molecules like cadherins and integrins which are found 
in the filopodia’s tip (Steketee and Tosnev, 2002). Also, upon pathogen invasion, 
filopodia will bind to pathogens and initiate their phagocytosis (Thomas et al., 
2010). Another role of filopodia is on wound healing and embryonic development. 
In these biological processes, epithelial cells fuse into sheet like structures and 
filopodia assist on the formation of adherens junctions between epithelial cells 
(Vasioukhin et al., 2000). Filopodia also participate in the migration and guidance 
of neuronal growth cones at the end of neurites for guidance towards 
chemoattractants. Apart from their function in neurite growth, they enable the 
formation of cortical neurons and dendritic spines (Sekino et al., 2007). 
4.1.2.2 Components of filopodia 
 Many proteins that are responsible for the regulation of the actin 
cytoskeleton are associated with filopodia formation. The major protein involved 
is the CDC42 that belongs to a family of Rho GTPases. The most common 
pathway that activates filopodia formation is via the ARP2/3-WASP complex 
(Ohta et al., 1999). This complex generates a branched F-actin network that leads 
to lamellipodial formation. Dia2 is a formin protein that initiates the development 
of unbranched actin filaments and along with RIF, a small GTPase, promotes 
 78 
 
elongation of filopodia. ENA/VASP proteins localize at the tips of filopodia and on 
focal adhesions stimulating their elongation (Figure 4.2).  
 
Figure 4.2: Schematic illustration of the key proteins involved in the 
formation of filopodia.  The actin cross-linking protein fascin produces an actin 
filament bundle. Adhesion molecules are localized to the filopodia tip by myosin-
X in order for the elongation process to begin. Dia2 controls the elongation and 
is localized at the tip complex. From Mattila and Lappalainen, 2008.   
 
 On the other hand, Myosin-X is a large group of motor proteins that “walk” 
across actin filaments to transport proteins to filopodia required for their formation 
(Ohta et al., 1999). A protein that maintains the F-actin bundles of filopodia is 
fascin. It is not directly linked to their formation, but it is associated with the 
production of parallel and stiff filament bundles. In addition to actin cytoskeleton 
reorganization, deformation of the plasma membrane has also been shown. 
During this deformation, an F-actin cross linking activity of IM/I-BAR domain leads 
to filopodia formation and plasma membrane protrusions (Scita et al., 2008). 
Lastly, some other proteins have been identified to be important for filopodia 
formation but their mechanism is not fully understood. Specifically, Sigal et al., 
published that a lipid phosphatase related protein, plays a role in filopodia 
dynamics in an independent manner of the ENA/VASP and ARP2/3 complex. It 
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probably resembles more the role of the I-BAR domain proteins in inducing 
membrane curvature but this still needs to be confirmed (Sigal et al., 2008). 
4.1.3 The use of surface ligands in nanotechnology 
The surface chemistry of a nanoparticle along with the choice, the design 
and the density of the ligands attached to it play a crucial role in the interaction of 
the nanoparticles with the cell membrane and cellular uptake. The use of 
appropriate ligands in nanotechnology provides the ability to control the 
nanoparticles surface properties from assembly and synthesis to biological 
interactions, leading to effective cellular uptake. Ligands can affect the stability, 
functionality, size and shape of the particles along with their agglomeration state. 
Advancements in characterization techniques and ligand design along with the 
choice of the solvent, the control of the temperature and pH during synthesis, 
provide the advantage to synthesize nanoparticles with various size and shapes, 
interacting in a desired way with a biological membrane or organ. 
4.1.3.1 Ligands for nanoparticle synthesis, assembly and stability  
 Ligands can kinetically affect the shape and the size of the nanoparticles 
under thermodynamic control (Yin and Alivisatos, 2005). For instance, the 
introduction of a ligand that selectively binds to a metal will reduce its growth rate. 
However, it is very difficult to estimate the adhesion energy of a ligand when 
synthesizing a nanoparticle because of their various binding affinities. Core-shell 
nanoparticles can be generated by the approach of having a growth starting at 
the core of an inorganic material and via a hydrolysis step a second inorganic 
precursor is formed to create a core-shell structure particle (Ling et al., 2014). In 
biomedical applications though there is a need of controlling the hydro-dynamic 
radius of a nanoparticle therefore, the use of a hydrophilic or hydrophobic ligand 
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is more applicable depending on the purpose/proposed uptake mechanism. 
Hydrophobic ligands are transported though the bloodstream attached to a 
hydrophilic carrier whereas hydrophilic ligands are binding to a cell surface. 
 Nevertheless, issues of stability and agglomeration exist by using a 
hydrophobic ligand. The approach to overcome these issues is to replace a 
hydrophobic ligand with a hydrophilic one by attaching a chelating motif of 
amines, thiols, carboxylic acids or phosphines to the nanoparticle (Ling et al., 
2014). Another approach is based on the formation of micelle like structures that 
include an amphiphilic ligand encapsulating nanoparticles via hydrophobic 
interactions (Dubertret et al., 2002, Yu et al., 2007).    
4.1.3.2 Ligands for biomedical applications 
PEGylated nanoparticles 
 Most of the time, nanoparticles are cleared too fast by the mononuclear 
phagocyte system, which is part of the immune system consisting of phagocytes. 
Therefore, the use of biocompatible ligands can enhance their effectiveness and 
aid the targeting of the nanoparticles to a specific place. One of the most widely 
used ligand attached to AuNPs for biomedical applications is the PEG molecule. 
PEG is a non-immunogenic and non-toxic polymer that is used in the 
biopharmaceuticals industry because of its advantageous pharmacokinetic 
properties. Some of these properties are decreased immunogenicity, enhanced 
nanoparticle solubility, stability and increased blood circulation time (Walkey et 
al., 2012, Otsuka et al., 2003, Jokerst et al., 2011). 
AuNPs are often coated with PEG via PEGylation. PEGylation is an 
important process in the synthesis of nanomaterials as it attributes specific 
physico-chemical features on the nanoparticles. These include changes in their 
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hydrophobicity, electrostatic binding and alterations in their pharmacokinetic 
profile (Kim et al., 2009, Choi et al., 2007). The effectiveness of the PEG coating 
is affected by both the length of the PEG chain and the surface density. For 
example, an increased coating thickness has been linked to a reduced 
radiosensitization effect (Xiao et al., 2011).  
The ligand density around the core of the nanoparticle interferes with the 
uptake of the particles by cells and with proteins present in the biological medium, 
forming a complex termed as protein corona. Protein corona formation is a 
phenomenon that depends upon both the nanoparticle and protein 
characteristics. The size, the type, the conformational flexibility of the protein 
along with the type of the nanoparticle, the charge, the shape, the size and the 
hydrophobicity affect the way the protein corona is formed around the 
nanoparticle (Cedervall et al., 2007, Yang et al., 2013). Also, medium related 
factors such as the ionic strength of the solution and the pH plays an important 
role (Monopoli et al., 2011).  
Various studies have shown that there is an optimum ligand density 
required for particle uptake (Ling et al., 2014). Decreased PEG density can lead 
to activation of macrophage surface receptors and adsorption of proteins 
whereas, less bound proteins on a higher density PEG coated nanoparticle can 
affect their uptake by macrophages (You et al., 2005). There is a baseline level 
at which uptake is independent of protein binding, which is a density of around 
0.5 molecules/ nm2 (Figure 4.3).  
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Figure 4.3: PEG density effects on the clearance of monocytes.  The protein 
corona formation is caused by exposure to serum and is affected by the density 
of the PEG molecules. An opsonin-like structure is formed at low densities of 
PEG, whereas high densities adsorb less proteins. From Ling et al., 2014. 
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Zwitterionic ligands  
 Unlike the PEG ligands, zwitterionic ligands adsorb less protein corona, 
leading to a longer circulation of the particles in the bloodstream without them 
being taken up by monocytes. Zwitterionic ligands can either be polymeric or 
small molecule ligands that are both described below. A recent study showed 
decreased clearance and better immunotolerance with zwitterionic poly-
carboxybetaine based nanomaterials (Young et al., 2014).  
Small molecule ligands 
 This type of ligands are easy to synthesize and have different 
functionalities. Enhanced adsorption of proteins is attracted to the nanoparticle 
surface when is coated with a monolayer of small molecule ligands. This type of 
ligand can be used for modifying the nanoparticle assembly and the interaction 
with cell surface receptors. A study has previously published the use of two small 
molecules as ligands, the OPAP and the PDP which hydrogen bonds with the 
polymer PS-b-P4VP in order to direct particle assembly over large scales (Zhao 
et al., 2009). A study from You and colleagues demonstrated cytochrome c and 
α-chymotrypsin targeting via the use of a nanoparticle coated with the 
hydrophobic amino acids phenylalanine and leucine (You et al., 2008).  Such 
approach yielded a high specificity and recognition capacity towards the targeted 
proteins with an approximately 20-fold higher affinity than nanoparticles with 
similar hydrophobicity (You et al., 2008).   
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Cell specific nanoparticle ligands 
 In most cases, the focus of the design of a nanomaterial is to include 
ligands that do not trigger an immune response. There is a bigger focus which is 
the targeting of the nanoparticle to a specific cell type or organ, such as in 
occasions of cancer targeting therapeutics. Hydrophobic particles can stick to the 
outer cell membrane which is of lipophilic nature leading to micropinocytic or 
endocytic uptake. However, hydrophobic coated nanoparticles tend to aggregate 
and will most likely create a protein corona around them thus ending up in 
agglomerated form before entering the cell (Weissleder et al., 2005). Therefore, 
hydrophilic ligands with small molecules, antibodies or peptides attached to them 
are preferred to overcome the agglomeration problem and trigger an endocytic 
uptake mechanism by binding to the desired receptor (McCarthy et al., 2008). A 
limitation arises here due to the fact that the triggering of a specific uptake 
mechanism is highly dependent on the expression of the receptor at the cell 
surface and the tissue or cell type.  
Microenvironment sensitive ligands  
 Contrary to designing ligands for cell specific interactions, targeting of a 
specific tissue is also possible. One example is the use of nanoparticles to target 
cancerous cells and tissues not by attaching to a specific receptor but by 
recognising the environment. Specifically, Ling et al. used neutral pH sensitive 
magnetic nanogrenades that become cationic when they encounter the 
decreased pH of the tumour microenvironment, but remained neutral during their 
circulation (Ling et al., 2014).  
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4.1.3.3 Ligand density and organization  
 It is interesting how a particular type of ligand can affect both the physico-
chemical properties of a nanoparticle but also the way it interacts with the cell 
and specific tissues. Apart from the types of ligands, ligand density and 
organization around the core of a nanoparticle is also vital. Lund et al. 
investigated how the ligand organization rather than the nanoparticles properties 
or charge can affect the rate of AuNPs uptake by colorectal cancer cells. AuNPs 
bearing 50:50 PEGamine:glucose were internalized 18 times more than AuNPs 
with only glucose or PEGamine, the structure of which is shown in the figure 
below (Figure 4.4). The mechanism by which the particles were found to be 
internalized was via an energy-dependent pathway through openings being 
created in the lipid-bilayer by the ligands of the AuNPs (Lund et al., 2011). 
  
Figure 4.4: Nanoparticle representation of the ligand structures used in the 
study described from Lund et al. 2011. From Lund et al., 2011. 
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 With regard to PEGylated AuNPs, the actual molecular weight of PEG and 
its density plays an important role to the physicochemical characteristics of the 
particles. The density of PEG ligands around the gold core initiates a transition 
from a disorganised “mushroom” like structure to a more “brush” like organisation. 
The total quantity of ligand molecules along with its mass, affects not only the 
properties of the nanoparticle but also its protein adsorption resistance. There is 
a contradiction on the published evidence as to what density is the correct one 
for uptake of nanoparticles by target cells and tissues.  
One study for example, demonstrated that high density packed AuNPs 
with nucleic acids enhanced cellular uptake in lung and cervix human and mouse 
tissues (Giljohann et al., 2007). On the other hand, if the ligands are packed too 
tightly it can lead to reduced uptake and an increase in the antagonism between 
multiple ligands for a single receptor (Elias et al., 2013). The study from Elias et 
al., suggested that an optimal density exists with HER2/neu ligands attached to 
supermagnetic iron oxide nanoparticles which showed an increased cell binding 
with intermediate density packing. Therefore, an optimization of the correct ligand 
density is of great significance when designing nanoparticles.  
 Two main approaches exist for control of ligand density around the 
nanoparticle core. The first one is by modulating the shape of the nanoparticle 
that changes the spatial arrangement of the ligands. In this way, ligand loading 
will be affected by alterations in the surface area (Sajanlal et al., 2011). Another 
approach, involves the control of the molar ratios of the nanoparticle and ligands 
during the conjugation process (Gu et al., 2008). In order for this approach to be 
effective, adjustment of the chemical environment including the pH conditions 
and the salt concentrations need to be done.  
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To conclude, research has given an insight into how different ligands can 
affect and control the desired properties of a nanomaterial but still more work 
needs to be done to fully understand processes and mechanisms of nanoparticle 
assemblies and synthesis. The main area of interest in the biomedical field is to 
design ligands and nanoparticles which can overcome biological clearance 
barriers, without interfering with nanoparticle clearance once the particles have 
fulfilled their purpose in the body. However, lack of translational success 
especially in the use of nanoparticles for cancer treatment, raises questions as to 
whether the design of the particles or our current understanding about the 
disease and the use of appropriate clinical models needs to be improved. Thus, 
nanotechnology will progress by both engineering of successful nanoparticles 
and enhancing our knowledge of endocytosis mechanisms.  
In the next chapter, the focus is on differences between three AuNPs with 
synthesis times of 1h, 2h and 5h. Results of the previous chapter revealed one 
of the parameters that played a vital role in toxicity of AuNPs to be their synthesis 
time. A full physicochemical analysis was conducted and the three AuNPs were 
evaluated for differences in their ligand density and uptake by HSC cells. The 
materials provided for these specific batches were synthesized in a small scale 
of 700 μl. Most of the analysis was based on 1h and 5h AuNP, unless otherwise 
stated, as they were the particles with significant differences observed in toxicity.   
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4.2 Results 
Variations in the cytotoxicity of the 50:50 αGal:PEGamine AuNPs were 
observed when scaling up to larger volume batches. This variation was attributed 
to the contact time of NaBH4 with the ligands during AuNP synthesis. To 
investigate the differences detected with the increasing synthesis time, AuNPs 
synthesised for 1h, 2h and 5h were tested for their physico-chemical 
characteristics and uptake by HSC cells.  
4.2.1 Physico-chemical characterization of 3 different synthesis time 
AuNPs 
4.2.1.1 Synthesis time effects on AuNP size 
Three different AuNPs, each bearing αGalactose:PEGamine ligands 
(50:50 input ratio) were synthesized under identical conditions except for 
differences in their contact time with NaBH4 during synthesis (1h, 2h and 5h). 
There was no surface plasmon band observed for these particles as shown by 
UV-Vis measurements (Figure 4.5A). This was confirmed using DLS to estimate 
their hydrodynamic size, which was less than 10nm (Figure 4.5B). TEM analysis 
revealed the AuNPs to be spherical (Figure 4.6A) with no significant differences 
in diameter (1h = 1.58±0.8 nm, 2h=1.58±0.9 nm, 5h = 1.52±0.7 nm) (Figure 4.6B).  
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Figure 4.5: AuNPs physicochemical characterization for 1h, 2h and 5h 
synthesis time. A. UV-Vis spectra and B. Average hydrodynamic diameter 
measured by DLS.  
 
 
Figure 4.6: Differences in AuNP size as calculated by TEM for 1h, 2h and 5h 
synthesis time.  A. TEM images of AuNPs, scale bar=5 nm. B. Size distribution 
histograms on i. 1h synthesis time AuNP, ii. 2h synthesis time AuNP and iii. 5h 
synthesis time AuNP. 
A. 
B. 
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TEM was selected as the best method to characterize nanoparticle size 
complementary to DLS and UV-Vis due to the fact that it provides the ability of 
visualizing individual nanoparticles in high resolution detail. This ability is crucial 
when quantifying any nanoparticle feature as it gives direct information about its 
dispersion, aggregation state and surface.  
The dispersion and aggregation state of the nanoparticles is affected by 
their environment (Hondow et al., 2014), therefore the preparation method and 
the solutions used for each quantification assay needed to be taken into account 
when estimating their size. In this case, all three of the above assays included a 
step of diluting particles in water, which was their storage solution. However, in 
order to test the aggregation state of the particles when internalized by cells, TEM 
of the particles diluted in culture media with the presence and absence of FBS 
was conducted (Figure 4.7A). It has been previously shown that AuNPs 
aggregate in saline aqueous media which is explained by a power kinetics law of 
ionic strengths (Guillermo et al. 2014). The 50:50 αGal:PEGamine AuNPs in this 
study did not aggregate in culture media in presence or absence of FBS, with 
only the 1h synthesis time AuNP to show a tendency for aggregation in  presence 
of FBS (Figure 4.7A, black arrow).  
Another method used to evaluate the aggregation of these AuNPs in 
media was the FPLC (Figure 4.7B). In this method, peaks of individual or 
aggregated particles pass through the column at different speeds and elute at 
different volumes. Both the 1h and 5h synthesis time AuNPs elute at the same 
volume, therefore it could be concluded that there were no signs of aggregation 
in either of the synthesis times. The reason why only the 1h and 5h particles were 
analysed by FPLC was because these were the two particles which showed the 
greatest differences in toxicity as presented in chapter 3. 
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Figure 4.7: Aggregation state of the AuNPs as determined by A. TEM 
images for the 1h, 2h and 5h AuNPs. Small dark dots represent the AuNPs, 
whereas the grey clouds appearing mostly in the +FBS images were attributed to 
serum components. The black arrow points slightly bigger particles within the 
serum clouds, indicating possible aggregation. Scale bar=5nm and B. FPLC 
chromatogram for the 1h and 5h AuNPs.  
  
A. 
B. 
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4.2.1.2 Effects of AuNP synthesis time on charge 
The average charge of the AuNPs was around +40 mV, although the 1h 
AuNP demonstrated extra peaks at 20 mV and 60 mV (Figure 4.8). Zeta potential 
measurements need to be carefully interpreted as values are solution and pH 
dependent.  
 
Figure 4.8: Zeta potential measurements for 1h and 5h synthesis AuNPs.  
Traces from a representative measurement and the calculated mean values (mV) 
± SD (mV) were presented.  
 
Considering the lack of robustness of the zeta potential measurements, 
the electrophoretic mobility of the particles was used as a complimentary method 
for charge analysis and was assessed by gel electrophoresis. 1% agarose gels 
provided good visualization of the particles. The AuNPs left a stain as they were 
migrating towards the negative electrode at 100 mV with two distinct bands to 
appear at the origin and at the bottom of the gel.  
It was evident that only the particles from the 1h synthesis time migrated 
towards the negative electrode into the gel, shown by the appearance of two 
bands in the respective lane of the gel and indicating that they had positive charge 
(Figure 4.9). The most intense band was the one very close to the well, showing 
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that the majority of the particles did not migrate under the tested conditions. For 
the 5h synthesis time particle no additional bands apart from the ones close to 
the well were visible. The failure of AuNP to migrate into the gel could either be 
charge or size related. The size of the particles did not change in water as shown 
in the section above (Figure 4.6). However, for the gel electrophoresis, the 
particles were diluted in TBE buffer, which might have caused aggregation or a 
change in the particle’s charge. Therefore, the only information drawn by this data 
was that the particles were positively charged. It was not possible to determine 
an accurate zeta potential value with either of the methods, therefore the values 
provided needed to be interpreted with caution, taking into account the limitations 
of each of the assays. 
                                         
Figure 4.9: Analysis of the AuNP charge by gel electrophoresis. AuNP 
synthesized for 1h and 5h were run on a 1% agarose gel to measure differences 
in their charge. 
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4.2.1.3 Examination into AuNP ligand ratio and density  
Ligand ratio was investigated by 1H-NMR and demonstrated no change 
between the two AuNPs to within 2% (αGalactose:PEGamine ratios: 1h= 
52.8:47.2,  5h= 51.2:48.8) (Figure 4.10A&B). The characteristic peaks from which 
the ratio was calculated are shown in the figure below for interpretation.  
 
Figure 4.10: Ligand ratio determination as obtained by 1H-NMR for A. 1h and 
B. 5h synthesis time AuNP. The input ratio of 50:50 ligands during synthesis 
yielded an output ratio of similar values ± 2% difference.   
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 The S:Au ratio was used as a determination for the ligand density 
surrounding the Au core of the particles, as Midatech’s GNP technology is based 
on the fact that the AuNPs comprise of a core of gold metal atoms to which an 
organic layer of galactose is attached via gold-sulphur bonds. The carbohydrate 
layer stabilises the gold core and makes the particle biocompatible and water 
soluble. In order to address the ligand density surrounding the Au core, the S:Au 
ratio was calculated based on three different techniques EDX, XPS and SEM. 
Each of these analytical techniques provide elemental analysis of the 
AuNPs samples and characterization of the S:Au ratio, which showed decreasing 
ligand density in all methods. The accuracy of each technique is affected by 
various factors such as detection limits (signal to noise ratio), peak intensity, 
analysis time, degradation during the analysis and the nature of the sample itself. 
With regard to the sample itself, parameters like the density of the sample, the 
amount and the composition can affect the way the sample reaches the detector. 
X-Ray emission peaks will be generated by any atom that is sufficiently excited 
by the electron beam and some elements have overlapping peaks that make any 
interpretation of the chemical composition difficult.   
SEM-EDX proved to be the most appropriate technique for the estimation 
of the ligand density as it was the most sensitive method of detecting low S levels 
(Figure 4.11A&B). The ligand density decreased with the longer the synthesis 
time (Table 4.1). S:Au calculation by EDX and XPS was difficult as the S signal 
detection limit was close to background level (Appendix Figure 9.1,Figure 9.2).  
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Figure 4.11: Elemental analysis of A. 1h synthesis time AuNP and B. 5h 
synthesis time AuNP as calculated by S:Au ratio on SEM. Representative 
spectra from a single run are shown with element peaks marked. Inserts 
represent SEM images showing the region analysed for each spectrum. 
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It was concluded that these two different AuNPs had similar 
physicochemical properties in terms of size, shape and ligand ratio (Table 4.1). 
As mentioned above, most of the analytical techniques focused on obtaining 
characterization data between 1h and 5h synthesis time as these were the AuNPs 
showing the biggest differences in toxicity in HSC cells. Ligand density decreased 
with synthesis time and the charge was positive for all the particles. No 
aggregation was obvious as FPLC data indicated. 
Table 4.1: Summary of the physicochemical characteristics of the two 
different AuNPs. 
AuNP 
Synthesis 
Time 
[Au]  
μg/
ml 
Size  
(d.nm) 
Ζ 
potential 
(mV) 
Plasmon 
band 
aGal:PEG 
ratio  
S:Au 
ratio  
1h 2.1 1.58±0.8 20.2±86.6 None 52.8:47.2 0.101±
0.0011 
5h 2.2 1.52±0.7 40.3±6.28 None 51.2:48.8 0.08± 
0.0018 
 
4.2.2 Toxicity of AuNPs to HSC cells with increasing synthesis time 
The cytotoxic potential of acute exposure to the three AuNPs was 
determined by clonogenic assays, using four different cell lines that represent 
normal or cancerous versions of human skin cells (HaCaT, HSC) and kidney cells 
(HEK-293, A498). For all the four cell lines, acute 3h exposure to AuNPs resulted 
in dose-dependent reductions in the number and size of cell colonies, with HSC 
cancer cells and kidney cell lines showing a greater reduction than HaCaT normal 
cells (Figure 4.12A&B). There were also noted AuNP synthesis time-dependent 
differences in colony number for HSC and HaCAT cells. In these cell lines, cell 
death was increased when using particles with 2h and 5h synthesis time 
compared to 1h synthesis time. No time-dependent differences were observed 
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for the kidney cell lines (Figure 4.12C&D). IC50 values for each AuNP are 
presented in Table 4.2 below.   
 
Figure 4.12: Comparison of the cytotoxicity of AuNPs with different 
synthesis times on A. HSC, B. HaCaT cells, C. A498 and D. HEK-293 cells. 
Significant differences between 1h and 2h synthesis AuNPs were marked by * 
symbols, while significant differences between 1h and 5h synthesis AuNPs were 
marked by § symbols. Data were expressed as % of control colonies and plotted 
as mean±SEM, n=3 independent experiments. One-way ANOVA, *P<0.05, 
**P<0.01, ***P<0.001. 
 
Table 4.2: IC50 values (μg/ml) obtained from clonogenic assays for the 3 
different AuNPs on HSC, HaCaT, HEK-293 and A498 cells.  
AuNP 
Sample 
 
HSC 
IC50 
(μg/ml) 
HaCaT 
IC50 
(μg/ml) 
HEK-293 
IC50 
(μg/ml) 
A498 
IC50 
(μg/ml) 
1h  10 >10 4 6.5 
2h  2.4 6 4 6.5 
5h  3.9 4 4 7 
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4.2.3 AuNPs adhere to filopodia in HSC cells 
In order to explain the differences in cytotoxicity between 1h and 5h AuNPs 
on HSC cells, their cellular uptake and distribution inside the cells was examined 
using TEM. The number of AuNPs was quantified in three areas: the cytoplasm 
(including the organelles and vesicular compartments), the nucleus and the cell 
surface. Due to limited availability of material, TEM was only conducted in HSC 
and HaCaT cells as these were the cell lines that showed the biggest variation in 
toxicity. For HSC cells, three independent experiments were conducted to obtain 
robust statistical significant data but for HaCaT cells there was only n=1 with two 
technical replicates. Therefore, data from HaCaT cells could not be statistically 
analysed and only showed a trend (Appendix Figure 9.4). Any comparisons 
between the cell lines need to be made with caution.  
To discriminate between energy-dependent and passive uptake, cell 
uptake studies were performed at 37oC or 4oC, respectively. At 37oC no 
significant differences were observed in the distribution of 1h and 5h AuNPs on 
HSC cells, which were predominantly in the cytoplasm (Figure 4.13A-D). 
However, at 4oC the distribution of both AuNPs was predominantly at the cell 
surface, specifically on filopodia, with significantly more 5h AuNPs sticking to 
filopodia than 1h AuNPs (Figure 4.14A-D). To confirm whether AuNPs were 
selectively binding to filopodia, HSC cells were pre-incubated with fascin G2, an 
inhibitor of filopodia formation that destabilizes filopodia and prevents their 
formation. Following fascin addition, cells incubated with AuNPs at 4oC showed 
a significant three-fold reduction of AuNPs at the cell surface (Figure 4.15A-C,G), 
while cells loaded with AuNPs at 37oC demonstrated significantly less AuNPs 
within the cytoplasm (Figure 4.15D-F,H). 
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Figure 4.13: Localization of silver enhanced 1h and 5h synthesis time 
AuNPs in HSC cells after an acute 3h exposure at 37oC and 10 μg/ml 
analysed by TEM.  A. No AuNP control, B. 1h AuNPs, C. 5h AuNPs. B’ and C’ 
show magnified portions of the boxed regions of B and C, respectively. D. 
Quantitation of AuNP counts per micron2 for nucleus and cytoplasm (left axis) 
and AuNP counts per micron for cell surface (right axis, bars with red border). 
Total numbers of AuNPs counted per category are shown on bars and data were 
plotted as mean±SEM, n=3 independent experiments with two technical 
replicates per condition. n=nucleus, cy=cytoplasm, f=filopodia. Scale bars in all 
images= 500nm. 
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Figure 4.14: Localization of silver enhanced 1h and 5h synthesis time 
AuNPs in HSC cells after an acute 3h exposure at 4oC and 10 μg/ml analysed 
by TEM.  A. No AuNP control, B. 1h AuNPs, C. 5h AuNPs. B’ and C’ show 
magnified portions of the boxed regions of B and C, respectively. D. Quantitation 
of AuNP counts per micron2 for nucleus and cytoplasm (left axis) and AuNP 
counts per micron for cell surface (right axis, bars with red border). Total numbers 
of AuNPs counted per category are shown on bars and data were plotted as 
mean±SEM, n=3 independent experiments with two technical replicates per 
condition, One-way ANOVA, *P<0.05. n=nucleus, cy=cytoplasm, f=filopodia. 
Scale bars in all images= 500nm. 
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Figure 4.15: Localization of silver enhanced 1h and 5h synthesis time 
AuNPs in HSC cells after an acute 3h exposure at 37oC and 4oC and 10 μg/ml 
analysed by TEM in A. the absence or B, C. the presence of fascin inhibitor, 
at 4oC and in D. the absence or E, F. the presence of fascin inhibitor at 37oC. 
Quantitation of AuNP counts per micron2 for nucleus and cytoplasm (left axis) 
and AuNP counts per micron for cell surface (right axis) with or without fascin 
inhibitor at either G. 4ºC or H. 37ºC. Total numbers of AuNPs counted per 
category are shown below bars and data were plotted as mean±SEM, n=3 
independent experiments with two technical replicates per condition, One-way 
ANOVA, *P<0.05, **P<0.01. Scale bars in all images= 500nm. 
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4.3 Discussion   
In this study, the cytotoxicity of 2nm AuNPs surface functionalised with a 
50:50 ratio of a αGal:PEGamine was found to increase with NaBH4 contact time 
during AuNP synthesis (from 1h to 5h). Ligand ratio remained unchanged, but 
ligand density decreased with synthesis time. Cytoplasmic uptake of AuNPs was 
not significantly affected by synthesis time. However, when energy-dependent 
transport was inhibited by lowering the temperature, a remarkable adhesion of 
AuNPs to filopodia was noted, mainly with the more toxic 5h synthesis time 
AuNPs. Inhibition of filopodial assembly prevented this AuNP binding. A possible 
link between increased adhesion to filopodia in HSC cells and mechanisms of 
cell death is presented in detail in the next chapter.  
4.3.1 Factors to be considered when measuring ligand density  
The SEM-EDX analysis showed that the ligand density decreased with 
AuNP synthesis time (Figure 4.11). However, there are multiple factors that need 
to be considered when addressing the ligand density measurements of the 
nanoparticles. These factors can be separated into two categories, ligand-related 
and nanoparticle-related. With regard to ligand-related factors, the actual quantity 
and spatial arrangement of the ligands is important in the interaction with the cell 
surface. These factors apart from the fact that they can affect the robustness of 
the ligand density quantification, they can also account for variations from sample 
to sample and between the batches. Thus, their control is of great significance.  
Firstly, there is a possibility of ligand dissociation during washing and 
purification steps. Purification is a significant step after the synthesis process of 
nanoparticles as it ensures that any unbound or unspecific ligands are washed 
off.  If the ligands are not strongly attached to the nanoparticle core, such as in 
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case of trisodium citrate on AuNPs, the ligand density on the nanoparticle core 
will be modified and their quantification will not be representative (Love et al., 
2005). Another aspect that could account for incorrect ligand quantification 
measures or batch variability, is the dynamic process of ligand adsorption. 
Variability between samples can be observed depending on the timing that the 
nanoparticles are exposed to excess ligands. Therefore, in order to assess ligand 
loading during the synthesis process, a time-dependent ligand quantification is 
important. Lastly, ligand density can also be influenced by non-covalent 
interactions and steric effects with the solvents in which they are coming in 
contact with. Ligand exchange equilibria and dynamics of ligands such as their 
conformation might be altered (Ansar et al., 2011, Wu and Jin, 2010).   
Regarding the nanoparticle-related properties, consideration of the core 
measurements of the nanoparticles is vital because these measurements 
determine the surface area of the nanoparticle. Then to calculate the ligand 
density surrounding the Au core, the total surface area is taken into account. For 
certain techniques and ligand quantification, particles need to exhibit specific size 
and composition to be detectable within the limits of the analytical method. For 
instance, localized surface plasmon resonance method need particles of specific 
size to be spectroscopically detectable and quantifiable (Wang et al., 2012). The 
surface area is influenced by both the core morphology and size of the particles 
thus the first part of the results shown in this chapter focused on presenting 
physico-chemical characterization of the different synthesis time AuNPs. In this 
case, size and shape related variability were excluded between the three AuNPs 
tested thus, differences in cytotoxicity found were attributed to changes in ligand 
density. 1H-NMR showed no changes in ligand ratio (Figure 4.10), while SEM 
demonstrated a decrease in ligand density (decreasing S:Au ratio).  
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Sodium borohydride is widely used as a reducing agent in organic and 
inorganic chemistry. The reaction of HAuCl4 with NaBH4 produces small stable 
nanoparticles and the action of NaBH4 can lead to the transition of metal salts to 
metal (0) in AuNPs synthesis (Brust et al., 2002). It has also been found by Ansar 
and colleagues that during AuNP synthesis, NaBH4 in water can remove 
molecular adsorbates on AuNPs and strip the ligands off their surface (Ansar et 
al., 2013). This is the mechanism proposed in this chapter for ligand density 
reduction as shown by SEM-EDX, which is with longer the synthesis time and the 
presence of NaBH4, this chemical leads to stripping ligands off leading to 
decreased ligand density around the Au core.  
4.3.2 Enhanced filopodia adhesion 
The longer the synthesis time the more toxic the AuNPs were for HSC and 
HaCaT, but not for HEK-293 and A498 cell lines. Such variability will be discussed 
in detail in chapter 6 when a comparison of toxicities of AuNPs is presented 
among a range of cell lines. As discussed in the introduction, ligand density can 
affect the toxicity of nanoparticles. The results presented here, showing that 
ligand density affected toxicity, confirms findings from previous studies. For 
example, Liu and co-workers showed a decreased toxicity in HeLa cells with high 
density PEG coated AuNPs, whereas another study from Yang et al., 
demonstrated that high ligand density PEG coated AuNPs were internalized by 
macrophages (Liu et al., 2015, Yang et al., 2014). Therefore, in this case, it could 
be possible that AuNPs with a synthesis time of 1h is less toxic due to its 
increased ligand density being associated with weaker cell surface interactions 
as opposed to 2h and 5h AuNPs, which they might have the required density to 
interact with higher affinity to the cell membrane. Other studies have also 
 106 
 
implicated variations in ligand density with differences in cellular uptake (Elias et 
al., 2013, Schubertova et al., 2015).    
The observation that AuNPs adhere to filopodia is novel and suggests that 
a better understanding of how ligand density influences this process could allow 
AuNPs to be engineered to exploit filopodial binding and enhance cellular uptake. 
Cellular morphology, polarity and controlled cell proliferation are the main 
characteristics of maintaining a tissue homeostasis. When this homeostasis is 
not maintained, cancer occurs, driving cell migration via metastasis and 
angiogenesis. Increased filopodial formation has been linked to support migration 
and cancer progression (Jacquemet et al., 2015).  One of the components of 
filopodia associated with cancer progression is fascin (Arjonen et al., 2011). The 
levels of fascin expression vary between cell types (Arjonen et al., 2011) thus a 
possible explanation in terms of the variable toxicity observed between the cell 
lines.  
Increased binding of AuNPs to filopodia could be linked to two events. 
Either the adhesion initiates a cascade of cell death events by binding and 
triggering to a specific receptor, or increased adhesion leads to higher 
internalization and phagocytosis of the AuNPs inside the cells. However, based 
on the observation that the uptake between AuNPs with 1h and 5h synthesis time 
into HSCs did not differ (Figure 4.13) whilst the particles with a 5h synthesis time 
had a higher toxicity (Figure 4.12) the second theory is discarded. Instead, data 
presented on the next chapter about caspase 8 inhibition, reinforced the idea of 
an involvement of the extrinsic apoptotic pathway. No evidence exists regarding 
the correlation between increased filopodia adhesion and extrinsic apoptosis as 
more work will be needed to identify such claim. Due to fascin inhibition and 
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reduced adhesion observed, only a proposal can be made about filopodia being 
an important player in the way these AuNPs interacted with the cell.  
The fact that AuNPs adhesion to filopodia was only visible under the TEM 
when energy-dependent transport was blocked (Figure 4.14), suggests that these 
particles were undergoing endocytosis. By lowering the temperature to 4oC 
during incubation of the particles, any active transport was blocked however 
passive transport was still possible, thus the low numbers of internalized particles 
noted in the graphs. Gromnicova et al., showed that the same αGal:PEGamine 
AuNPs were internalized via an active transport mechanism in endothelial cells 
(Gromnicova et al., 2016).   
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5 Chapter 5: Analysis of The Mechanisms of Cell 
Death Caused by AuNPs 
5.1 Introduction  
 AuNP properties affect biological activities such as cellular uptake and 
toxicity, as discussed in chapter 3. A growing body of nanotechnology research 
is focusing on understanding the safety of these nanomaterials and the 
mechanism by which they cause toxicity and cell death. There are two main 
categories of cell death: apoptosis and necrosis. The types of cell death are 
defined by morphological criteria and biochemical features. The Nomenclature 
Committee on Cell Death (NCCD) proposes the types and definitions of cell death 
according to latest research published in this area (Galluzzi et al., 2018). 
Apoptosis is divided into two subcategories, which include the extrinsic and 
intrinsic pathways.  
 These pathways are dependent on the origin of the stimuli (surface death 
receptors for extrinsic or cellular stress for intrinsic apoptosis). Both act via a 
cascade of caspases activation and are explained in a more detail below (Fuchs 
et al., 2015). Necrosis is an uncontrolled and accidental cell death but evidence 
revealed that it can also be programmed and controlled like the apoptotic pathway 
(Weinlich et al., 2017). On the other hand, autophagy is interpreted as a survival 
mechanism instead of type of cell death, which is activated during nutrient and 
growth factor deprivation. Despite not being a cell death mechanism itself, an 
upregulation of autophagy has also been associated with cellular stress, which in 
turn can lead to necrotic and apoptotic cell death (Galuzzi et al., 2012).  
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5.1.1 Apoptosis  
 Apoptosis is a crucial process during development and in maintenance of 
tissue homeostasis. Tumour progression is attributed amongst other factors to 
impairment of apoptosis. Apoptosis is a type of suicidal cell death that is divided 
into intrinsic and extrinsic pathways, dependent on cellular stress and the 
activation of plasma membrane death receptors, respectively (Figure 5.1) 
(Conrad et al., 2016). Both pathways are caspase dependent. Caspases are 
cysteine and aspartate specific proteases, which are involved in inflammation, 
differentiation and cell death (Galluzzi et al., 2016, Ollie et al., 1998). Their 
classification is based on their size, function and cleavage specificity. Regulation 
of apoptosis is controlled by two classes of the caspases family, the initiator (-2, 
-8, -9 and -10) and the effector (-3, -6 and -7) caspases (Kroemer et al., 2009).  
5.1.1.1 Extrinsic pathway  
 Extrinsic apoptosis is mediated via TNF-related transmembrane receptors. 
Ligands such as TNF-α, Fas ligand and TRAIL bind to death receptors at the cell 
surface, leading to their oligomerization, followed by a cascade of signalling 
events that trigger apoptotic cell death. This pathway relies on the formation of 
caspase 8 active dimer from caspase 8 monomers on the intracellular side of the 
death receptors. All death receptors share a conserved, cytoplasmic sequence 
termed as death domain. For instance, in case of Fas ligand, the death domain 
enables binding of Fas to the adaptor protein FADD, leading to the recruitment of 
pro-caspase 8 and pro-caspase-10 (Galluzzi et al., 2018). As a result, a 
multiprotein complex named DISC (death inducing signalling complex) is formed 
which acts as a platform for caspase activation (Fuchs et al., 2015). Depending 
on the cell type, extrinsic apoptosis could be either mitochondria dependent or 
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independent. Mitochondria independent extrinsic apoptosis occurs via activation 
of caspase 8 which leads to proteolysis of pro-caspase-3 into active caspase 3 
(Czabotar et al., 2014). Alternatively, caspase 8 can lead to cleavage of Bid, a 
BH3 protein, creating a form of mitochondria targeted tBid, which is responsible 
for the amplification of death signal through mitochondria. Other proteins such as 
cFLIP and cIAPs could also be involved in extrinsic apoptosis (Kim et al., 2006, 
Galluzzi et al., 2018).  
5.1.1.2 Intrinsic pathway  
 Activation of the intrinsic apoptotic pathway is a result of numerous types 
of cellular stress stimuli including cytosolic calcium overload, oxidative stress, 
DNA damage and ER stress (Roos et al., 2016). There are multiple events that 
can lead to intrinsic apoptotic pathway activation. Some of these events include 
the release of pro-apoptotic proteins into the cytosol, such as endonuclease G, 
cytochrome c and apoptosis inducing factor, and dissipation of mitochondrial 
membrane potential (Li et al., 1997, Galluzzi et al., 2018, Julien et al., 2016). 
Release of cytochrome c occurs via members of Bcl-2 family which regulate 
apoptosis. The cytosolic translocation of cytochrome c initiates the formation of a 
complex termed the apoptosome, which consists of pro-caspase-9, Apaf-1, dATP 
and cytochrome c (Riedl et al., 2007, Li et al., 1997). The apoptosome acts as a 
platform for the activation of signalling cascades downstream of mitochondria and 
activation of caspase 9 (Galluzzi et al., 2018). 
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Figure 5.1: Schematic illustration of the intrinsic and extrinsic apoptotic 
pathways.  Extrinsic pathway is initiated by ligation of death receptors (such as 
Fas, TNF, DR4 and DR5) by their specific ligands (FasL and TRAIL) leading to 
activation of procaspase 8 and subsequent caspase 8 activation. Apoptosis is 
induced by either caspase 3 activation or cleavage of bid. Cleavage of bid leads 
to mitochondrial dysfunction and cytochrome c release, activating caspase 9 and 
3. Caspase 3 promotes the typical apoptosis features, including DNA 
fragmentation and cell death. The intrinsic pathway is mitochondria dependent 
and influenced by bcl family members bound to the mitochondrial membrane, 
which regulate the release of cytochrome c. A complex termed as apoptosome is 
formed by cytochrome c, dATP and APAF-1. The apoptosome is responsible for 
the recruitment of procaspase 9, caspase 9 and 3, resulting in apoptosis and cell 
death. From Loreto et al., 2014. 
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5.1.2 Necrosis  
 Necrosis is considered as an accidental and uncontrolled form of cell 
death. However, evidence accumulated from recent research showed that 
necrosis is regulated by a cascade of signal transduction pathways and can be 
controlled like the apoptotic mechanism of cell death (Conrad et al., 2016). Thus, 
some authors proposed the term “necroptosis”, a subset of necrosis, to specify 
the controlled nature of necrosis (Pasparakis et al., 2015, Weinlich et al., 2017). 
This term was first introduced by Yuan and colleagues who showed the inhibitory 
effect of necrostatin-1 on the necrosis caused by death receptor ligation (Yuan et 
al., 2016). Morphologically, necrosis is characterized by plasma membrane 
rupture, swelling of organelles and a gain in cell volume followed by loss of 
intracellular contents. Death domain receptors such as Fas, TNFR1 and TLR3/4, 
have been implicated in necrotic cell death, which in most cases is dependent on 
the serine/threonine kinase RIP-1 and -3 (Galluzzi et al., 2018).  
 The exact mechanism of necrosis is still not well understood but is 
accepted that several organelles, cellular processes and mediators are involved. 
For instance, production of ROS, mitochondrial alterations and membrane 
permeabilization are some of the phenomena underlying this type of cell death 
(Roos et al., 2016). Lysosomal and nuclear changes such as hyper-activation of 
PARP-1 and lipid degradation has also been addressed. Lastly, elevation of 
cytoplasmic Ca2+ levels lead to mitochondrial Ca2+ overload and activation of non-
caspase proteases like cathepsins and calpains, which lead the activation of Jun-
N terminal kinase and generation of sphingomyelinase mediated ceramide 
(Weinlich et al., 2017). Hitomi et al., pointed out the importance of understanding 
that apoptosis and necroptosis or necrosis pathways are well interconnected and 
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defining the signalling networks underpinning each process is difficult. More 
recent studies validate the interconnected nature of the different cell death 
pathways (Hitomi et al., 2008). For example, caspase-8, FADD and cFLIP, a 
regulator of caspase 8 activity, has been shown to inhibit RIPK-1 and -3, 
indicating the intertwined nature of both necroptosis and apoptosis (Hitomi et al., 
2008). A schematic representation of the 3 main pathways described so far is 
presented below (Figure 5.2).  
 
Figure 5.2: A schematic representation of the relationship between 
apoptosis, necrosis and autophagy. Increased intracellular Ca2+, ROS 
generation, ATP and NAD+ depletion is a result of therapeutic or metabolic stress. 
Autophagy indicates a survival mechanism induced via a range of stress 
regulators such as AMPK pathway. Bak and Bax activation leads to apoptosis via 
the release of cytochrome c and the initiation of the caspase pathway. Necrosis 
is independent of the acute survival signals activation. From Amaravadi and 
Thompson, 2007. 
 
 
 
 
 114 
 
5.1.3 Other types of cell death 
 Other types of cell death have been characterized but they all share 
common morphological features with either apoptosis or necrosis. For instance, 
“aponecrosis” has been proposed as a type of cell death by Formigli et al., who 
described a dynamic and molecular similarity between apoptosis and necrosis 
when inhibiting the mitochondrial respiratory chain with antimycin A (Formigli et 
al., 2000). Also, another type of cell death named as “paraptosis” has been 
established, referring to an alternative form of caspase-9 death independent of 
Apaf-1 (Dal Canto and Gurney, 1994, Turmaine et al., 2000).  
 A controversial debate exists with regard to whether autophagy is 
categorized as a mechanism of cell death or not. Autophagy plays an important 
role in homeostasis, leading to the recycling of cellular building blocks by 
mediating the removal of damaged or dysfunctional organelles. In this case, it 
constitutes a survival mechanism utilized by cells to cope with nutrient starvation 
and deprivation. On the other hand, cell death can result from unrestrained 
autophagy (Schwartz et al., 1993, Gozuacik and Kimchi, 2004, Debnath et al., 
2005).  
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5.1.4 Assays to determine mechanisms of cell death 
 Evaluating the mechanism of cell death triggered by nanomaterials and 
AuNPs is highly complex. Certain cellular events, like mitochondrial dysfunction 
or ROS generation, are shared between both cell death pathways and thus, it is 
difficult to distinguish between them. Various assays can be used, each with their 
advantages and disadvantages to aid the identification of the type of the 
molecular pathway being involved in cell death. These assays are designed 
based on the detection of early or late apoptotic and necrotic events. The assay 
output is dependent upon cell type, concentration of test compounds and choice 
of the assay’s endpoint. Some of the basic assays used to determine apoptotic 
cell death mechanisms and to distinguish them from the necrotic, are: cyto-
morphological changes, DNA fragmentation, detection of activated caspases, 
membrane alterations and mitochondrial assays. 
5.1.4.1 Cyto-morphological changes 
 Apoptotic or necrotic cells can be detected by light microscopy using 
methylene or toluidine blue dyes. Such approach is dependent on the cytoplasmic 
and nuclear condensation that occurs during these events. A more detailed 
method includes TEM analysis which confirms apoptotic or dead cells based on 
the following easily detectable morphological characteristics: nuclear 
fragmentation, electron dense nucleus, disorganized cytoplasmic organelles, 
large clear vacuoles and damaged cell membrane (White and Cinti, 2004, 
Weinlich et al., 2017). 
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5.1.4.2 DNA fragmentation 
 Later stages of apoptosis involve endonuclease fragmentation of the DNA. 
Methods to detect fragmented DNA include agarose gel electrophoresis, which 
shows a laddering or smear of the DNA (Wyllie, 1980). Another technique is the 
TUNEL assay, in which a fluorescent dye is added, binding specifically to the 
ends of fragmented DNA, thus staining nuclei of apoptotic cells fluorescent 
(Kressel and Groscurth, 1994, Otsuki, 2003). 
5.1.4.3 Detection of activated caspases 
 Various caspase activity assays have been established for the detection 
of more than 13 different caspases (Galluzzi et al., 2018). Several monoclonal 
and polyclonal antibodies specific to the individual caspases have been designed 
for the detection of both active caspases and procaspases. These can be used 
to detect specific caspases by Western blotting, immunohistochemistry or 
immunofluorescence. Fluorescent substrates are also used for the detection of 
active caspases. Apoptosis pathway specific gene panels offer the advantages 
of determining the profile of the expression of at least 112 genes involved in 
apoptosis by PCR microarrays (Hofmann et al., 2001, Vallat et al., 2003). 
5.1.4.4 Membrane alterations 
 Phosphatidylserine is maintained asymmetrically on the inner leaflet of the 
cell membrane by the action of Flippase enzymes. However, during early 
apoptosis, this process ceases, and phosphatidylserine randomly partitions to 
both sides of the cell membrane. Such externalization can be detected by the 
phosphatidylserine binding protein Annexin V (Bossy-Wetzel and Green, 2000). 
Fluorescently-tagged Annexin V labels apoptotic cells, which are visualized and 
 117 
 
quantified by fluorescent microscopy or flow cytometry. However, loss of 
membrane integrity is a feature of necrotic cell death as well, therefore necrotic 
cells should be stained with specific membrane-impermeant dyes, for example 
trypan blue or propidium iodide to distinguish between apoptosis (Annexin V 
positive and PI negative) and necrosis (Annexin V and PI positive). 
5.1.4.5 Mitochondrial assays 
 Changes in the early phase of the intrinsic apoptotic pathway can be 
detected by mitochondrial assays and cytochrome c release. Mitochondrial Ca2+ 
concentration, mitochondrial redox status, reactive oxygen species generation, 
membrane depolarization and permeability are some of the biological readouts 
used to address early apoptotic events. Fluorescent indicators are often utilized 
for measurement of the cellular metabolic activity, ROS levels and mitochondrial 
membrane or redox potential. Fluorescence microscopy can assess cytochrome 
c release from mitochondria and regulator proteins such as Bcl-2 and Bid 
(Scorrano et al., 2002, Tsien, 1998, Zhang et al., 2002).  
 In conclusion, understanding the mechanism of cell death is of crucial 
significance. Distinguishing between the types and identifying key regulators in 
each process can provide an important advantage in targeting a specific disease 
state. Apoptosis is considered a regulated, controlled energy-dependent process 
characterized by specific biochemical and morphological features, with caspase 
activation to be the most important feature. Several studies have noted the cross-
talk between cell death pathways and therefore, multiple assays should be used 
when addressing the mechanism of cell death following nanomaterials exposure. 
The next section of this chapter will unravel the mechanism of cell death caused 
by the 50:50 αGal:PEGamine AuNPs. 
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5.2 Results 
 This chapter will focus on unravelling the mechanisms by which the 50:50 
αGal:PEGamine AuNPs cause cell death and toxicity. Firstly, method 
development and assay validation are presented. Secondly, results obtained by 
these optimized assays are discussed regarding the mechanisms of cell death 
caused by this specific type of AuNPs. 
5.2.1 Assay and method development  
 Unravelling the mechanism of cell death was achieved using fluorescent 
dyes and analysed via three main methods: fluorescence microscopy, microplate 
reader and Tali cytometer. Each method had its advantages and disadvantages. 
For instance, fluorescence microscopy provided high resolution detail of the 
localization of the dyes along with high sensitivity, however quantification of 
fluorescence intensities was time consuming. The microplate reader might 
represent the most effective, quick, high-throughput assessment for the 
evaluation of multiple dyes simultaneously along with quick data output, yet this 
was not the desired method in this case due to sensitivity issues (Appendix Figure 
9.6). Cytometry on the other hand proved to be the best approach for obtaining 
qualitative and quantitative results. Two cytometry methods were available in the 
facilities of The Open University, a flow cytometry machine and a Tali Image-
Based Cytometer. Both instruments provide analysis of individual cells within a 
population with the main difference between the two methods being that the Tali 
provides an image-based output for every field of quantification.  
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 The same experiment was performed and analysed by both Tali and flow 
cytometry to compare whether the two cytometric methods produced similar 
results. HSC cells were treated with 10 μg/ml AuNPs for an acute 3h exposure. 
At 24h and 48h after exposure, cells were harvested without fixation and treated 
with PI to determine the percentage of dead cells. Both methods showed a base 
line level of ~ 6% dead cells for the control sample, slightly increasing to 10% at 
the 48h time-point (Figure 5.3A&B). For the sample treated with AuNP, no 
significant difference was observed between the 24h time-point and the control 
with both methods. However, after 48h, the AuNP treated cells showed 3-fold 
more PI staining than the control with both methods. Therefore, Tali and flow 
cytometry showed the same trend and similar values of percent PI positive cells.   
  
 120 
 
 
 
Figure 5.3: Comparison of the two cytometric assays available for the 
determination of cell death caused in HSC cells after an acute 3h exposure 
at 10 μg/ml.  A. % PI positive cells as calculated by the Tali cytometer and B. by 
flow cytometry. n=1 experiment, with 3 technical replicates per condition. Data 
were plotted as mean±SEM. 
  
Flow Cytometry 
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 Since Tali and Fflow cytometry did not show significant differences in the 
percentage of PI positive cells calculated after an exposure to AuNPs for two 
post-exposure time-points, the Tali method was chosen for the following reasons: 
1) the visual output it produces, allowing to judge the data quality better than a 
flow cytometry analysis, 2) using a smaller quantity of cells and 3) less processing 
required for a time-efficient quantification. A method development had to be 
conducted regarding the procedure of harvesting the cells from the mutli-wells in 
which they were cultured. Specifically, every cytometry assay requires a 
trypsinization step before the stained cells can be analysed.  
 However, it was observed that prior to trypsinization there were always 
some cells floating in the medium. These were either dead cells, or cells that 
detached during division. To decide whether to include the detached cells in the 
data analysis, or whether to use only attached cells for the analysis, a pilot 
experiment was performed. The supernatant, including the detached cells, was 
taken off the cells prior to trypsinisation, and then the attached cells were 
trypsinised. Both were then stained with PI and analysed using the Tali (Figure 
5.4). This was performed for control cells and using two concentrations of AuNPs 
to evaluate the detachment profile of cells. The percent of detached cells was 
calculated as less than <1% for both AuNPs concentrations used at 48h time 
point. The protocol for the Tali cytometry assay was established to include any 
detached and attached trypsinized cells since the apparent loss of cells could be 
attributed to detachment. Also, harvesting all cells allowed analysis within the 
entire population. 
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Figure 5.4: Detachment profile of HSC cells to establish experimental 
protocol for the Tali cytometry assay.  Cells were exposed to 0, 5 and 10 μg/ml 
AuNPs for 3h and trypsinized (attached) cells at 48h. Floating cells (detached) 
were also calculated by Tali for the total cell number. n=1 pilot experiment, with 
3 technical replicates per condition. Data were plotted as mean±SEM.  
 
5.2.2 Time-course of cell death events after AuNP exposure 
 It was crucial to establish a time-course of cell death events along with the 
type of cell death occurred after AuNP exposure. The time-points tested were 3, 
24, 48 and 72h after an acute 3h exposure of 10 μg/ml AuNPs on HSC cells. To 
determine the type of cell death, assays to measure caspase activation and 
inhibition, ROS generation and mitochondrial membrane depolarization were 
performed. These allowed to distinguish between necrosis and intrinsic or 
extrinsic pathways of apoptosis. Also, cell cycle arrest was examined as a 
possible factor contributing to cell death or inhibition of proliferation.  
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5.2.2.1 Apoptotic vs necrotic mechanism of cell death   
 The fluorescent dyes PI and Annexin V are widely used to test cell viability 
and discriminate between necrotic or apoptotic pathways based on differences in 
plasma membrane integrity and phosphatidylserine membrane asymmetry. PI is 
a nuclear stain that enters the cell depending on the membrane permeability. This 
dye will not stain live or early apoptotic cells that have an intact plasma 
membrane. Instead, necrotic and late apoptotic cells allow PI entry due to a 
decreased plasma and nuclear membrane integrity, displaying a red fluorescence 
in the nucleus (Vermes et al., 2000, Darzynkiewicz et al., 1992). Annexin V on 
the other hand, binds to phosphatidylserine. Normally, phosphatidylserine is 
found in the inner leaflet of the plasma membrane, but it gets externalised during 
apoptosis. As a consequence, when added to the outside of cells, Annexin V will 
only label apoptotic cells (Vermes et al., 1995).  
 HSC cells were exposed to 10 μg/ml AuNPs for 3h.  Staurosporine was 
used as a positive control for inducing apoptosis at 1 μM (Thuret et al., 2003). 
The percentage of cells positive for staining with PI and Annexin V was quantified. 
There was a trend for the percentage of PI positive cells to increase from ~15% 
to 30% between 24h and 48h for the AuNP treated sample. The percentage 
remained at that level until the end of the time-course at 72h (Figure 5.5A). A 
trend for an increase in the percentage of AnnexinV positive cells was noticed, 
beginning from 48h and only reaching ~ 12-15% (Figure 5.5B). However, neither 
of these increases were statistically significant compared with the controls. In 
contrast, staurosporine produced large and significant increases in the 
percentage of PI and AnnexinV positive cells within 24h, compared with the 
control. 
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Figure 5.5: PI and Annexin V staining in HSC cells to determine the type of 
cell death caused by AuNPs after an acute 3h exposure of 10 μg/ml AuNPs 
throughout a 72h time-course. Results were quantified via Tali machine using 
A. PI and B. Annexin V fluorescent dyes. Staurosporine was used as a positive 
control for the induction of apoptosis. n=3 independent experiments. Data were 
plotted as mean±SEM. One-way ANOVA, Tukey’s multiple comparison test, 
****P<0.0001, *** P<0.001, ** P<0.01.  
 
5.2.2.2 Caspases inhibition and activation 
 Extrinsic and intrinsic apoptotic pathways utilise different caspases. One 
way of distinguishing between the two pathways is the selective inhibition of 
certain caspases, or to measure their activation. In this case, various caspases 
were inhibited to determine if this inhibition prevented cell death. In parallel 
experiments, the activation of three caspases was assessed using specific 
fluorescent probes. Caspase 8 was selected because it is apical in the extrinsic 
pathway and caspase 9 because it is apical in the intrinsic pathway. Caspase 3/7 
was selected since it is the executioner caspase at the end of both caspase 
cascades that commits to apoptotic cell death (Roos et al., 2016).  The same 
protocol was followed for every assay. A time-course of 3, 24, 48 and 72h was 
investigated for caspase 3/7 activation after an acute 3h exposure of 10 μg/ml 
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AuNPs to HSC cells. This concentration was validated for its toxic potential by 
clonogenic assays.  
 A slight but non-significant increase of around 10% in caspase 3/7 positive 
cells was noted between the 3h and 24h time-point, followed by a steady level 
response throughout the time-course (Figure 5.6). Staurosporine as a positive 
control significantly increased the caspase 3/7 activity at all time-points. 
 
Figure 5.6: Determination of caspase 3/7 positive cells after an acute 3h 
exposure of 10 μg/ml AuNPs on HSC cells throughout a 72h time-course. 
Results were quantified via Tali machine using CellEvent caspase 3/7 fluorescent 
dye. Staurosporine was used as a positive control for the induction of apoptosis. 
n=3 independent experiments. Data were plotted as mean±SEM. One-Way 
ANOVA, Tukey’s multiple comparison test, ****P<0.0001, *P< 0.05.  
 
 Caspase 8 and 9 activation assays could not be made to work reliably 
(Appendix Figure 9.17). For all caspases, inhibition assays were performed and 
are shown below. Co-incubation of cells with both caspase 3/7 inhibitor and 5 
μg/ml AuNPs (the value represents the IC50 value of this batch of AuNPs) 
resulted in rescue of HSC cells from AuNP induced cell death as shown by 
clonogenic assays (Figure 5.7A). Such observation validates the above data of 
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Annexin V and caspase 3/7 activation, that apoptosis was involved in the cell 
death mechanism caused by this type of particles.  
 To discriminate between the extrinsic and intrinsic apoptotic pathway, cells 
were co-incubated with either caspase 8 or caspase 9 inhibitors along with 5 
μg/ml AuNPs. Caspase 8 inhibition prevented AuNP toxicity, whereas caspase 9 
inhibition had no significant effect on the prevention of AuNP induced cell death 
(Figure 5.7B&C). Addition of the caspase inhibitors reduced cell viability by ~30 
%. Antimycin A (AMA) and Apo2L were used as positive controls and induced 
cell death similar to that seen by the AuNPs. The cell death caused by the positive 
controls was prevented by all three caspase inhibitors tested, showing that they 
prevented activation of the respective apoptotic pathways. Inhibition of caspase 
8 and caspases 3/7 stopped the AuNP-induced cell death and brought it back to 
the level observed after addition of the inhibitors alone. Contrary, caspase 9 
inhibition had no effect on the AuNP-induced cell death. These results indicate 
that AuNPs possibly activated the extrinsic apoptotic pathway.   
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Figure 5.7: Caspase inhibition effect on HSC cells after an acute 3h exposure of 5 μg/ml (IC50 value) AuNPs, as obtained by 
clonogenic assays. A. Caspase 3/7 inhibition, B. Caspase 8 inhibition, C. Caspase 9 inhibition. Data were expressed as % control colonies 
and plotted as mean±SEM. Positive controls included AMA and Apo2L. n=3 independent experiments with technical triplicates per 
condition. One-Way ANOVA, *P< 0.05, **P<0.01. 
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5.2.2.3 ROS Production   
 To detect whether ROS generation correlated with AuNP-induced cell 
death, a ROS responsive fluorescent dye (ROS Brite) was used and the 
fluorescence was quantified by Tali. ROS Brite selectively reacts with superoxide 
and hydroxyl radical (www.aatbio.com). HSC cells were incubated at 10 μg/ml 
AuNPs for 3h and intracellular ROS generation was quantified by ROS Brite at 
the time-points previously used to characterise the AuNP-induced cell death 
mechanisms. AuNPs did not cause a significant ROS production at any time 
point, whilst the positive control TBHP increased ROS production after 48h and 
72h (Figure 5.8)  
 
Figure 5.8: Determination of ROS production after an acute 3h exposure of 
10 μg/ml AuNPs on HSC cells throughout a 72h time-course. Data were 
expressed as RFU/Cell and quantified by Tali using ROS Brite. TBHP was 
used as a positive control for ROS generation. n=3 independent experiments, 
Data were plotted as mean±SEM. One-Way ANOVA, Tukey’s multiple 
comparison test, ****P<0.0001. 
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5.2.2.4 Mitochondrial membrane potential changes  
 JC-10 was used as a fluorescent dye to evaluate the changes of the 
mitochondrial membrane potential in HSC cells after an acute 3h exposure of 
AuNPs. In intact mitochondria with normal membrane potential, JC-10 
concentrates in the mitochondrial matrix forming red fluorescent aggregates. In 
necrotic or apoptotic cells, or after a collapse of the mitochondrial membrane 
potential, the dye diffuses out of mitochondria, changes to a monomeric form and 
has green cytoplasmic fluorescence. Staurosporine and FCCP were used as 
positive controls to induce apoptotic cell death and membrane depolarization, 
respectively.  
 The change of mitochondrial membrane potential was measured as the 
ratio between red aggregated and green monomeric forms of JC-10 after AuNP 
exposure for a 48h time-course. Increasing ratios indicate mitochondrial 
membrane depolarization. Addition of FCCP caused a depolarisation of the 
mitochondria and a collapse of the mitochondrial membrane potential indicating 
that the assay was functional. Activating apoptosis with staurosporine increased 
the ratio of the JC-10 signal after 24h and 48h, whilst AuNP addition only caused 
changes after 48h (Figure 5.9) showing that changes to mitochondria and the 
collapse of the mitochondrial membrane potential occurred at a late stage in the 
cell death mechanism. 
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Figure 5.9: Determination of mitochondrial membrane potential changes 
occurred after an acute 3h exposure of 10 μg/ml AuNPs on HSC cells 
throughout a 48h time-course. Data were expressed as fluorescence ratio 
between aggregate (Em = 515 nm) and monomeric forms (Em = 590 nm) of the 
JC-10 dye and were quantified by Tali. Staurosporine and FCCP were used as 
positive controls for apoptosis and membrane depolarization, respectively. n=3 
independent experiments, data were plotted as mean=±SEM. One-Way ANOVA, 
Tukey’s multiple comparison test, ****P<0.0001, *P<0.05.  
 
5.2.3 Cell cycle 
 Following a 3h exposure of 10 μg/ml AuNPs to HSC cells, the percentage 
of cells at G0/G1, S and G2/M cell cycle phases were determined by Tali either 
immediately or after 24h. Nocodazole was used as a positive control at a 
concentration of 50 nM to cause cell cycle arrest at G2/M phase. No significant 
differences were noted with the AuNP treated sample, neither with 3h or 24h 
exposure on HSC cells (Figure 5.10A&B). In contrast, nocodazole caused a G2/M 
cell cycle arrest as expected after 24h.   
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Figure 5.10: Investigation into possible cell cycle arrest caused after an 
acute A. 3h or B. 24h exposure of 10 μg/ml AuNPs on HSC cells. Data were 
expressed as % cells at G0/G1, S and G2/M cell cycle phases as quantified by 
Tali. Nocodazole was used as a positive control for G2/M cell cycle arrest. n=3 
independent experiments, Data were plotted as mean=±SEM. One-Way ANOVA, 
Tukey’s multiple comparison test, ****P<0.0001, *P<0.05.  
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5.2.4 The role of cell density in AuNP-induced cell death  
 From all the above assays it was evident that the positive controls were 
working. However, it was noted that only rarely significant differences were 
observed between the AuNP treated sample and the control, even though the 
AuNPs were applied at twice the IC50 value estimated from the clonogenic 
assays. The only difference between the cytometry assays and the clonogenic 
assays was the cell density. Clonogenic assays were conducted on cells grown 
at a very low confluency, because otherwise cells would not grow in colonies. 
Contrary to this approach, the Tali machine requires higher cell density numbers 
for cell sorting, which is typically achieved by using a higher seeding density.  
 The observation of differences between the two assays presented in 
chapter 3 (toxicity assays based on the clonogenic method, with 10 μg/ml of 
AuNPs to be 2x the IC50 value) and this chapter (same AuNP concentration to 
trigger a trend of cell death as quantified by Tali) led to a series of experiments 
testing the localization of the particles. These experiments were based on using 
cells that were seeded in a similar high density to the ones used in the above 
experiments and a repetition of the experiments using cells plated at the same 
density but using higher AuNP concentrations. Firstly, silver staining assay was 
conducted for visualization of the AuNPs on HSC cells after their acute 3h 
exposure in a range of cell densities (Figure 5.11). In high cell densities the cells 
grew not in an isolated manner, but instead occurred as several clusters of cells. 
AuNPs accumulated on the outermost cells of such clusters, with very poor 
staining of cells deeper within the cluster. This implies that only cells at the edges 
received a toxic dose of AuNPs. 
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Figure 5.11: Silver staining of HSC cells after an acute 3h exposure of 10 μg/ml AuNPs as visualized under light microscopy at 
both 20x and 40x objective. 3 different cell densities were tested, 15,000, 25, 000 and 50,000 cells/well. Scale bar=500 μm.  
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 Since the cell density was identified to play an important role as to how 
AuNPs interact with the cell surface, the total cell count after AuNP exposure was 
obtained using a CyQUANT cell proliferation assay. Data were presented as 
fluorescence intensity/seeding density quantified by using the microplate reader 
at Ex480/Em520 nm. Three different seeding densities were examined, 1,000, 
2,000 and 4,000 cells/well in a 12-well plate, illustrating that AuNPs only reduced 
the cell proliferation significantly at the lowest seeding density (Figure 5.12).  
 
Figure 5.12: Cell proliferation of HSC cells after an acute 3h exposure of 10 
μg/ml AuNP in a range of cell densities.  Data were expressed as fluorescence 
intensity/seeding density as obtained by microplate reader at Ex480/Em520 nm 
and the CyQUANT cell proliferation assay. n=3 independent experiments, Data 
were plotted as mean=±SEM. Unpaired two-tailed t-test, **P<0.01.  
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 These experiments highlighted a correlation between the cell density and 
the toxic effects of AuNPs, making it necessary to evaluate a series of AuNP 
concentrations in order to identify which is the concentration that triggers cell 
death in the higher cell densities required for cytometry assays. However, time 
restrictions of the project did not allow such experiments to be performed. Future 
directions include the identification of this AuNP concentration and repetition of 
all the assays presented above for a clearer illustration of the mechanism of cell 
death.  
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5.3 Discussion 
 This chapter focussed on investigating the mechanism of cell death 
caused by the 50:50 αGal:PEGamine AuNPs. A series of time-course 
experiments was conducted from 3h to 72h after an acute 3h exposure of AuNPs 
to HSC cells. The assays distinguished between necrosis and apoptosis, and 
between the extrinsic or intrinsic apoptotic pathway, quantified ROS production, 
mitochondrial membrane depolarization and phases of the cell cycle. These 
assays were chosen due to a literature search highlighting them as significant 
after exposure of metal nanomaterials to different types of cells. Within this thesis, 
the 50:50 αGal:Pegamine AuNPs generally produced non-significant trends in 
the assays presented above.  
 Different physico-chemical parameters such as the size and the shape of 
the particles, will produce a distinctive cellular response, therefore the data of this 
thesis based on the 50:50 αGal:PEGamine AuNPs cannot be directly compared 
with any other AuNPs used in the literature due to the possibility of the particles 
having dissimilar properties. It has to be mentioned that in this study, no 
significant effects were observed in most of the assays. This observation could 
be attributed to not necessarily a failure of the assays, due to the positive controls 
used working, but more likely to the mechanism of death triggered by these 
AuNPs, which was not tested for. However, cell density could also be responsible 
for the failure to observe cell death. In conclusion, either the AuNPs did not cause 
cell death by the tested mechanisms, or the cell density or timing used in the 
assays caused the toxicity of the particles to be different from that seen in other 
chapters. 
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 In general, AuNPs appeared to induce both apoptosis and necrosis as 
shown by the PI/AnnexinV assay. A late cell death event was noted between 24h 
and 48h after an acute 3h exposure of AuNPs to HSC cells. It is not clear whether 
apoptosis or necrosis was initiated. Most studies propose apoptosis as the main 
mechanism of cell death caused by AuNPs. Necrosis has also been reported. For 
example, necrosis was induced by ROS production in hBMSC cells after 
exposure to AuNPs (Fan et al., 2011). Both necrosis and apoptosis was also 
observed in a study based on CTAB-capped AuNPs in A431 skin cancer cells 
(Nirmala et al., 2017). A table summarizing the properties of the AuNPs (size or 
surface) along with the cell type tested and the mechanism of cell death observed 
is presented below (Table 5.1).  
Table 5.1: Comparison between the different published studies on AuNPs 
and the type of cell death observed.  
AuNPs Properties Cell Type Cell Death Ref. 
Size Surface Normal Cancer Apoptosis Necr
osis 
Auto-
phagy 
 
1 nm BSA  HepG-2 + + N/A Dong et 
al., 2015 
1.5 
nm 
 
TMAT 
(positive 
charge), 
MES 
(negative 
charge) 
HaCaT  + - N/A Schaeubl
in et al., 
2011 
2.3 
nm 
 
L/D-
glutathione 
 MGC-
803 
+(d-
glutathione 
> 
L-
glutathione) 
- N/A Zhang et 
al., 2015 
2.7 
nm 
2-mercapto-
1-
methylimida
zole 
 SH-
SY5Y 
+ N/A N/A Imperato
re et al., 
2015 
1–
10 
nm 
sodium 
polyacrylate 
(negative 
charge) 
freshly 
isolated 
human 
 + N/A N/A Duoroch
er et al., 
2017 
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neutrop
hils 
4 
nm, 
100 
nm 
PEG liver 
tissue of 
BALB/c 
mice 
 +(4 nm ~ 
100 nm) 
N/A N/A Cho et 
al., 2009 
25.1 
nm 
CTAB  MCF-7 + + N/A Bhamidip
ati et al., 
2017 
37 
nm 
N/A  A549 + -  Ramalin
gam et 
al., 2016 
20 
nm 
morin PBMCs, 
HBL-
100 cells 
 - - N/A Kondath 
et al., 
2014 
 
 The triggering of the apoptotic pathway by the AuNPs was confirmed by 
caspase 3/7 activation (Figure 5.6) and inhibition data (Figure 5.7). These data 
showed that a similar late response of HSC cells to AuNPs, with caspase 3/7 
being affected between 3h and 24h after an acute 3h AuNP exposure. In the 
attempt to distinguish between extrinsic and intrinsic apoptotic pathway, inhibitors 
of both caspase 8 and 9 indicated possible involvement of extrinsic pathway as 
inhibition of caspase 8 led to rescue of cell death, but inhibition of caspase 9 did 
not. ROS was not elevated throughout the time-course of interest (Figure 5.8) 
consistent with the activation of extrinsic apoptosis, since ROS generation is 
usually associated with intrinsic apoptosis. Mitochondrial membrane 
depolarization was evident after 48h (Figure 5.9) but no cell cycle arrest was 
observed (Figure 5.10).  
 It has been shown before that the main mechanism by which AuNPs elicit 
apoptosis is via intrinsic apoptotic pathway, including ER and mitochondria 
related pathways. ROS production has also been linked to mitochondria related 
apoptosis. For instance, platinum coated AuNPs and gold mesoporous silica NPs 
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induced mitochondria related intrinsic apoptosis via ROS production in MCF-7 
cells (Ahamed et al., 2016, Liu et al., 2015). Another study confirmed the 
mitochondria related apoptosis with citrate-coated AuNPs to elicit cytochrome c 
release and Bax translocation in HL7702 human liver cells (Gao et al., 2011). 
Most studies measure the activation of caspase 3/7, and thus not distinguish 
between extrinsic and intrinsic apoptosis. The activation of extrinsic apoptosis 
has not yet reported with AuNPs. Previously, only one study reported cleavage 
of caspase 8 in HaCaT cells after exposure to titanium dioxide nanoparticles for 
6h, without apoptosis induction (Wright et al., 2017). Results presented in this 
thesis showed that inhibition of the extrinsic apoptotic pathway reduced the AuNP 
toxicity, which could be one of the first examples of the triggering of this pathway 
by AuNPs. Association of such observation with increased filopodia binding as 
depicted in the previous chapter should be made with caution.  
 In the case of the experiments performed in this thesis, no ROS changes 
could be measured. However, the mitochondrial membrane potential was altered 
48h after an acute AuNP exposure. Specifically, mitochondrial membrane 
depolarization has been linked to the initiation of apoptosis and cytochrome c 
release. Although, release of cytochrome c is responsible for initiation of 
apoptosis in a caspase dependent manner, a study showed that such process is 
not necessarily the inevitable one (Ward et al., 2000). Mitochondrial membrane 
depolarization could just indicate a disturbance in the cellular ion homeostasis 
and depending on the level of depolarization it can lead to apoptosis in 
accordance with increased ROS production and ATP loss (Bossy-Wetzel et al., 
1998). Therefore, it is assumed that since ROS was not elevated after exposure 
to the 50:50 AuNPs but membrane depolarization was evident, probably the level 
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of membrane potential alteration was not high enough to trigger the intrinsic 
apoptotic pathway.  
 Recent published research demonstrated the association of AuNPs with 
cell cycle arrest without the induction of necrosis or apoptosis. Ramalingan and 
colleagues indicated that biogenic AuNPs induced cell cycle arrest via oxidative 
stress and mitochondrial membrane alterations in A549 lung cancer cells 
(Ramalingan et al., 2016). In this study, no cell cycle arrest was observed with 
the 50:50 AuNPs neither with the 3h acute nor with the longer 24h exposure. 
5.3.1 Limitations of the experimental design 
5.3.1.1 Choice of time-points/time-course 
 As described in the chapter introduction, cell death is a highly complex 
process, which is characterized by a range of biochemically and morphologically 
distinct pathways. Many of the markers used to characterise e.g. apoptosis only 
show a transient, rather than a sustained increase. For instance, in Jurkat cells, 
caspase 8 activity peaks after around 3 hours, whereas caspase 3/7 peaks after 
around 7 hours (Sandquist et al., 2006). Consequently, cell death events and 
their timings are highly dependent on the cell type, apoptosis-inducing agent, 
exposure time and its concentration. Also, the same population of cells can 
undergo apoptosis at different time-points due to differences in the cell cycle 
phases of individual cells.  
 It is therefore possible that the markers chosen to characterise the type of 
cell death mechanisms in this study were the right ones, but the fact that very few 
changes were measured could be due to the wrong time points being chosen (for 
the chosen concentration of AuNPs). Therefore, the choice of the time-points 
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might represent a limitation of the experimental design. For future studies, it is 
crucial to initially determine the time-points at which the activity of interest peaks 
at the chosen AuNP concentration. Careful interpretation of the data is of great 
significance, as the absence of a change or a low signal could be misinterpreted 
as no apoptosis or necrosis induction occurring, rather than a time-point being 
missed.  
5.3.1.2 Cell line 
 Also, the range of cell death assays presented in this chapter have been 
only examined on HSC cells, as this was the main cell line of the focus of this 
thesis. Depending on the cell line and cell type, some cell death events may be 
underestimated due to the cell line not expressing a protein or a receptor required 
for the induction of e.g. extrinsic apoptosis. For instance, MCF-7 cells lack a 
functional caspase 3 product thus assays detecting caspase 3/7 activity using 
DEVD substrate, will produce no signal (Kroemer et al., 2005).  
5.3.1.3 AuNP concentration and exposure time 
 As mentioned above, the concentration and exposure time of the cell 
death-inducing agents, in this case, the AuNPs, can influence the type of stimulus 
produced and the mechanism of cell death. A less intense stimulus is triggered 
with low drug concentrations and shorter exposure times. With a longer exposure 
time, a compound’s IC50 value decreases, meaning that it has higher toxicity 
(Riss and Moravec, 2004). For instance, applying high concentrations of 
tamoxifen on HepG2 cells, generated a caspase 3 activation within 1-2 hours, as 
opposed to lower concentrations of tamoxifen which triggered a caspase 3 
response only after 24 hours (Sandquist et al., 2006). The values of 10 μg/ml 
AuNP and 3h acute exposure time were chosen based on the toxicity assays 
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performed in clonogenic assays (chapter 3), representing double the estimated 
IC50 values derived from it.  
5.3.1.4 Cell culture conditions and cell density 
 The discrepancy in the large extent of cell death observed in the 
clonogenic assays performed in chapter 3 and the low amount of cell death noted 
in this chapter caused to consider what parameters differed between the 
experiments. The most obvious one was that for the experiments presented in 
this chapter, the cells were cultured at a higher density compared to the 
clonogenic assays. A high cell number of HSC cells appeared to deliver a 
protective effect towards the toxic AuNPs, leading to a decreased signal observed 
in all the assays. The role of cell density in the toxicity of nanoparticles has also 
been shown by previous studies (Elias et al., 2013). A study of different 
concentrations of tamoxifen on different densities of HepG2 cells showed that 
drug potency increased with lower cell densities (Riss and Moravec, 2004).  
 In conclusion, a possible extrinsic apoptotic mechanism was noted with 
the 50:50 AuNPs. No ROS production or cell cycle arrest was noted. 
Mitochondrial membrane depolarization was evident 48h after the acute 
exposure. Data need to be interpreted with caution to avoid leading to false 
conclusions. The choice of assays presented above intended to deliver a broad 
overview of the possible basic processes involved during a cell death event. If 
time allowed, a different approach would have been adopted for the experimental 
design without assuming that the IC50 value obtained by clonogenic assays will 
translate in a similar way to another experimental set up, this of the cytometry. 
However, an important aspect was raised in this chapter when performing toxicity 
assays, this of the cell density role in AuNP toxicity.     
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6 Chapter 6: Evaluation of AuNP Toxicity in a Range of 
Cancer and Normal Cell Lines 
6.1 Introduction 
Different tumour types are characterized by genetic and epigenetic 
variations depending on their tissue origin leading to differences in clinical 
outcomes. These variations render the cancer mechanism of action difficult to 
understand (Vargo-Gogola and Rosen, 2007). To enhance this understanding, 
various experimental models have been developed. These models include 
primary tumours (Burdall et al., 2003), genetically engineered mice (Vargo-
Gogola and Rosen, 2007), xenografts (Leonetti et al., 2006), paraffin embedded 
samples, primary cell and 3D cultures (Lacroix and Leclercq, 2004) and cancer 
cell lines (Staveren et al., 2009).  
Various types of cell lines are used in in vitro experiments as 
representative models of a cancer or a normal cell due to their ease of handling 
and molecular characterization, overcoming the limitations that exist with other 
models. Some of these limitations are the ethical approval of animal use, 
manipulation and characterization analysis (Staveren et al., 2009, Engel et al., 
1978). In this chapter, the toxicity of different cancer cell lines and associated 
normal cells after an acute 3h exposure of the AuNPs will be presented.  
6.1.1 Cancer cell lines as an experimental model in cancer therapy 
  Cancer cell lines are extensively studied for the effectiveness and the 
development of anti-cancer drugs (Yamori, 2003, Gazdar et al., 2010) or for 
identification of the phenotypic properties and biology of cancer such as migration 
capacity and proliferation rates (Kim et al., 2004). Other studies have shown the 
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use of cancer cell lines for the investigation of cellular pathways and genetic 
alterations or for screening of a possible biomarker for diagnostic purposes 
(Ferreira et al., 2013).  
6.1.1.1 Advantages and disadvantages of cell lines in cancer research  
Many advantages are associated with the use of cell lines in cancer 
research. They are easily genetically modified using siRNA, demethylation 
agents or expression vectors (Leone et al., 2003, Kawasaki et al., 2004). The 
main advantage is the creation of a well-characterized “library” of cells that can 
be used by different laboratories for results to be easily comparable. Also, if any 
contamination occurs during the experimental procedure, there is a possibility of 
substitution and maintenance of reproducible results if following the same 
experimental set up. The most important disadvantage that exist with their use is 
the genomic instability noted between the original tumour and the representative 
cell line (Anglard et al., 1992).  
During continuous cell cultures, a phenotypic and genotypic drift might be 
possible if the correct conditions are not maintained (Vargo-Gogola and Rosen, 
2007). Also, some cell lines might have been cross-contaminated and 
mycoplasma infections are recurrent. Lastly, the microenvironment of a cell 
culture differs from the original tumour which lead to a greater heterogeneity and 
morphological/molecular changes (Bright et al., 1997). Some of these 
disadvantages can be overcome by the use of other experimental model systems 
as discussed above. However, the use of cancer cell lines represents the most 
valuable tool as a first approach for a drug screening and effectiveness, which is 
the main focus of this chapter.  
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Despite the essential value of the use of cell lines in cancer studies, 
controversial research exists about their relevance as representative models of 
an original tumour (Lacroix and Leclercq, 2004, Wistuba et al., 1998). On one 
hand, there is an agreement that there is a genomic similarity of cancer cell lines 
with the original tumour they derived from (Fang et al., 2009). During the first cell 
culture passages, cancer cell lines retain the same molecular and morphological 
features as the primary tumour (Wistuba et al., 1998). Angiogenesis induction 
differs between the cell line and the tumour as stromal tissues presence is 
required. A study by Tomlinson et al., presented early evidence of the similarity 
argument. They reported that a breast cancer cell line shares a range of features 
with the original tumour, such as the same allelic loss and BRCA1 mutation 
(Tomlinson et al., 1998). On the other hand, many reports have shown that 
cancer cell lines undergo extensive oncogene mutations, chromosomal 
rearrangements, gene amplification and allelic loss (Kao et al., 2009, Gazdar et 
al., 2010). As a result, prolonged period of cell culturing, leads to phenotypic and 
molecular alterations and cellular pathways modifications (Ferreira et al., 2013).  
6.1.1.2 Comparison between cancer and normal cell lines in cytotoxicity 
drug testing 
 The use of cell lines allows for cytotoxicity evaluation of specific drug 
candidates, understanding of a drug’s mechanism of action and signalling 
pathways activation, biomarker identification, dose responses and screening of 
sensitivity/resistance profile for different cell types. Comparability between 
different tests even months apart can be achieved by using batches of cells 
stored at the same passage. The outcome is cell line dependent as some cell 
types are more sensitive or resistant than the others (Ferreira et al., 2013) (Table 
6.1). For instance, 60 nm cationic polystyrene nanosphere particles were toxic to 
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macrophages, whereas the same particles were less toxic to hepatoma and 
human microvascular endothelial cells (Xia et al., 2008).  
Table 6.1: Comparison between the different published studies of AuNPs 
on cancer versus normal cell lines. 
Size 
(nm) 
Shape Coating Exposure Time Toxicity Cell 
line 
Ref. 
Cancer cell lines 
1.4 Spherical 
cluster 
Ph2PC6
H4SO3H 
< 0.4 mM 24h IC50 0.24 
μM 
IC50 0.30 
μM 
MV3, 
BLM 
Tsoli et 
al., 2005 
4, 
12, 
18 
Spheres CTAB, 
citrate, 
cysteine, 
glucose, 
biotin 
0.001-0.25 
μM 
72h MTT 
assay, 
CTAB-
NPs 18 nm 
not toxic 
up to 25 
μM 
K562 
human 
leukemi
a 
Connor 
et al., 
2005 
50, 
20 
Rods CTAB, 
PEG, 
anti-
HER2 
0.06 nM 24h ICP-MS, 
AuNPs/cel
l 
(8,000 for 
CTAB, 
3,000 for 
PEG, 
4,400 for 
anti-
HER2) 
non toxic 
SK-BR-
3 
Cho et 
al., 2014 
35.9 
± 6.7 
Spheres Cetuxim
ab 
antibody 
100 nM - AuNPs not 
toxic for 
cama-1, 
cell death 
for Panc-1 
(IC50 ~ 
100 nM) 
and via a 
necrosis 
pathway 
Panc-1 
Cama-
1 
Glazer et 
al., 2010 
3.7  Spheres PEG 0.08-100 
μM 
6-72h Low 
toxicity 
(70% 
viability 
after 72h 
of up to 10 
μM AuNPs 
exposure) 
HeLa Gu et al., 
2009 
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33 Spheres CTAB 
and 
citrate 
0-120 nM 48h No toxicity 
for this cell 
line 
HepG2 Patra et 
al., 2007 
40x1
8 
Rods CTAB 1 nM 6h Slight 
toxicity at 
150 μM in 
serum free 
media 
(20.8 % 
cell death) 
HeLa Hauck et 
al., 2007 
Normal cell lines 
33 Spheres CTAB 
and 
citrate 
0-120 nM 48h No toxicity 
observed 
for BHK21 
up to 120 
nM 
BHK21 Patra et 
al., 2007 
1.5 Spheres MEEE, 
TMAT 
0-100 
μg/ml 
25 μg/ml 
6-24h LD50 < 10 
μg/ml for 
TMAT and 
LD50 = 25 
μg/ml for 
MEEE 
HaCaT Schaeubl
in et al., 
2011 
15 Spheres - 51 – 561 
ng/cm2 
4- 
24 h 
No 
induction 
of 
oxidative 
stress or 
inflammat
ory 
response 
MDM, 
MDCC 
Branden
berger et 
al., 2010  
13, 
45 
Spheres - Up to 180 
μg/ml 
3 to 6 
days 
75% and 
100% cell 
death by 
apoptosis 
pathway 
after 45 
nm AuNPs 
exposure 
at 25 
μg/ml for 3 
days and 
from 20 
μg/ml for 6 
days. 
CF-31 
primary 
dermal 
human 
fibrobla
st 
Mironava 
et al., 
2010 
 
 
Normal cells undergo apoptosis, a programmed cell death for the removal 
of senescent or damaged cells and for tissue remodelling. Also, they divide by 
signals sent from adjacent cells and communicate via gap junctions in their cell 
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membranes with neighbouring cells (Bhowmick et al., 2004). Cancer cells on the 
other hand, are resistant to apoptotic signals, they divide uncontrollably and have 
lost gap junctions. Moreover, normal cells can repair any DNA damage as 
opposed to cancer cells which allow mutations to accumulate often accompanied 
by chromosomal alterations such as gene amplifications, deletions, 
translocations (Lowe et al., 2004). 
Cellular senescence is a feature of normal cells indicating that there is a 
limit in the number of cell divisions any cell type can undergo (Collado et al., 
2010). Cancer cells indefinitely divide. During cell division, telomerase enables 
telomere replication, which in normal cells shortens after every cell cycle (Evan 
and Littlewood, 1998). Cancer cells constitutively express telomerase, 
maintaining the length of telomeres.  
 In the next section of this chapter, the cytotoxicity of the 50:50 
αGal:PEGamine AuNPs is presented in a range of cancer and normal cell lines.  
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6.2 Results 
 The cytotoxicity of the 50:50 αGal:PEGamine AuNPs was evaluated in a 
range of cancer and corresponding normal cell lines. As discussed in chapter 3, 
clonogenic assays were used to determine the cytotoxic potential of the AuNPs 
in HSC and HaCaT cell lines. However, the same assay could not be used for 
other cell types as they do not have the ability to grow in colonies needed for a 
clonogenic assay. Therefore, an assay similar to the clonogenic assay was 
conducted for the range of cell lines tested, which was the CyQUANT cell 
proliferation assay. Both assays measure the proliferative capability of cells after 
an acute 3h exposure to AuNPs.  
CyQUANT is an assay that accurately measures the proliferation rate of a 
cell population based on cellular DNA content and can be used as an indicator of 
cytotoxicity. It is a highly sensitive, accurate and fast way of analysing the number 
of cultured cells in a microplate set up as it can detect as few as 10-50 cells 
remaining on the plate (Jones et al., 2001). This assay is independent of the 
metabolic state of cells, generating steady fluorescent signal across a range of 
cell types and conditions (Jones et al., 2001).  The results presented below from 
CyQUANT assays were a result of a time-course and do not represent an end-
point toxicity. An end-point of day 6 is also presented and compared between the 
cell types tested to mimic the time-point at which the clonogenic assays were 
performed. The time-course provided complimentary information into the timing 
of cell death and allowed to distinguish between a cytostatic or cytotoxic potential 
of the AuNPs. A comparison between the control and the highest concentration 
AuNP for all cell lines is also depicted in a bar chart towards the end of this 
section. 
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In the CyQUANT assays, fluorescence intensity was measured which 
relates to the amount of DNA remaining in the well after exposure to AuNPs. To 
translate this value into cell number measurements, a standard curve relating the 
fluorescence intensity to the actual cell number was plotted. The standard curve 
was only conducted for HSC cells and is presented below (Figure 6.1). Within this 
study it was attempted to directly correlate the cell proliferation and amounts of 
DNA between the cell lines. The cells were seeded at different confluences and 
allowed to attach to the plates for a minimum of 6h before fixation by freezing as 
required by the assay protocol. This should not have allowed sufficient time for 
the cells to divide, but either loss of non-attached cells, or cell division could affect 
the accuracy of the results. Therefore, it was concluded that an accurate estimate 
of the cell number based on measurements of fluorescence intensity was not 
possible and the data will be presented as changes in the fluorescence 
normalised to the number of seeded cells. 
 
Figure 6.1: Standard curve to correlate the number of HSC cells with the 
fluorescence measured in the CyQUANT assay. Data were obtained on the 
day of seeding and were expressed as mean±SEM, n=1 with 3 replicates. Dotted 
lines represent 95% CI. 
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A list of all the cell lines and their origin investigated in this chapter are 
presented in chapter 2 (Table 2.2). The tissue types examined include skin 
(HSC/HaCaT), breast (MCF-7/HMEC), kidney (A498/HEK-293), brain (U-
373/hA), cervical (HeLa) and colorectal (Caco-2). Their choice was based on the 
fact that they represent cells from possible target organs for AuNPs toxicity. The 
focus of this analysis was to test a range of cancer and corresponding normal cell 
lines in vitro from different tissue types throughout the body in order to determine 
the cytotoxic potential of the AuNPs. Therefore, the above cell lines were 
considered a good in vitro model for a general screening of the AuNPs toxicity. 
Also, the availability and easy access to these cell types as they were taken from 
The Open University bank of cells was an advantage.  
CyQUANT assays were performed every day for a time-course of 6 days. 
The concentrations of the AuNPs used were 0, 5 and 10 μg/ml. These 
concentrations were chosen according to the maximum concentration used in 
clonogenic assays in chapter 3, which resulted in < 5 colonies left after an acute 
3h exposure of the 50:50 αGal:PEGamine AuNPs. 
6.2.1 HSC/HaCaT skin cancer and human keratinocyte cell lines 
 Regarding the skin cancer HSC and normal keratinocyte cell lines, a 
selective toxicity was noted throughout the time-course of the assay. Specifically, 
in HSC cells AuNPs at 10 μg/ml were toxic from day 1 (Figure 6.2A) and 
fluorescence intensity remained at a baseline level, as opposed to the normal 
growth observed for HaCaT cells for the same concentration (Figure 6.2B).  
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6.2.2 MCF-7/HMEC 
 For the breast cancer MCF-7 and mammary epithelial HMEC non-
cancerous cells, the results were similar with regard to the different 
concentrations of AuNPs. Compared to untreated controls, the highest AuNPs 
concentration increased the toxicity ~2 fold for both the MCF-7 and HMEC cells. 
The pattern of fluorescence intensity for the MCF-7 throughout the days was 
inconsistent. For the HMEC cell line, an increase in fluorescence was noted 
throughout the time-course (Figure 6.2C&D).  
6.2.3 A498/HEK-293 
 The kidney cancer and normal cell lines, A498 and HEK-293 appeared to 
be less affected by the AuNPs in terms of their fluorescence and cell number. For 
the A498 cell line, a pattern of exponential growth and increase in fluorescence 
was noted, with both 5 and 10 μg/ml AuNPs concentration to have a slight effect 
from day 2, leading to a decrease in fluorescence intensity without causing a 
stationary result, but allowing cells to proliferate (Figure 6.2E). Data for HEK-293 
showed an increase in fluorescence intensity with 10 μg/ml AuNPs concentration, 
plateauing from day 5 to day 6 (Figure 6.2F).   
6.2.4 U-373/hA astrocytes 
 For the U-373 and primary astrocytes hA cell lines, the toxic potential of 
the AuNPs was not evident. Both cell lines were not affected by the AuNPs, with 
no change in fluorescence to be observed for U-373 from day 1 to day 2 for both 
5 and 10 μg/ml AuNPs concentration as opposed to the control cells (Figure 
6.2G). hA astrocytes growth appeared to be much slower as compared to any 
other cell line (Figure 6.2H). 
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Figure 6.2: Cell proliferation assays throughout a 6 day time-course on a range of cancerous and normal cell lines after an acute 
3h exposure of 50:50 αGal:PEGamine AuNPs at 0, 5, and 10 μg/ml.  The cell lines tested included A. HSC, B. HaCaT, C. MCF-7, D. 
HMEC, E. A498, F. HEK-293, G. U-373 and H. hA astrocytes. The fluorescence measured for each well was normalized to the 
corresponding seeding density and the calculated factor was plotted as a measure of the relative number of cells. Data were plotted as 
mean±SEM from 3 independent experiments, with n=3 per condition.
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6.2.5 Caco-2 and HeLa  
Two additional types of cancer cell lines were also examined. Caco-2 and 
HeLa do not represent a pair of cancer and corresponding normal cell lines tested 
but were evaluated for the potential toxicity of AuNPs. They both showed a similar 
response to AuNPs. Data for the Caco-2 cell line indicated that this type of cell 
line was not affected by the AuNPs exposure and there was an increase of 
fluorescence intensity observed throughout the time-course (Figure 6.3A). On the 
other hand, data for HeLa cells, showed a slight inconsistent decrease in 
fluorescence between day 3 and day 5, with cells to recover any toxic potential 
of the highest concentration AuNPs (Figure 6.3B).   
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Figure 6.3: CyQUANT cell proliferation assay throughout a 6-day time-
course on A. Caco-2 and B. HeLa cells after an acute 3h exposure of 50:50 
αGal:PEGamine AuNPs at 0, 5, and 10 μg/ml. The fluorescence measured for 
each well was normalized to the corresponding seeding density and the 
calculated factor was plotted as a measure of the relative number of cells. Data 
were plotted as mean ±SEM from 3 independent experiments, with n=3 per 
condition.  
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 A comparison of the toxicity caused by the highest concentration of AuNPs 
on day 6, a time-point similar to the endpoint of the clonogenic assays presented 
in Chapter 3, is shown below (Figure 6.4). This allows a comparison of the 
significance of the cytotoxic potential of AuNPs long term after an acute 3h 
exposure as performed in this chapter using the CyQUANT assay. These data 
depicted that 6 days after an acute 3h AuNP exposure, the different cell types 
were differently affected by 10 μg/ml AuNPs. Specifically, HSC, MCF-7, HMEC, 
A-498 and HEK-293 cells showed a lack of proliferation ability caused by AuNPs 
exposure, whilst the rest of the cell lines tested were not affected.  
 
Figure 6.4: Comparison of cytotoxicity of AuNPs after an acute 3h exposure 
to 0 and 10 μg/ml at day 6 of a time-course for CyQUANT cell proliferation 
assay. Results were plotted as fluorescence intensity/seeding density and as 
mean±SEM from 3 independent experiments, with n=3 per condition. Two-way 
Anova, Sidak’s multiple test, **** P<0.0001, ***P<0.001, **P<0.01 
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6.3 Discussion 
A variety of cancer and normal cell lines were investigated for the toxic 
potential of 50:50 αGal:PEGamine AuNPs at 0, 5 and 10 μg/ml. These 
concentrations were chosen from previous assessments on cytotoxicity of these 
particles. CyQUANT cell proliferation assays showed that AuNPs were toxic for 
some of the cell lines whereas others remained unaffected. In summary, 
proliferation of HSC, MCF-7, HMEC, A498 and HEK-293 cells (Figure 6.4) was 
affected at the highest concentration of 10 μg/ml AuNPs, whereas HaCaT, Caco-
2, HeLa, U-373 and hA cells did not show any significant decrease in their 
normalized fluorescence intensity value throughout the 6 day time-course after 
an acute 3h AuNP exposure.  
The results obtained for the different cell lines were expressed as 
normalized fluorescence intensity/seeding density. Cells were seeded at different 
densities at day 0 of the experiment because of their different proliferation rates. 
Cell proliferation refers to the increase of cell number over time and is a result of 
a balance between cell divisions and cell death (Cooper, 2000). Cancer cells 
have increased proliferation rates (Tubiana, 1989). Therefore, the goal was to 
achieve ~80% confluency on day 6 at the end of the time-course and cell 
densities for each cell type were adjusted accordingly. Plotting the fluorescence 
intensity without converting it to cell number for each time-point in the time-course 
is acceptable according to other studies and literature searches. Specifically, 
effects on cell proliferation have been used as a measure to evaluate the 
cytotoxic potential of compounds. A number of fluorescence based assays have 
been widely used in order to determine the cell proliferation capacity of cells. 
These assays are based on the DNA content of cells, their metabolic activity or 
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cell division (Cooper, 2000, Salic and Mitchison, 2008, Duellman et al., 2015, 
Mosman et al., 1983).  
On the other hand, many studies have examined the cytotoxic potential of 
nanoparticles by the use of techniques such as MTT or alamarBlue reagent which 
measures the reductive ability of cells (Berridge and Tan, 1993). Cell cycle 
distribution studies have also been utilized mainly for detecting alterations in 
growth patterns of cells (Kurowaka et al., 2008). Advantages and disadvantages 
of each method are not the focus of this section, thus it is not discussed in more 
detail. However, as a concluding remark CyQUANT was chosen based on 
literature searches as the most robust, sensitive and fast to perform method. Also, 
its protocol has minimal interference with any other substance and experimental 
design required straight-forward characterization of reagents concentrations and 
incubations times (Jones et al., 2001).  
Another point that needs to be mentioned is that the fluorescence intensity 
level measured in control cells, not treated with AuNPs, varied between the cell 
lines. Such effect could be attributed to firstly, different cell types having different 
amounts of DNA and secondly, it could be dependent on their stage of cell cycle. 
Cells at G0/G1 phase have one set of paired chromosomes/cell, in the S phase 
the amount of DNA varies due to DNA synthesis and in the G2/M phase there are 
two sets of paired chromosomes prior to cell division (Cooper, 2000).  Depending 
on the phase of cell cycle, different amount of DNA was measured in the samples. 
Therefore, comparisons within the cell type being investigated were presented 
for the control and treated with AuNPs sample, without comparing differences 
between cell lines.  
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6.3.1 AuNPs toxicity in a range of normal and cancer cell lines 
 As presented above, a cell type dependent toxicity was observed with 
some of the cell lines to be affected and some others not. Such effect is in 
agreement with other studies that showed the same pattern (Sohaebuddin et al., 
2010). Most of the research on this area is published for silica nanoparticles and 
not for AuNPs in vitro. A previous study suggested that differences in cytotoxicity 
of silica nanoparticles between cell lines could be due to the differences in their 
metabolic and proliferation rates (Chang et al., 2007). Another study that 
discussed the cytotoxic effects of 15, 60 and 200 nm silica nanoparticles on A549, 
HaCaT, THP-1 and NRK-52E proposed that toxicity is both cell and nanoparticle 
size dependent (Hsiao et al., 2014). They depicted that HaCaT cells were tolerant 
due to lower uptake of NPs (Hsiao et al., 2014).  
Other studies such as this of Nabeshi et al., has correlated NP uptake with 
toxicity (Nabeshi et al., 2010). As shown in chapter 3, HaCaT cells were also not 
affected in this study, confirming the data from published research showing that 
epithelial cells or tumour cells are less sensitive to phagocytic or fibroblast cells 
for silica nanoparticles (Lanone et al., 2009). No selective toxicity pattern was 
observed in any cell line other than HSC and HaCaT cells and in a smaller 
degree, MCF-7and HMEC. A discussion of the possible features that could play 
a role in the sensitivity and resistance of the cell lines is attempted below.  
As previous studies have shown and are cited above, the amount of Au 
inside the cells could play a role in their toxicity. However, it was evident in 
chapter 4 that amount of Au did not correlate with toxicity. Instead the amount of 
AuNPs sticking to the cell surface via filopodia was. Due to time limitations, the 
actual amount of Au inside the cells was not counted in each cell line. However, 
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data presented for HSC cells, showed that the number of filopodia and the AuNPs 
sticking to them play an important role in the toxicity of these AuNPs. Not a lot of 
research has investigated the filopodia density in different cell types. In cancer 
cell lines, increased filopodia protrusions have been observed (Jacquemet et al., 
2017).  FiloQuant is an automated tool utilized to obtain information on filopodia 
dynamics, length and density (Jacquemet et al., 2017).  It is the only example 
found for an assay that measures filopodia dynamics and density. When being 
applied to a range of cell types, an increased filopodia density was shown in MCF-
10 breast cancer cells (Jacquemet et al., 2017). In order to assess the validity of 
the theory, that filopodia density could be correlated to toxicity in vitro, FiloQuant 
analysis should be applied to the range of cell lines tested followed by TEM 
counts of AuNPs in cells.  
Another theory that could explain why different cells appeared to be more 
or less sensitive to the AuNPs toxicity could be the localization and the type of 
internalization/uptake mechanism of the AuNPs and the mechanism of cell death 
that was triggered. For example, silica nanoparticles have been tested for their 
cytotoxic potential in HUVEC and HeLa cells, showing differential responses to 
the cell types examined and attributing this effect to potential differences in their 
uptake and localization (Blechinger et al., 2013). Also, the function of each cell 
type and the properties of the nanoparticles interacting with their cell surface 
could be of vital significance to how toxic these particles are.  
Lastly, there is another cell structure apart from filopodia that is important 
for the contact of particles with the cell membrane, this of glycocalyx. The 
glycocalyx is a structure of glycolipids and glycoproteins on the outside of the cell 
membrane, which contributes to cell communication, recognition and adhesion 
(Reitsma, 2007). The thickness of the glycocalyx is dependent on the cell type 
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(Tarbel and Cancel, 2016). Specifically, cancer cells are found to have thicker 
and more robust glycocalyx than normal cell types (Tarbel and Cancel, 2016). 
This structure could be of great importance for the interaction of AuNPs with the 
cell membrane or the internalization of the particles into the cells and could thus 
explain any differential toxicity observed between the cell lines.  
To conclude, a range of cell lines have been tested for the AuNPs toxicity. 
In general, the heterogeneity of each cell line is a complex topic and multiple 
factors can be responsible for the variation in the toxicity of AuNPs observed 
between the cell lines. An important issue has to be mentioned with regard to the 
cell lines being taken from The Open University’s liquid nitrogen bank. The 
significance of any cell line characterization prior to experiments is vital in order 
to avoid data misinterpretation. Such significance is noted by Horbach and 
Hallfman, who illustrated that misidentification of cell types has led to 
approximately 32,755 published articles to contain data from mislabelled or 
cross-contaminated cell lines (Horbach and Hallfman, 2017).  
Lastly, the cytotoxic potential of the 50:50 αGal:PEGamine AuNPs was 
investigated in a range of cell lines but it can be concluded that depending on the 
cell type, these particles can be used either as a toxic agent at a concentration of 
around 10 μg/ml or as a drug delivery agent below that concentration to ensure 
no toxic potential of the drug carrier for specific cell types.  
  
 163 
 
7 Chapter 7: Conclusions and Future Directions 
Despite important breakthroughs in cancer biology throughout the years, 
cancer remains a challenge and a leading cause of death worldwide. The 
importance of nanomedicine and utilizing formulations at the nano-scale level 
which selectively cause toxicity on cancer cells without affecting the normal cell 
lines, was highlighted by Patra et al., which described how AuNPs induced 
selective responses between a human carcinoma lung cell line, a baby hamster 
kidney cell line and a human hepatocellular liver carcinoma (Patra et al., 2007). 
The work presented in this thesis has contributed to the field of nanomedicine 
by a) identifying key parameters during the synthesis of AuNPs that play a 
significant role in their toxicity, such this of their synthesis time and ligand density, 
b) flagging an issue of batch variability and how it should be addressed to avoid 
any data misinterpretation, c) demonstrating the uptake of AuNPs by skin cancer 
cells and their preference to bind to filopodia, d) providing an insight into the 
mechanism of cell death caused by AuNPs and e) increasing the understanding 
that toxicity of nanomaterials is cell type dependent.  
 In chapter 3, the cytotoxicity of 2 nm αGal:PEGamine AuNPs was 
presented. Firstly, a batch variability issue was identified regarding the differential 
toxicities of the AuNPs on HSC and HaCaT cells, based on their IC50 values as 
obtained by clonogenic assays. A series of experiments were designed in a way 
to unravel the factor responsible for the variability detected. By eliminating and 
narrowing down factors, a novel feature was identified that played a significant 
role in the toxicity of these AuNPs, this of their synthesis time (Figure 3.11).  
In chapter 4, the focus was on three AuNPs, with synthesis times of 1h, 2h 
and 5h. Full physicochemical analysis was conducted, with the only difference 
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noted between them to be the ligand density surrounding the Au core.  Increasing 
synthesis time led to a less dense ligand packed particle. Uptake by HSC cells 
was also examined and a remarkable adhesion of the AuNPs to filopodia was 
discovered under TEM (Figure 4.14). Gromnicova et al., showed that the same 
αGal:PEGamine AuNPs were internalized via an active transport mechanism, 
thus further studies into the uptake of these nanoparticles involving chemical 
inhibitors did not follow (Gromnicova et al., 2016).  
In chapter 5, an attempt to distinguish between the apoptotic and necrotic 
cell death mechanisms was presented. Cytotoxicity of the AuNPs was prevented 
by co-incubation with a caspase 8 inhibitor, but with not a caspase 9 inhibitor, 
suggesting a possible extrinsic apoptotic mechanism of cell death (Figure 5.7). 
The role of cell density was evaluated, indicating that the toxicity of the AuNPs 
was affected by this factor (Figure 5.11). 
In chapter 6, the cytotoxicity of the 50:50 αGal:PEGamine AuNPs was 
tested in a range of cancer and normal cell lines. Data presented in this part of 
the thesis illustrated that depending on the cell type, these particles can either be 
used as a toxic agent at a concentration of around 10 μg/ml or as a drug delivery 
agent below that concentration to ensure no toxic potential of the drug carrier.  
Limitations of this study were analysed and discussed throughout the 
various chapters. The main limitations can be summarized into the following 
statements: 
- Batch variability consisted a major challenge at the beginning of the 
project. This thesis led to identification of the parameters producing 
such variability. Full physicochemical characterization and control of 
the AuNPs synthesis process can minimize batch to batch variations. 
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Also, moving production of the AuNPs to continuous flow processing 
could ensure consistent manufacturing of the particles.  
- The reason of the choice of experimental assays and design was 
analysed in appropriate parts throughout the thesis. However, 
limitations might exist regarding types of assays used, incubation 
times, seeding densities and choice of time-courses, especially for 
unravelling the mechanism of cell death.  
- Characterization of cell lines presented on chapter 6 and cellular 
maturation test was out of the scope of this study, but the importance 
of it was highlighted by Horbach and Halffman due to the significant 
amount of published data based on misidentified cell types (Horbach 
and Halffman, 2017).  
Future directions include the identification of the AuNP concentration 
appropriate for the cell death assays and repetition of the experiments presented 
in chapter 5 for a clearer illustration of the mechanism of cell death. Also, a better 
insight into the role of filopodia and the cell type needs to be gained. Lastly, 
evaluation of whether AuNPs can either be utilized as drug delivery agents or 
toxic agents at a specific concentration, dependent on cell type, needs to be 
confirmed.   
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9 Appendix  
 
 
Figure 9.1: High resolution XPS spectra of A. Au 4f and B. S2p peaks. i) 1h 
synthesis, ii) 2h, iii) 5h synthesis AuNPs. The expected positions for the Au(I) 
and Au(0) states are at around 84.6 eV and 83.6 eV for the Au 4f7/2 peak. The 
expected position for the sulfide S 2p3/2 peak is at around 162.7 eV and S-O 
bonds at around 168.0 eV. Calculated S:Au ratios: 1h=0.054, 2h=0.048, 5h= 
0.047. 
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Figure 9.2: EDX spectra of 1h AuNP.  % Wt element was analysed to obtain 
S:Au ratio for the determination of lihand density surrounding the Au core. S value 
was at baseline level. 
 
     
 
Figure 9.3: Silver staining of 1h and 5h synthesis time AuNPs after an acute 
3h exposure at 40C degrees on HEK-293 and A498 cells. Pictures are taken 
under a light microscope at 40x objectives and only silver staining channel is 
shown. Scale bar=500nm.   
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Figure 9.4: Quantification based on TEM images of silver enhanced 1h and 
5h synthesis time AuNPs  after an acute 3h exposure of 10 μg/ml on HaCaT 
cells.  A. At 370C, B. at 40C, C. with +/- fascin for 1h AuNPs and D. +/- fascin for 
the 5h AuNPs. Quantitation of AuNP counts was conducted per micron2 for 
nucleus and cytoplasm (left axis) and AuNP counts per micron for cell surface 
(right axis, bars with red border). n=1 with two technical replicates per condition.  
 
Figure 9.5: Representation of the percentage AuNPs of 1h and 5h synthesis times 
sticking to filopodia or cell surface for A. HaCaT cells, B. HSC cells, C. % filopodia 
decorated with AuNPs on HaCaT cells and D. % filopodia decorated with AuNPs on HSC 
cells. n=1 with two technical replicates per condition. 
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Figure 9.6: Fluorescence intensity measurements of ROS Brite on HSC cells for 
the investigation of ROS generation after an acute 3h exposure of AuNPs at 10 
μg/ml and 20 μg/ml. TBHP was used as a positive control and various concentrations. 
The measurements were obtained by FluoStar fluorescence microplate reader at 
Ex556/Em 566 nm. n=1. 
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Figure 9.7: Fluorescence intensity measurements of ROS Brite on HSC cells 
after an acute 3h exposure of AuNPs at 10 μg/ml. The measurements were 
obtained by FluoStar fluorescent microplate reader at 556/566 nm at specific 
time-points of 3, 24 and 48h, throughout a time-course after AuNP exposure. 
TBHP was used as a positive control for ROS production. n=1 pilot experiment, 
with 3 replicates per condition, Error bars=±SEM. 
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Figure 9.8: Spectra of PI/AnnV fluorescence as generated by Tali  after an acute 
3h exposure of AuNPs on HSC cells. A time-course of 72h was followed and included 
3h, 24, 48 and 72h time-points. Staurosporine (St) was used as a positive control. 
 
Figure 9.9: Images of composite channels of PI/AnnV signals as obtained by Tali 
after an acute 3h exposure of AuNPs on HSC cells. Staurosporine was used as a 
positive control. Images were taken at 24h time-point after the acute exposure.  
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Figure 9.10: Spectra of Caspase 3/7 fluorescence as generated by Tali after an 
acute 3h exposure of AuNPs on HSC cells. A time-course of 72h was followed and 
included 3h, 24, 48 and 72h time-points. Staurosporine (St) was used as a positive 
control. 
 
 
Figure 9.11: Images of composite channels of Caspase 3/7 signals  as obtained 
by Tali after an acute 3h exposure of AuNPs on HSC cells. Staurosporine was used 
as a positive control. Images were taken at 24h time-point after the acute exposure.  
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Figure 9.12: Spectra of ROS Brite fluorescence as generated by Tali after an acute 
3h exposure of AuNPs on HSC cells. A time-course of 72h was followed and included 
3h, 24, 48 and 72h time-points. TBHP was used as a positive control. 
 
 
Figure 9.13: Images of composite channels of ROS Brite signals as obtained by 
Tali after an acute 3h exposure of AuNPs on HSC cells. TBHP was used as a positive 
control. Images were taken at 48h time-point after the acute exposure.  
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Figure 9.14: Spectra of JC-10 fluorescence as generated by Tali after an acute 3h 
exposure of AuNPs on HSC cells. A time-course of 72h was followed and included 3h, 
24, 48 and 72h time-points. Staurosporine (St) was used as a positive control. 
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Figure 9.15: Images of composite channels of JC-10 signals as obtained by Tali 
after an acute 3h exposure of AuNPs on HSC cells. FCCP was used as a positive 
control for membrane depolarization. Images were taken at 24h time-point after the acute 
exposure.  
 
 
Figure 9.16: Spectra of cell cycle fluorescence as generated by Tali after an acute 
3h exposure of AuNPs on HSC cells. A time-course of 72h was followed and included 
3h, 24, 48 and 72h time-points. Nocodazole was used as a positive control. 
 
 
 
 207 
 
 
 
Figure 9.17: Determination of caspase 8 activation on HSC cells after an 
acute 3h exposure of AuNPs at 10 μg/ml. Results were quantified via Tali. 
Apo2L was used as a positive control for the activation of caspase 8. A time-
course of 3h, 24h and 48h was conducted. n=1 
 
 
 
 
 
  
 
 
 
 
 
 
 
